<!DOCTYPE html><html lang="en" class="scroll-smooth"><head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Heparin Lmwh Direct Thrombin Inhibitors Thromolytics Warfarin  Antiplatelets - Brain And Scalpel</title>
    <link rel="preload" href="assets/background.jpg" as="image">
    <script src="https://cdn.tailwindcss.com"></script>
    <!-- HLS.js for M3U8 support -->
    <script src="https://cdn.jsdelivr.net/npm/hls.js@latest"></script>
    <style>
        
/* Liquid Glass Morphism Universal Theme - Enhanced & Mobile-First */
:root {
  --glass-bg: rgba(0, 0, 0, 0.6);
  --glass-bg-light: rgba(255, 255, 255, 0.1);
  --glass-bg-medium: rgba(255, 255, 255, 0.15);
  --glass-bg-heavy: rgba(255, 255, 255, 0.2);
  --glass-border: rgba(255, 255, 255, 0.2);
  --glass-border-light: rgba(255, 255, 255, 0.1);
  --text-primary: rgba(255, 255, 255, 0.95);
  --text-secondary: rgba(255, 255, 255, 0.7);
  --text-tertiary: rgba(255, 255, 255, 0.5);
  --accent-blue: #60a5fa;
  --accent-purple: #a855f7;
  --accent-green: #34d399;
  --accent-orange: #fb923c;
  --accent-red: #f87171;
  --accent-yellow: #fbbf24;
}

* {
  margin: 0;
  padding: 0;
  box-sizing: border-box;
}

html {
  scroll-behavior: smooth;
}

body {
  margin: 0;
  min-height: 100vh;
  font-family: system-ui, -apple-system, BlinkMacSystemFont, 'Segoe UI', sans-serif;
  position: relative;
  overflow-x: hidden;
  color: var(--text-primary);
  background-color: #000;
}

/* iOS Background Fix */
body::before {
  content: '';
  position: fixed;
  top: 0;
  left: 0;
  height: 100vh;
  width: 100vw;
  z-index: -2;
  background: url("assets/background.jpg") center center / cover no-repeat;
}

body::after {
  content: "";
  position: fixed;
  inset: 0;
  background: rgba(0, 0, 0, 0.4);
  backdrop-filter: blur(10px);
  -webkit-backdrop-filter: blur(10px);
  z-index: -1;
}

/* Glass morphism components */
.glass {
  background: var(--glass-bg);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid var(--glass-border);
  border-radius: 16px;
}

.glass-light {
  background: var(--glass-bg-light);
  backdrop-filter: blur(15px);
  -webkit-backdrop-filter: blur(15px);
  border: 1px solid var(--glass-border-light);
  border-radius: 12px;
}

.glass-medium {
  background: var(--glass-bg-medium);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid var(--glass-border);
  border-radius: 16px;
}

.glass-heavy {
  background: var(--glass-bg-heavy);
  backdrop-filter: blur(25px);
  -webkit-backdrop-filter: blur(25px);
  border: 1px solid var(--glass-border);
  border-radius: 20px;
}

.glass-card {
  background: rgba(255, 255, 255, 0.08);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid rgba(255, 255, 255, 0.15);
  border-radius: 20px;
  transition: all 0.3s cubic-bezier(0.4, 0, 0.2, 1);
  box-shadow: 0 8px 32px rgba(0, 0, 0, 0.3);
}

.glass-card:hover {
  transform: translateY(-8px);
  background: rgba(255, 255, 255, 0.12);
  border-color: rgba(255, 255, 255, 0.25);
  box-shadow: 0 20px 60px rgba(0, 0, 0, 0.4);
}

.glass-button {
  background: linear-gradient(135deg, rgba(96, 165, 250, 0.8), rgba(168, 85, 247, 0.8));
  backdrop-filter: blur(15px);
  -webkit-backdrop-filter: blur(15px);
  border: 1px solid rgba(255, 255, 255, 0.2);
  border-radius: 12px;
  color: white;
  font-weight: 600;
  transition: all 0.3s cubic-bezier(0.4, 0, 0.2, 1);
  box-shadow: 0 4px 20px rgba(96, 165, 250, 0.3);
  cursor: pointer;
  border: none;
}

.glass-button:hover {
  transform: translateY(-2px);
  box-shadow: 0 8px 30px rgba(96, 165, 250, 0.4);
  background: linear-gradient(135deg, rgba(96, 165, 250, 0.9), rgba(168, 85, 247, 0.9));
}

.glass-button:disabled {
  opacity: 0.5;
  cursor: not-allowed;
  transform: none;
}

.glass-input {
  background: rgba(255, 255, 255, 0.08);
  backdrop-filter: blur(15px);
  -webkit-backdrop-filter: blur(15px);
  border: 1px solid rgba(255, 255, 255, 0.2);
  border-radius: 12px;
  color: var(--text-primary);
  transition: all 0.3s ease;
}

.glass-input:focus {
  outline: none;
  border-color: var(--accent-blue);
  background: rgba(255, 255, 255, 0.12);
  box-shadow: 0 0 20px rgba(96, 165, 250, 0.3);
}

.glass-input::placeholder {
  color: var(--text-tertiary);
}

/* Performance analysis styles */
.performance-card {
  background: rgba(255, 255, 255, 0.08);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid rgba(255, 255, 255, 0.15);
  border-radius: 20px;
  box-shadow: 0 8px 32px rgba(0, 0, 0, 0.3);
}

.score-circle {
  position: relative;
  width: 150px;
  height: 150px;
  margin: 0 auto;
}

.score-circle svg {
  transform: rotate(-90deg);
}

.score-circle .circle-bg {
  fill: none;
  stroke: rgba(255, 255, 255, 0.1);
  stroke-width: 8;
}

.score-circle .circle-progress {
  fill: none;
  stroke-width: 8;
  stroke-linecap: round;
  transition: stroke-dasharray 2s cubic-bezier(0.4, 0, 0.2, 1);
}

.score-text {
  position: absolute;
  top: 50%;
  left: 50%;
  transform: translate(-50%, -50%);
  text-align: center;
}

/* Review question styles */
.review-question {
  background: rgba(255, 255, 255, 0.05);
  border: 1px solid rgba(255, 255, 255, 0.1);
  border-radius: 16px;
  padding: 20px;
  margin-bottom: 20px;
}

.review-question.correct {
  border-left: 4px solid #22c55e;
}

.review-question.incorrect {
  border-left: 4px solid #ef4444;
}

.review-question.not-attempted {
  border-left: 4px solid #6b7280;
}

/* Gradient backgrounds for accents */
.gradient-blue {
  background: linear-gradient(135deg, var(--accent-blue), #3b82f6);
}

.gradient-purple {
  background: linear-gradient(135deg, var(--accent-purple), #8b5cf6);
}

.gradient-green {
  background: linear-gradient(135deg, var(--accent-green), #10b981);
}

.gradient-orange {
  background: linear-gradient(135deg, var(--accent-orange), #f97316);
}

.gradient-red {
  background: linear-gradient(135deg, var(--accent-red), #ef4444);
}

.gradient-yellow {
  background: linear-gradient(135deg, var(--accent-yellow), #f59e0b);
}

/* Navigation button styles */
.nav-btn-not-attempted {
  background: rgba(255, 255, 255, 0.1);
  border: 1px solid rgba(255, 255, 255, 0.2);
  color: rgba(255, 255, 255, 0.7);
}

.nav-btn-current {
  background: linear-gradient(135deg, var(--accent-blue), #3b82f6);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
  box-shadow: 0 0 20px rgba(96, 165, 250, 0.4);
}

.nav-btn-correct {
  background: linear-gradient(135deg, var(--accent-green), #10b981);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-incorrect {
  background: linear-gradient(135deg, var(--accent-red), #ef4444);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-bookmarked {
  background: linear-gradient(135deg, var(--accent-yellow), #f59e0b);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-marked-review {
  background: linear-gradient(135deg, var(--accent-purple), #8b5cf6);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-answered {
  background: linear-gradient(135deg, #6b7280, #4b5563);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

/* Option button styles - REVISED FOR INLINE FEEDBACK */
.option-button {
  background: rgba(255, 255, 255, 0.05);
  border: 1px solid rgba(255, 255, 255, 0.15);
  transition: all 0.3s cubic-bezier(0.4, 0, 0.2, 1);
  position: relative;
  overflow: hidden;
  width: 100%;
  text-align: left;
  padding: 1rem;
  border-radius: 12px;
  color: var(--text-primary);
  cursor: pointer;
  display: flex;
  align-items: center;
  gap: 1rem;
  font-size: 1rem;
}

.option-button:hover {
  background: rgba(255, 255, 255, 0.1);
  border-color: rgba(96, 165, 250, 0.5);
  transform: translateX(8px);
}

.option-button.selected {
  background: linear-gradient(135deg, rgba(96, 165, 250, 0.3), rgba(59, 130, 246, 0.3));
  border-color: var(--accent-blue);
  transform: translateX(8px);
}

#optionsContainer.answered .option-button:hover {
    transform: translateX(0); /* Disable hover effect after answering */
}

#optionsContainer.answered .option-button {
    cursor: not-allowed;
    pointer-events: none;
}

#optionsContainer.answered .option-button:not(.correct):not(.incorrect) {
    opacity: 0.5;
}

.option-button.correct {
    background: linear-gradient(135deg, #22c55e, #16a34a);
    border-color: #22c55e;
    color: white;
    transform: translateX(0);
}

.option-button.incorrect {
    background: linear-gradient(135deg, #ef4444, #dc2626);
    border-color: #ef4444;
    color: white;
    transform: translateX(0);
}

.option-letter {
  background: rgba(255, 255, 255, 0.1);
  border: 1px solid rgba(255, 255, 255, 0.2);
  transition: all 0.3s ease;
  width: 2.5rem;
  height: 2.5rem;
  border-radius: 50%;
  display: flex;
  align-items: center;
  justify-content: center;
  font-weight: bold;
  color: var(--text-primary);
  flex-shrink: 0;
}

.option-button.selected .option-letter {
  background: var(--accent-blue);
  border-color: var(--accent-blue);
  color: white;
}

.option-button.correct .option-letter, .option-button.incorrect .option-letter {
    background: rgba(255, 255, 255, 0.2);
    border-color: rgba(255, 255, 255, 0.3);
}

.option-text {
  flex: 1;
  font-size: 1rem;
  line-height: 1.5;
}

/* Stats bar responsive grid */
.stats-grid {
  display: grid;
  grid-template-columns: repeat(5, 1fr);
  gap: 1rem;
  align-items: center;
  justify-items: center;
}

@media (max-width: 768px) {
  .stats-grid {
    grid-template-columns: repeat(3, 1fr);
    gap: 0.5rem;
  }
  
  .stats-grid > div:nth-child(4),
  .stats-grid > div:nth-child(5) {
    grid-column: span 1;
  }
}

@media (max-width: 480px) {
  .stats-grid {
    grid-template-columns: repeat(2, 1fr);
  }
  
  .stats-grid > div:last-child {
    grid-column: span 2;
    justify-self: center;
  }
}

/* Animations */
@keyframes float {
  0%, 100% { transform: translateY(0px); }
  50% { transform: translateY(-20px); }
}

@keyframes pulse-glow {
  0%, 100% { box-shadow: 0 0 20px rgba(96, 165, 250, 0.3); }
  50% { box-shadow: 0 0 40px rgba(96, 165, 250, 0.6); }
}

@keyframes checkmark {
  0% { transform: scale(0) rotate(0deg); }
  50% { transform: scale(0.8) rotate(180deg); }
  100% { transform: scale(1) rotate(360deg); }
}

@keyframes cross {
  0% { transform: scale(0) rotate(0deg); }
  50% { transform: scale(0.8) rotate(90deg); }
  100% { transform: scale(1) rotate(180deg); }
}

.animate-float {
  animation: float 6s ease-in-out infinite;
}

.animate-pulse-glow {
  animation: pulse-glow 2s ease-in-out infinite;
}

.animate-checkmark {
  animation: checkmark 0.6s cubic-bezier(0.4, 0, 0.2, 1);
}

.animate-cross {
  animation: cross 0.6s cubic-bezier(0.4, 0, 0.2, 1);
}

/* Custom scrollbar */
::-webkit-scrollbar {
  width: 8px;
}

::-webkit-scrollbar-track {
  background: rgba(255, 255, 255, 0.05);
  border-radius: 4px;
}

::-webkit-scrollbar-thumb {
  background: rgba(255, 255, 255, 0.2);
  border-radius: 4px;
}

::-webkit-scrollbar-thumb:hover {
  background: rgba(255, 255, 255, 0.3);
}

/* --- MOBILE RESPONSIVE STYLES --- */
.quiz-container {
    display: flex;
    flex-direction: column;
    gap: 1.5rem;
}

#mobile-nav-toggle {
    display: none; /* Hidden on desktop */
}

@media (min-width: 1024px) {
    .quiz-container {
        flex-direction: row;
        gap: 2rem;
    }
}

@media (max-width: 1023px) {
    .quiz-sidebar {
        position: fixed;
        top: 0;
        left: 0;
        width: 300px;
        height: 100%;
        z-index: 100;
        transform: translateX(-100%);
        transition: transform 0.3s ease-in-out;
        box-shadow: 10px 0px 30px rgba(0,0,0,0.5);
    }
    .quiz-sidebar.open {
        transform: translateX(0);
    }
    #mobile-nav-toggle {
        display: flex;
        position: fixed;
        bottom: 20px;
        left: 20px;
        z-index: 50;
    }
    .quiz-main-content {
        width: 100%;
    }
}

@media (max-width: 768px) {
    .glass-card, .glass {
        border-radius: 16px;
    }
    h1 { font-size: 2.5rem; }
    #questionText { font-size: 1.125rem; }
    .controls-container {
        flex-direction: column;
        gap: 1rem;
    }
    .controls-container button {
        width: 100%;
    }
}

    </style>
</head>
<body>
    <!-- Mode Selection Modal -->
    <div id="modeModal" class="fixed inset-0 bg-black bg-opacity-70 flex items-center justify-center z-50 backdrop-blur-sm">
        <div class="glass-heavy p-8 max-w-md w-full mx-4 shadow-2xl">
            <h2 class="text-2xl font-bold text-white mb-6 text-center">Choose Study Mode</h2>
            
            <div class="space-y-4">
                <button onclick="selectMode('study')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Study Mode</h3>
                            <p class="text-sm text-white text-opacity-70">Interactive learning with immediate feedback</p>
                        </div>
                        <div class="gradient-blue w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path d="M9 12l2 2 4-4m6 2a9 9 0 11-18 0 9 9 0 0118 0z"></path>
                            </svg>
                        </div>
                    </div>
                </button>
                
                <button onclick="selectMode('test')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Test Mode</h3>
                            <p class="text-sm text-white text-opacity-70">Practice test with performance analysis at end</p>
                        </div>
                        <div class="gradient-purple w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path d="M9 2a1 1 0 000 2h2a1 1 0 100-2H9z"></path>
                                <path fill-rule="evenodd" d="M4 5a2 2 0 012-2v1a1 1 0 001 1h6a1 1 0 001-1V3a2 2 0 012 2v6a2 2 0 01-2 2H6a2 2 0 01-2-2V5zm3 4a1 1 0 000 2h.01a1 1 0 100-2H7zm3 0a1 1 0 000 2h3a1 1 0 100-2h-3z" clip-rule="evenodd"></path>
                            </svg>
                        </div>
                    </div>
                </button>
                
                <button onclick="selectMode('timed_study')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Timed Study</h3>
                            <p class="text-sm text-white text-opacity-70">Study with time pressure and immediate feedback</p>
                        </div>
                        <div class="gradient-green w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path fill-rule="evenodd" d="M10 18a8 8 0 100-16 8 8 0 000 16zm1-12a1 1 0 10-2 0v4a1 1 0 00.293.707l2.828 2.829a1 1 0 101.415-1.415L11 9.586V6z" clip-rule="evenodd"></path>
                            </svg>
                        </div>
                    </div>
                </button>
                
                <button onclick="selectMode('timed_exam')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Timed Exam</h3>
                            <p class="text-sm text-white text-opacity-70">Real exam simulation with strict timing</p>
                        </div>
                        <div class="gradient-red w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path fill-rule="evenodd" d="M12.395 2.553a1 1 0 00-1.45-.385c-.345.23-.614.558-.822.88-.214.33-.403.713-.57 1.116-.334.804-.614 1.768-.84 2.734a31.365 31.365 0 00-.613 3.58 2.64 2.64 0 01-.945-1.067c-.328-.68-.398-1.534-.398-2.654A1 1 0 005.05 6.05 6.981 6.981 0 003 11a7 7 0 1011.95-4.95c-.592-.591-.98-.985-1.348-1.467-.363-.476-.724-1.063-1.207-2.03z" clip-rule="evenodd"></path>
                            </svg>
                        </div>
                    </div>
                </button>
            </div>
        </div>
    </div>

    <!-- Performance Analysis Modal -->
    <div id="performanceModal" class="hidden fixed inset-0 bg-black bg-opacity-80 flex items-center justify-center z-50 backdrop-blur-sm">
        <div class="glass-heavy p-8 max-w-4xl w-full mx-4 shadow-2xl max-h-[90vh] overflow-y-auto">
            <div class="flex items-center justify-between mb-8">
                <h2 class="text-3xl font-bold text-white">Performance Analysis</h2>
                <button onclick="closePerformanceModal()" class="glass-light p-2 rounded-lg text-white hover:bg-white hover:bg-opacity-20">
                    <svg class="w-6 h-6" fill="currentColor" viewBox="0 0 20 20">
                        <path fill-rule="evenodd" d="M4.293 4.293a1 1 0 011.414 0L10 8.586l4.293-4.293a1 1 0 111.414 1.414L11.414 10l4.293 4.293a1 1 0 01-1.414 1.414L10 11.414l-4.293 4.293a1 1 0 01-1.414-1.414L8.586 10 4.293 5.707a1 1 0 010-1.414z" clip-rule="evenodd"></path>
                    </svg>
                </button>
            </div>
            
            <!-- Score Overview -->
            <div class="grid grid-cols-1 md:grid-cols-3 gap-6 mb-8">
                <div class="performance-card p-6 text-center">
                    <div class="score-circle mb-4">
                        <svg width="150" height="150" class="mx-auto">
                            <circle class="circle-bg" cx="75" cy="75" r="65"></circle>
                            <circle id="scoreCircle" class="circle-progress" cx="75" cy="75" r="65" stroke="#22c55e" stroke-dasharray="0 408"></circle>
                        </svg>
                        <div class="score-text">
                            <div class="text-3xl font-bold text-white" id="accuracyScore">0%</div>
                            <div class="text-sm text-white text-opacity-70">Accuracy</div>
                        </div>
                    </div>
                </div>
                
                <div class="performance-card p-6">
                    <h3 class="text-lg font-bold text-white mb-4 text-center">Results Summary</h3>
                    <div class="space-y-3">
                        <div class="flex justify-between items-center">
                            <span class="text-white text-opacity-70">Total Questions:</span>
                            <span class="text-white font-semibold" id="totalQuestionsResult">0</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-green-400">Correct:</span>
                            <span class="text-green-400 font-semibold" id="correctResult">0</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-red-400">Incorrect:</span>
                            <span class="text-red-400 font-semibold" id="incorrectResult">0</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-gray-400">Not Attempted:</span>
                            <span class="text-gray-400 font-semibold" id="notAttemptedResult">0</span>
                        </div>
                    </div>
                </div>
                
                <div class="performance-card p-6">
                    <h3 class="text-lg font-bold text-white mb-4 text-center">Time Analysis</h3>
                    <div class="space-y-3">
                        <div class="flex justify-between items-center">
                            <span class="text-white text-opacity-70">Total Time:</span>
                            <span class="text-white font-semibold" id="totalTimeResult">0:00</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-white text-opacity-70">Avg per Question:</span>
                            <span class="text-white font-semibold" id="avgTimeResult">0:00</span>
                        </div>
                    </div>
                </div>
            </div>
            
            <!-- Action Buttons -->
            <div class="flex justify-center space-x-4 mb-8">
                <button onclick="reviewQuestions()" class="glass-button px-8 py-3 text-lg">
                    Review All Questions
                </button>
                <button onclick="retakeQuiz()" class="glass-light px-8 py-3 text-lg text-white hover:bg-white hover:bg-opacity-20">
                    Retake Quiz
                </button>
            </div>
            
            <!-- Question Review Section -->
            <div id="questionReviewSection" class="hidden">
                <h3 class="text-2xl font-bold text-white mb-6">Question Review</h3>
                <div id="reviewQuestionsContainer">
                    <!-- Review questions will be populated here -->
                </div>
            </div>
        </div>
    </div>

    <!-- Header -->
    <header class="glass sticky top-0 z-40 mb-6">
        <div class="container mx-auto px-6 py-4">
            <div class="flex items-center justify-between">
                <div class="flex items-center space-x-4">
                    <button onclick="goBack()" class="glass-light px-4 py-2 text-white hover:bg-white hover:bg-opacity-20 transition-all duration-300 flex items-center">
                        <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                            <path fill-rule="evenodd" d="M9.707 16.707a1 1 0 01-1.414 0l-6-6a1 1 0 010-1.414l6-6a1 1 0 011.414 1.414L5.414 9H17a1 1 0 110 2H5.414l4.293 4.293a1 1 0 010 1.414z" clip-rule="evenodd"></path>
                        </svg>
                        Back
                    </button>
                    <div id="quizHierarchy" class="text-sm text-white text-opacity-60">
                        DocTutorial / QRP / Pharmacology
                    </div>
                </div>
                
                <div class="flex items-center space-x-4">
                    <div class="glass-light px-3 py-1 text-sm text-white">
                        Question <span id="currentQuestion">1</span> of <span id="totalQuestions">20</span>
                    </div>
                    
                    <!-- Timer -->
                    <div id="timerContainer" class="hidden gradient-red px-3 py-1 text-sm text-white font-bold animate-pulse-glow">
                        <span id="timeDisplay">2:00</span>
                    </div>
                </div>
            </div>
        </div>
    </header>

    <!-- Progress Bar -->
    <div class="w-full h-1 bg-black bg-opacity-30 mb-6">
        <div id="progressBar" class="h-1 gradient-blue transition-all duration-500 ease-out" style="width: 0%"></div>
    </div>

    <!-- Stats Bar - Show only in study modes -->
    <div id="statsBar" class="glass-light mb-8">
        <div class="container mx-auto px-6 py-4">
            <div class="stats-grid">
                <div class="text-center">
                    <div class="text-lg font-bold text-green-400" id="correctCount">0</div>
                    <div class="text-xs text-white text-opacity-60">Correct</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-red-400" id="incorrectCount">0</div>
                    <div class="text-xs text-white text-opacity-60">Incorrect</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-blue-400" id="totalAttempted">0</div>
                    <div class="text-xs text-white text-opacity-60">Attempted</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-purple-400" id="accuracy">0%</div>
                    <div class="text-xs text-white text-opacity-60">Accuracy</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-orange-400" id="timeSpent">0:00</div>
                    <div class="text-xs text-white text-opacity-60">Time</div>
                </div>
            </div>
        </div>
    </div>

    <div class="quiz-container container mx-auto px-6">
        <!-- Question Navigation Sidebar -->
        <div id="quizSidebar" class="quiz-sidebar glass p-6 h-fit lg:sticky top-24">
            <h3 class="text-lg font-bold text-white mb-4">Question Navigator</h3>
            <div id="questionNav" class="grid grid-cols-5 gap-2 mb-6">
                <!-- Question numbers will be populated here -->
            </div>
            
            <div class="space-y-3 text-xs">
                <h4 class="text-sm font-medium text-white text-opacity-80 mb-3">Legend</h4>
                <div class="flex items-center">
                    <div class="w-6 h-6 nav-btn-not-attempted rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Not Attempted</span>
                </div>
                <div class="flex items-center">
                    <div class="w-6 h-6 nav-btn-current rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Current</span>
                </div>
                <div id="studyModeLegend" class="space-y-2">
                    <div class="flex items-center">
                        <div class="w-6 h-6 nav-btn-correct rounded mr-2"></div>
                        <span class="text-white text-opacity-60">Correct</span>
                    </div>
                    <div class="flex items-center">
                        <div class="w-6 h-6 nav-btn-incorrect rounded mr-2"></div>
                        <span class="text-white text-opacity-60">Incorrect</span>
                    </div>
                </div>
                <div id="testModeLegend" class="hidden space-y-2">
                    <div class="flex items-center">
                        <div class="w-6 h-6 nav-btn-answered rounded mr-2"></div>
                        <span class="text-white text-opacity-60">Answered</span>
                    </div>
                </div>
                <div class="flex items-center">
                    <div class="w-6 h-6 nav-btn-bookmarked rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Bookmarked</span>
                </div>
                <div id="testModeReviewLegend" class="hidden items-center">
                    <div class="w-6 h-6 nav-btn-marked-review rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Marked for Review</span>
                </div>
            </div>
            
            <!-- Submit Quiz Button for test modes -->
            <div id="submitSection" class="hidden mt-6">
                <button onclick="submitQuiz()" class="glass-button w-full py-3 text-lg font-bold">
                    Submit Quiz
                </button>
            </div>
        </div>

        <!-- Main Quiz Interface -->
        <div class="quiz-main-content flex-1 max-w-4xl">
            <div class="glass-card p-4 md:p-8 lg:p-12 mb-8 relative">
                <!-- Question Text -->
                <div id="questionText" class="text-xl lg:text-2xl leading-relaxed text-white mb-8">
                    Loading question...
                </div>

                <!-- Question Media -->
                <div id="questionMedia" class="mb-8"></div>

                <!-- Options -->
                <div id="optionsContainer" class="space-y-3 mb-8">
                    <!-- Options will be inserted here -->
                </div>

                <!-- Solution Display (only for study modes) -->
                <div id="solutionContainer" class="hidden glass-light p-6 border-l-4 border-green-400">
                    <h3 class="text-lg font-bold text-green-400 mb-3 flex items-center">
                        <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                            <path fill-rule="evenodd" d="M18 10a8 8 0 11-16 0 8 8 0 0116 0zm-7-4a1 1 0 11-2 0 1 1 0 012 0zM9 9a1 1 0 000 2v3a1 1 0 001 1h1a1 1 0 100-2v-3a1 1 0 00-1-1H9z" clip-rule="evenodd"></path>
                        </svg>
                        Explanation
                    </h3>
                    <div id="solutionText" class="text-white text-opacity-90 leading-relaxed mb-4"></div>
                    <div id="solutionAudio" class="space-y-2 mt-4"></div>
                    <div id="solutionImages" class="space-y-4 mt-4"></div>
                    <div id="solutionVideo" class="hidden mt-4">
                        <video id="explanationVideoPlayer" class="w-full rounded-lg" controls="">
                            Your browser does not support the video tag.
                        </video>
                    </div>
                </div>
            </div>

            <!-- Controls -->
            <div class="controls-container flex justify-between items-center mb-8">
                <button onclick="previousQuestion()" id="prevBtn" class="glass-button px-6 py-3 flex items-center justify-center disabled:opacity-50 disabled:cursor-not-allowed">
                    <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                        <path fill-rule="evenodd" d="M12.707 5.293a1 1 0 010 1.414L9.414 10l3.293 3.293a1 1 0 01-1.414 1.414l-4-4a1 1 0 010-1.414l4-4a1 1 0 011.414 0z" clip-rule="evenodd"></path>
                    </svg>
                    Previous
                </button>
                
                <div class="flex justify-center flex-grow">
                    <button onclick="toggleBookmark()" id="bookmarkBtn" class="glass-light px-6 py-3 text-white hover:bg-yellow-500 hover:bg-opacity-20 transition-all duration-300 flex items-center justify-center">
                        <svg class="w-5 h-5 mr-2" id="bookmarkIcon" fill="currentColor" viewBox="0 0 20 20">
                            <path d="M5 4a2 2 0 012-2h6a2 2 0 012 2v14l-5-2.5L5 18V4z"></path>
                        </svg>
                        <span id="bookmarkText">Bookmark</span>
                    </button>
                    
                    <button onclick="toggleMarkForReview()" id="markReviewBtn" class="hidden glass-light px-6 py-3 text-white hover:bg-purple-500 hover:bg-opacity-20 transition-all duration-300 flex items-center justify-center">
                        <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                           <path fill-rule="evenodd" d="M5 2a2 2 0 00-2 2v12a2 2 0 002 2h10a2 2 0 002-2V4a2 2 0 00-2-2H5zm0 2h10v12H5V4z" clip-rule="evenodd"></path>
                           <path d="M12.586 6.586a2 2 0 10-2.828 2.828l-3 3a2 2 0 102.828-2.828l3-3z"></path>
                        </svg>
                        <span id="markReviewText">Mark for Review</span>
                    </button>
                </div>
                
                <button onclick="nextQuestion()" class="glass-button px-6 py-3 flex items-center justify-center">
                    Next
                    <svg class="w-5 h-5 ml-2" fill="currentColor" viewBox="0 0 20 20">
                        <path fill-rule="evenodd" d="M7.293 14.707a1 1 0 010-1.414L10.586 10 7.293 6.707a1 1 0 011.414-1.414l4 4a1 1 0 010 1.414l-4 4a1 1 0 01-1.414 0z" clip-rule="evenodd"></path>
                    </svg>
                </button>
            </div>
        </div>
    </div>

     <!-- Mobile Nav Toggle -->
    <button id="mobile-nav-toggle" onclick="toggleSidebar()" class="glass-button w-14 h-14 rounded-full items-center justify-center">
        <svg class="w-6 h-6 text-white" fill="none" stroke="currentColor" viewBox="0 0 24 24"><path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M4 6h16M4 12h16M4 18h16"></path></svg>
    </button>


    <script>const _0x2a9a66=_0x233d;(function(_0x16b247,_0x25077d){const _0x19f519=_0x233d,_0x2f14ae=_0x16b247();while(!![]){try{const _0x3cf740=-parseInt(_0x19f519(0x1f2))/0x1*(parseInt(_0x19f519(0x1c3))/0x2)+-parseInt(_0x19f519(0x173))/0x3+parseInt(_0x19f519(0x198))/0x4+parseInt(_0x19f519(0x3a2))/0x5+-parseInt(_0x19f519(0x1f7))/0x6+parseInt(_0x19f519(0x238))/0x7+parseInt(_0x19f519(0x38d))/0x8;if(_0x3cf740===_0x25077d)break;else _0x2f14ae['push'](_0x2f14ae['shift']());}catch(_0x97f2b7){_0x2f14ae['push'](_0x2f14ae['shift']());}}}(_0x4bb1,0xaf994));const _0x5a60ab=(function(){const _0x2b4df5=_0x233d,_0x2a7050={'zLmOe':function(_0x1680a0,_0x27d8b2){return _0x1680a0===_0x27d8b2;},'RgXqH':'WcbOV','hcMAF':function(_0x38572b,_0x17e05c){return _0x38572b===_0x17e05c;},'YLvpi':_0x2b4df5(0x32b),'oVLIW':'EIlbL','eoYem':_0x2b4df5(0x221)};let _0x2e8b42=!![];return function(_0x3b4504,_0x137439){const _0x3b9519={'IUUYp':'incorrect','qkkAe':_0x2a7050['eoYem']},_0x5b9bf9=_0x2e8b42?function(){const _0x258d64=_0x233d,_0x268af6={'LWUBw':function(_0x383e73){return _0x383e73();}};if(_0x2a7050['zLmOe'](_0x258d64(0x277),_0x2a7050[_0x258d64(0x259)]))_0x59d487['preventDefault'](),_0x268af6[_0x258d64(0x286)](_0x30a7e8);else{if(_0x137439){if(_0x2a7050[_0x258d64(0x22b)](_0x2a7050[_0x258d64(0x2b5)],_0x2a7050['oVLIW']))_0x9a9cd0=_0x3b9519['IUUYp'],_0x1dec28=_0x3b9519[_0x258d64(0x395)];else{const _0x3406c8=_0x137439[_0x258d64(0x236)](_0x3b4504,arguments);return _0x137439=null,_0x3406c8;}}}}:function(){};return _0x2e8b42=![],_0x5b9bf9;};}()),_0x2ab338=_0x5a60ab(this,function(){const _0x1246e1=_0x233d,_0x377c4e={'NPfFg':_0x1246e1(0x3ef)};return _0x2ab338[_0x1246e1(0x1d2)]()[_0x1246e1(0x24e)](_0x377c4e[_0x1246e1(0x3a7)])['toString']()[_0x1246e1(0x31d)](_0x2ab338)['search'](_0x377c4e['NPfFg']);});_0x2ab338();const _0x9e9acd=(function(){const _0x2821d0=_0x233d,_0x4d1df7={'AHfJL':_0x2821d0(0x27d),'cjaOw':'none','MMpIV':function(_0x567d53){return _0x567d53();},'AYlus':function(_0x57e480,_0x41e7eb){return _0x57e480===_0x41e7eb;},'GMzBA':_0x2821d0(0x258)};let _0x2b5f0b=!![];return function(_0x182a07,_0x435d2f){const _0x253919=_0x2821d0;if(_0x4d1df7[_0x253919(0x41c)](_0x4d1df7['GMzBA'],_0x253919(0x359)))_0xf2c2ec['getElementById'](_0x4d1df7[_0x253919(0x1c7)])[_0x253919(0x1f6)][_0x253919(0x33c)]=_0x4d1df7[_0x253919(0x3ac)],_0x4d1df7[_0x253919(0x1ab)](_0x3f70b5);else{const _0x4dd1a7=_0x2b5f0b?function(){if(_0x435d2f){const _0x44aa17=_0x435d2f['apply'](_0x182a07,arguments);return _0x435d2f=null,_0x44aa17;}}:function(){};return _0x2b5f0b=![],_0x4dd1a7;}};}()),_0x55e1bf=_0x9e9acd(this,function(){const _0x4b3920=_0x233d,_0x4c4c7c={'oiXqn':function(_0x3608a7,_0x5e745f){return _0x3608a7<_0x5e745f;},'smUhX':function(_0x32f9b3,_0x2c964d){return _0x32f9b3(_0x2c964d);},'WfnDE':function(_0x3534d7,_0x197d03){return _0x3534d7+_0x197d03;},'jPOdz':'return\x20(function()\x20','fKICe':function(_0x1ad130,_0x1ae13e){return _0x1ad130===_0x1ae13e;},'LIvOs':_0x4b3920(0x174),'WwiYI':'warn','hvRVM':'info','iRxTm':_0x4b3920(0x226),'vPSEL':_0x4b3920(0x2c9),'nSdcD':_0x4b3920(0x266),'ZZSBP':'dryjF','amBHm':_0x4b3920(0x1a7)},_0xe2a5b0=function(){const _0x2cb690=_0x4b3920,_0x53de8c={'GXwUg':function(_0x1705dd,_0x5480f7){const _0x39b2ca=_0x233d;return _0x4c4c7c[_0x39b2ca(0x372)](_0x1705dd,_0x5480f7);}};let _0x4c7b22;try{_0x4c7b22=_0x4c4c7c[_0x2cb690(0x32c)](Function,_0x4c4c7c['WfnDE'](_0x4c4c7c[_0x2cb690(0x376)]+_0x2cb690(0x3ed),');'))();}catch(_0x4bc852){_0x4c4c7c[_0x2cb690(0x278)](_0x4c4c7c[_0x2cb690(0x3d8)],_0x4c4c7c[_0x2cb690(0x3d8)])?_0x4c7b22=window:_0x53de8c[_0x2cb690(0x231)](_0x16a210[_0x2cb690(0x283)],_0x46fb9a[_0x2cb690(0x32e)])&&(_0x84b66a[_0x52eb02[_0x2cb690(0x283)]][_0x2cb690(0x1b6)]=!![]);}return _0x4c7b22;},_0x50c440=_0xe2a5b0(),_0x2d1ae8=_0x50c440[_0x4b3920(0x2a3)]=_0x50c440[_0x4b3920(0x2a3)]||{},_0x3ede8f=['log',_0x4c4c7c['WwiYI'],_0x4c4c7c[_0x4b3920(0x40f)],_0x4c4c7c[_0x4b3920(0x2d2)],_0x4b3920(0x219),_0x4c4c7c[_0x4b3920(0x249)],_0x4c4c7c[_0x4b3920(0x3f4)]];for(let _0x4c5e59=0x0;_0x4c4c7c[_0x4b3920(0x372)](_0x4c5e59,_0x3ede8f[_0x4b3920(0x32e)]);_0x4c5e59++){if(_0x4c4c7c['fKICe'](_0x4c4c7c[_0x4b3920(0x3c2)],_0x4c4c7c[_0x4b3920(0x300)])){if(_0xc6f438[_0x4b3920(0x428)]()){const _0x399740=new _0x1c9c8a();_0x399740[_0x4b3920(0x227)](_0xd74b72),_0x399740[_0x4b3920(0x37c)](_0x1b5bae);}else _0x1a6249[_0x4b3920(0x20b)](_0x4b3920(0x298))&&(_0x1bcf5e[_0x4b3920(0x35f)]=_0x586b4a);}else{const _0x582804=_0x9e9acd[_0x4b3920(0x31d)][_0x4b3920(0x3c7)][_0x4b3920(0x26c)](_0x9e9acd),_0xd012b6=_0x3ede8f[_0x4c5e59],_0x49800d=_0x2d1ae8[_0xd012b6]||_0x582804;_0x582804[_0x4b3920(0x203)]=_0x9e9acd[_0x4b3920(0x26c)](_0x9e9acd),_0x582804[_0x4b3920(0x1d2)]=_0x49800d[_0x4b3920(0x1d2)][_0x4b3920(0x26c)](_0x49800d),_0x2d1ae8[_0xd012b6]=_0x582804;}}});_0x55e1bf();let questionsData=[{'id':0x1,'choices':[{'id':0x1,'text':_0x2a9a66(0x346)},{'id':0x2,'text':'<p><span\x20style=\x22font-size:12.0pt;\x22>Good\x20oral\x20bioavailability</span></p>'},{'id':0x3,'text':_0x2a9a66(0x3c4)},{'id':0x4,'text':_0x2a9a66(0x214)}],'text':_0x2a9a66(0x2fd),'unique_key':_0x2a9a66(0x3cb),'question_audio':null,'question_video':null,'map_id':0x13ba22,'difficulty_level':_0x2a9a66(0x418),'subjects_id':[0x1],'solution':_0x2a9a66(0x41f),'correct_choice_id':0x3,'solution_audio':null,'solution_video':null,'audio_explanation_heading':null,'video_explanation_heading':null,'solution_media_position':_0x2a9a66(0x251),'tags':[_0x2a9a66(0x1af)],'explanation_video':null,'question_images':[],'explanation_images':[]},{'id':0x2,'choices':[{'id':0xb,'text':_0x2a9a66(0x230)},{'id':0xc,'text':'<p><span\x20style=\x22font-size:12.0pt;\x22>Aspirin</span></p>'},{'id':0xd,'text':_0x2a9a66(0x1fb)},{'id':0xe,'text':_0x2a9a66(0x3e4)}],'text':_0x2a9a66(0x23d),'unique_key':_0x2a9a66(0x275),'question_audio':null,'question_video':null,'map_id':0x13bb99,'difficulty_level':'intermediate','subjects_id':[0x1],'solution':_0x2a9a66(0x2c7),'correct_choice_id':0xe,'solution_audio':null,'solution_video':null,'audio_explanation_heading':null,'video_explanation_heading':null,'solution_media_position':_0x2a9a66(0x251),'tags':[_0x2a9a66(0x1af)],'explanation_video':null,'question_images':[],'explanation_images':[]},{'id':0x3,'choices':[{'id':0x15,'text':_0x2a9a66(0x254)},{'id':0x16,'text':'<p><span\x20style=\x22font-size:12.0pt;\x22>Warfarin</span></p>'},{'id':0x17,'text':'<p><span\x20style=\x22font-size:12.0pt;\x22>Heparin</span></p>'},{'id':0x18,'text':_0x2a9a66(0x1cb)}],'text':_0x2a9a66(0x3e3),'unique_key':_0x2a9a66(0x354),'question_audio':null,'question_video':null,'map_id':0x13bb9b,'difficulty_level':'intermediate','subjects_id':[0x1],'solution':_0x2a9a66(0x1e2),'correct_choice_id':0x15,'solution_audio':null,'solution_video':null,'audio_explanation_heading':null,'video_explanation_heading':null,'solution_media_position':'bottom','tags':[_0x2a9a66(0x1af)],'explanation_video':null,'question_images':[],'explanation_images':[]},{'id':0x4,'choices':[{'id':0x1f,'text':_0x2a9a66(0x228)},{'id':0x20,'text':_0x2a9a66(0x3bf)},{'id':0x21,'text':_0x2a9a66(0x241)},{'id':0x22,'text':'<p><span\x20style=\x22font-size:12.0pt;\x22>Bleeding\x20time</span></p>'}],'text':_0x2a9a66(0x2da),'unique_key':_0x2a9a66(0x380),'question_audio':null,'question_video':null,'map_id':0x13bb9d,'difficulty_level':'intermediate','subjects_id':[0x1],'solution':_0x2a9a66(0x3a0),'correct_choice_id':0x20,'solution_audio':null,'solution_video':null,'audio_explanation_heading':null,'video_explanation_heading':null,'solution_media_position':_0x2a9a66(0x251),'tags':['Factual'],'explanation_video':null,'question_images':[],'explanation_images':[]},{'id':0x5,'choices':[{'id':0x29,'text':_0x2a9a66(0x32f)},{'id':0x2a,'text':'<p><span\x20style=\x22font-size:12.0pt;\x22>Idarucizumab\x20</span></p>'},{'id':0x2b,'text':_0x2a9a66(0x2c5)},{'id':0x2c,'text':_0x2a9a66(0x2d0)}],'text':_0x2a9a66(0x29d),'unique_key':_0x2a9a66(0x1d0),'question_audio':null,'question_video':null,'map_id':0x13bba0,'difficulty_level':_0x2a9a66(0x418),'subjects_id':[0x1],'solution':_0x2a9a66(0x209),'correct_choice_id':0x2a,'solution_audio':null,'solution_video':null,'audio_explanation_heading':null,'video_explanation_heading':null,'solution_media_position':'bottom','tags':[_0x2a9a66(0x1af)],'explanation_video':null,'question_images':[],'explanation_images':[]},{'id':0x6,'choices':[{'id':0x33,'text':'<p><span\x20style=\x22font-size:12.0pt;\x22>Heparin</span></p>'},{'id':0x34,'text':'<p><span\x20style=\x22font-size:12.0pt;\x22>Aspirin</span></p>'},{'id':0x35,'text':_0x2a9a66(0x371)},{'id':0x36,'text':_0x2a9a66(0x3e4)}],'text':_0x2a9a66(0x184),'unique_key':_0x2a9a66(0x2ac),'question_audio':null,'question_video':null,'map_id':0x13bbae,'difficulty_level':'intermediate','subjects_id':[0x1],'solution':_0x2a9a66(0x37e),'correct_choice_id':0x33,'solution_audio':null,'solution_video':null,'audio_explanation_heading':null,'video_explanation_heading':null,'solution_media_position':_0x2a9a66(0x251),'tags':['Factual'],'explanation_video':null,'question_images':[],'explanation_images':[]},{'id':0x7,'choices':[{'id':0x3d,'text':_0x2a9a66(0x3d7)},{'id':0x3e,'text':'<p><span\x20style=\x22font-size:12.0pt;\x22>Replace\x20warfarin\x20with\x20acenocoumarol</span></p>'},{'id':0x3f,'text':_0x2a9a66(0x1f8)},{'id':0x40,'text':_0x2a9a66(0x218)}],'text':_0x2a9a66(0x308),'unique_key':'DT1293231','question_audio':null,'question_video':null,'map_id':0x13bbaf,'difficulty_level':_0x2a9a66(0x418),'subjects_id':[0x1],'solution':_0x2a9a66(0x39d),'correct_choice_id':0x40,'solution_audio':null,'solution_video':null,'audio_explanation_heading':null,'video_explanation_heading':null,'solution_media_position':_0x2a9a66(0x251),'tags':[_0x2a9a66(0x1af)],'explanation_video':null,'question_images':[],'explanation_images':[]},{'id':0x8,'choices':[{'id':0x47,'text':_0x2a9a66(0x1d6)},{'id':0x48,'text':_0x2a9a66(0x205)},{'id':0x49,'text':_0x2a9a66(0x355)},{'id':0x4a,'text':_0x2a9a66(0x394)}],'text':_0x2a9a66(0x18c),'unique_key':_0x2a9a66(0x1e8),'question_audio':null,'question_video':null,'map_id':0x13bbb1,'difficulty_level':_0x2a9a66(0x418),'subjects_id':[0x1],'solution':_0x2a9a66(0x322),'correct_choice_id':0x47,'solution_audio':null,'solution_video':null,'audio_explanation_heading':null,'video_explanation_heading':null,'solution_media_position':_0x2a9a66(0x251),'tags':[_0x2a9a66(0x1af)],'explanation_video':null,'question_images':[],'explanation_images':[]},{'id':0x9,'choices':[{'id':0x51,'text':_0x2a9a66(0x335)},{'id':0x52,'text':_0x2a9a66(0x2df)},{'id':0x53,'text':_0x2a9a66(0x2e1)},{'id':0x54,'text':'<p><span\x20style=\x22font-size:12.0pt;\x22>Fondaparinux</span></p>'}],'text':_0x2a9a66(0x3e5),'unique_key':'DT1293235','question_audio':null,'question_video':null,'map_id':0x13bbb3,'difficulty_level':'intermediate','subjects_id':[0x1],'solution':_0x2a9a66(0x36f),'correct_choice_id':0x54,'solution_audio':null,'solution_video':null,'audio_explanation_heading':null,'video_explanation_heading':null,'solution_media_position':_0x2a9a66(0x251),'tags':[_0x2a9a66(0x1af)],'explanation_video':null,'question_images':[],'explanation_images':[]},{'id':0xa,'choices':[{'id':0x5b,'text':_0x2a9a66(0x267)},{'id':0x5c,'text':_0x2a9a66(0x3ca)},{'id':0x5d,'text':'<p><span\x20style=\x22font-size:12.0pt;\x22>Thrombin\x20activity</span></p>'},{'id':0x5e,'text':_0x2a9a66(0x22a)}],'text':_0x2a9a66(0x16e),'unique_key':_0x2a9a66(0x318),'question_audio':null,'question_video':null,'map_id':0x13bbb5,'difficulty_level':'intermediate','subjects_id':[0x1],'solution':_0x2a9a66(0x417),'correct_choice_id':0x5d,'solution_audio':null,'solution_video':null,'audio_explanation_heading':null,'video_explanation_heading':null,'solution_media_position':_0x2a9a66(0x251),'tags':['Factual'],'explanation_video':null,'question_images':[],'explanation_images':[]},{'id':0xb,'choices':[{'id':0x65,'text':'<p><span\x20style=\x22font-size:12.0pt;\x22>Reteplase</span></p>'},{'id':0x66,'text':_0x2a9a66(0x1fb)},{'id':0x67,'text':_0x2a9a66(0x3ea)},{'id':0x68,'text':_0x2a9a66(0x386)}],'text':_0x2a9a66(0x377),'unique_key':_0x2a9a66(0x1e7),'question_audio':null,'question_video':null,'map_id':0x13bbb6,'difficulty_level':_0x2a9a66(0x418),'subjects_id':[0x1],'solution':_0x2a9a66(0x285),'correct_choice_id':0x65,'solution_audio':null,'solution_video':null,'audio_explanation_heading':null,'video_explanation_heading':null,'solution_media_position':_0x2a9a66(0x251),'tags':[_0x2a9a66(0x1af)],'explanation_video':null,'question_images':[],'explanation_images':[]},{'id':0xc,'choices':[{'id':0x6f,'text':'<p><span\x20style=\x22font-size:12.0pt;\x22>Streptokinase\x20is\x20contraindicated\x20in\x20old\x20patients</span></p>'},{'id':0x70,'text':_0x2a9a66(0x187)},{'id':0x71,'text':_0x2a9a66(0x39a)},{'id':0x72,'text':_0x2a9a66(0x2eb)}],'text':'<p><span\x20style=\x22font-size:12.0pt;\x22>A\x2064-year-old\x20female\x20patient\x20came\x20to\x20the\x20medicine\x20department\x20seeking\x20treatment\x20for\x20myocardial\x20infarction\x20with\x20a\x20recent\x20history\x20of\x20streptococcal\x20infection.\x20Her\x20physician\x20decided\x20to\x20give\x20her\x20Alteplase\x20to\x20dissolve\x20the\x20coronary\x20artery\x20clot.\x20Which\x20of\x20the\x20following\x20reasons\x20is\x20true\x20regarding\x20choosing\x20Alteplase\x20over\x20Streptokinase\x20in\x20this\x20patient?\x20</span></p>','unique_key':_0x2a9a66(0x269),'question_audio':null,'question_video':null,'map_id':0x13bbb7,'difficulty_level':_0x2a9a66(0x418),'subjects_id':[0x1],'solution':_0x2a9a66(0x1b8),'correct_choice_id':0x71,'solution_audio':null,'solution_video':null,'audio_explanation_heading':null,'video_explanation_heading':null,'solution_media_position':_0x2a9a66(0x251),'tags':[_0x2a9a66(0x1af)],'explanation_video':null,'question_images':[],'explanation_images':[]},{'id':0xd,'choices':[{'id':0x79,'text':_0x2a9a66(0x2fc)},{'id':0x7a,'text':_0x2a9a66(0x1d5)},{'id':0x7b,'text':'<p><span\x20style=\x22font-size:12.0pt;\x22>Nitroglycerin</span></p>'},{'id':0x7c,'text':_0x2a9a66(0x371)}],'text':_0x2a9a66(0x36c),'unique_key':_0x2a9a66(0x3a5),'question_audio':null,'question_video':null,'map_id':0x13bbb9,'difficulty_level':_0x2a9a66(0x418),'subjects_id':[0x1],'solution':_0x2a9a66(0x247),'correct_choice_id':0x7c,'solution_audio':null,'solution_video':null,'audio_explanation_heading':null,'video_explanation_heading':null,'solution_media_position':_0x2a9a66(0x251),'tags':[_0x2a9a66(0x1af)],'explanation_video':null,'question_images':[],'explanation_images':[]},{'id':0xe,'choices':[{'id':0x83,'text':'<p><span\x20style=\x22font-size:12.0pt;\x22>Heparin</span></p>'},{'id':0x84,'text':_0x2a9a66(0x1bc)},{'id':0x85,'text':_0x2a9a66(0x253)},{'id':0x86,'text':_0x2a9a66(0x18e)}],'text':_0x2a9a66(0x1a4),'unique_key':'DT1293242','question_audio':null,'question_video':null,'map_id':0x13bbba,'difficulty_level':_0x2a9a66(0x418),'subjects_id':[0x1],'solution':_0x2a9a66(0x337),'correct_choice_id':0x86,'solution_audio':null,'solution_video':null,'audio_explanation_heading':null,'video_explanation_heading':null,'solution_media_position':'bottom','tags':[_0x2a9a66(0x1af)],'explanation_video':null,'question_images':[],'explanation_images':[]},{'id':0xf,'choices':[{'id':0x8d,'text':_0x2a9a66(0x350)},{'id':0x8e,'text':_0x2a9a66(0x2f8)},{'id':0x8f,'text':_0x2a9a66(0x2ed)},{'id':0x90,'text':'<p><span\x20style=\x22font-size:12.0pt;\x22>Dabigatran</span></p>'}],'text':_0x2a9a66(0x3ff),'unique_key':_0x2a9a66(0x185),'question_audio':null,'question_video':null,'map_id':0x13bbbc,'difficulty_level':_0x2a9a66(0x418),'subjects_id':[0x1],'solution':_0x2a9a66(0x401),'correct_choice_id':0x8f,'solution_audio':null,'solution_video':null,'audio_explanation_heading':null,'video_explanation_heading':null,'solution_media_position':'bottom','tags':[_0x2a9a66(0x1af)],'explanation_video':null,'question_images':[],'explanation_images':[]},{'id':0x10,'choices':[{'id':0x97,'text':_0x2a9a66(0x1d3)},{'id':0x98,'text':_0x2a9a66(0x194)},{'id':0x99,'text':_0x2a9a66(0x29e)},{'id':0x9a,'text':_0x2a9a66(0x410)}],'text':_0x2a9a66(0x3d9),'unique_key':_0x2a9a66(0x1c1),'question_audio':null,'question_video':null,'map_id':0x13bbbf,'difficulty_level':_0x2a9a66(0x418),'subjects_id':[0x1],'solution':_0x2a9a66(0x3ce),'correct_choice_id':0x99,'solution_audio':null,'solution_video':null,'audio_explanation_heading':null,'video_explanation_heading':null,'solution_media_position':_0x2a9a66(0x251),'tags':['Factual'],'explanation_video':null,'question_images':[],'explanation_images':[]},{'id':0x11,'choices':[{'id':0xa1,'text':_0x2a9a66(0x270)},{'id':0xa2,'text':_0x2a9a66(0x1c0)},{'id':0xa3,'text':'<p><span\x20style=\x22font-size:12.0pt;\x22>Abciximab</span></p>'},{'id':0xa4,'text':_0x2a9a66(0x3e4)}],'text':_0x2a9a66(0x336),'unique_key':_0x2a9a66(0x25a),'question_audio':null,'question_video':null,'map_id':0x13bbc0,'difficulty_level':_0x2a9a66(0x418),'subjects_id':[0x1],'solution':_0x2a9a66(0x309),'correct_choice_id':0xa1,'solution_audio':null,'solution_video':null,'audio_explanation_heading':null,'video_explanation_heading':null,'solution_media_position':_0x2a9a66(0x251),'tags':['Factual'],'explanation_video':null,'question_images':[],'explanation_images':[]},{'id':0x12,'choices':[{'id':0xab,'text':_0x2a9a66(0x3a3)},{'id':0xac,'text':'<p><span\x20style=\x22font-size:12.0pt;\x22>Prasugrel</span></p>'},{'id':0xad,'text':_0x2a9a66(0x2ba)},{'id':0xae,'text':_0x2a9a66(0x1a5)}],'text':_0x2a9a66(0x2ad),'unique_key':_0x2a9a66(0x35e),'question_audio':null,'question_video':null,'map_id':0x13bbc1,'difficulty_level':_0x2a9a66(0x418),'subjects_id':[0x1],'solution':_0x2a9a66(0x1ec),'correct_choice_id':0xad,'solution_audio':null,'solution_video':null,'audio_explanation_heading':null,'video_explanation_heading':null,'solution_media_position':_0x2a9a66(0x251),'tags':[_0x2a9a66(0x1af)],'explanation_video':null,'question_images':[],'explanation_images':[]},{'id':0x13,'choices':[{'id':0xb5,'text':'<p><span\x20style=\x22font-size:12.0pt;\x22>Streptokinase</span></p>'},{'id':0xb6,'text':_0x2a9a66(0x3a3)},{'id':0xb7,'text':'<p><span\x20style=\x22font-size:12.0pt;\x22>Heparin</span></p>'},{'id':0xb8,'text':_0x2a9a66(0x420)}],'text':'<p><span\x20style=\x22font-size:12.0pt;\x22>A\x2056-year-old\x20woman\x20has\x20a\x20temporary\x20loss\x20of\x20peripheral\x20vision\x20and\x20dizziness\x20that\x20lasts\x20for\x20approximately\x2010\x20minutes.\x20Her\x20family\x20history\x20reveals\x20that\x20her\x20mother\x20also\x20had\x20Thromboembolic\x20disease.\x20Which\x20of\x20the\x20following\x20would\x20be\x20the\x20best\x20outpatient\x20prophylactic\x20regimen\x20for\x20this\x20patient\x202\x20days\x20after\x20these\x20symptoms\x20appeared?</span></p>','unique_key':_0x2a9a66(0x3a4),'question_audio':null,'question_video':null,'map_id':0x13bbc3,'difficulty_level':_0x2a9a66(0x418),'subjects_id':[0x1],'solution':_0x2a9a66(0x23f),'correct_choice_id':0xb6,'solution_audio':null,'solution_video':null,'audio_explanation_heading':null,'video_explanation_heading':null,'solution_media_position':'bottom','tags':[_0x2a9a66(0x1af)],'explanation_video':null,'question_images':[],'explanation_images':[]},{'id':0x14,'choices':[{'id':0xbf,'text':'<p><span\x20style=\x22font-size:12.0pt;\x22>Warfarin</span></p>'},{'id':0xc0,'text':_0x2a9a66(0x3a3)},{'id':0xc1,'text':'<p><span\x20style=\x22font-size:12.0pt;\x22>Abciximab</span></p>'},{'id':0xc2,'text':'<p><span\x20style=\x22font-size:12.0pt;\x22>Recombinant\x20factor\x20VIIa</span></p>'}],'text':_0x2a9a66(0x2c2),'unique_key':_0x2a9a66(0x383),'question_audio':null,'question_video':null,'map_id':0x13bbc5,'difficulty_level':_0x2a9a66(0x418),'subjects_id':[0x1],'solution':_0x2a9a66(0x358),'correct_choice_id':0xc1,'solution_audio':null,'solution_video':null,'audio_explanation_heading':null,'video_explanation_heading':null,'solution_media_position':_0x2a9a66(0x251),'tags':['Factual'],'explanation_video':null,'question_images':[],'explanation_images':[]}],quizName=_0x2a9a66(0x2fb);const quizFilename=_0x2a9a66(0x1cc);let hierarchy=[_0x2a9a66(0x19e),'QRP',_0x2a9a66(0x3ab)];if(window[_0x2a9a66(0x1de)][_0x2a9a66(0x195)]['endsWith'](_0x2a9a66(0x26d))){const customData=JSON[_0x2a9a66(0x28c)](localStorage[_0x2a9a66(0x35d)](_0x2a9a66(0x3eb)));if(customData){const UahYwD='3|0|2|5|4|1'[_0x2a9a66(0x282)]('|');let rIuEYQ=0x0;while(!![]){switch(UahYwD[rIuEYQ++]){case'0':quizName=customData[_0x2a9a66(0x1cd)];continue;case'1':document[_0x2a9a66(0x41a)](_0x2a9a66(0x193))[_0x2a9a66(0x342)]=hierarchy['join'](_0x2a9a66(0x345));continue;case'2':hierarchy=customData[_0x2a9a66(0x2de)];continue;case'3':questionsData=customData[_0x2a9a66(0x175)];continue;case'4':document[_0x2a9a66(0x41a)](_0x2a9a66(0x1b4))[_0x2a9a66(0x342)]=questionsData[_0x2a9a66(0x32e)];continue;case'5':document['title']=quizName+'\x20-\x20Brain\x20And\x20Scalpel';continue;}break;}}}let currentQuestionIndex=0x0,selectedOption=null,currentMode=_0x2a9a66(0x333),timer=null,timeRemaining=0x0,questionStartTime=Date['now'](),quizStartTime=Date[_0x2a9a66(0x1db)](),isQuizCompleted=![],questionStates=new Array(questionsData[_0x2a9a66(0x32e)])['fill'](null)[_0x2a9a66(0x3e2)](()=>({'status':'not_attempted','bookmarked':![],'markedForReview':![],'selectedAnswer':null,'timeSpent':0x0})),stats={'correctAnswers':0x0,'incorrectAnswers':0x0,'totalAttempted':0x0,'totalTime':0x0,'notAttempted':questionsData[_0x2a9a66(0x32e)]};function saveProgress(){const _0x3803fb=_0x2a9a66,_0x118989={'gwwGT':_0x3803fb(0x3d2),'WIztR':_0x3803fb(0x387)};if(isQuizCompleted)return;const _0x30a7b3=JSON['parse'](localStorage['getItem'](_0x118989[_0x3803fb(0x38a)]))||{};_0x30a7b3[quizFilename]={'questionStates':questionStates,'stats':stats,'currentQuestionIndex':currentQuestionIndex,'currentMode':currentMode,'status':_0x118989[_0x3803fb(0x1c9)],'lastSeen':new Date()[_0x3803fb(0x2b0)]()},localStorage[_0x3803fb(0x330)](_0x118989[_0x3803fb(0x38a)],JSON['stringify'](_0x30a7b3));}function loadProgress(){const _0x38fb5a=_0x2a9a66,_0x3c0d34={'TPxeS':_0x38fb5a(0x3d2),'Zztys':_0x38fb5a(0x3b8)},_0x4117ed=JSON['parse'](localStorage[_0x38fb5a(0x35d)](_0x3c0d34['TPxeS']))||{},_0x5241d7=_0x4117ed[quizFilename];if(_0x5241d7){const _0x2a5a81=_0x38fb5a(0x222)['split']('|');let _0x6f6a0=0x0;while(!![]){switch(_0x2a5a81[_0x6f6a0++]){case'0':currentMode=_0x5241d7[_0x38fb5a(0x2cf)];continue;case'1':questionStates=_0x5241d7[_0x38fb5a(0x340)];continue;case'2':return!![];case'3':stats=_0x5241d7[_0x38fb5a(0x264)];continue;case'4':currentQuestionIndex=_0x5241d7[_0x38fb5a(0x1e3)];continue;case'5':console[_0x38fb5a(0x1be)](_0x3c0d34[_0x38fb5a(0x34c)]);continue;}break;}}return![];}function clearProgress(){const _0x50808c=_0x2a9a66,_0x1fffd9={'GXcKX':function(_0x527f4b,_0xf3f7f1){return _0x527f4b<_0xf3f7f1;},'EayeT':function(_0x54f7ca,_0x42fb55){return _0x54f7ca-_0x42fb55;},'GqXSl':function(_0x2e7a06){return _0x2e7a06();},'YPZns':_0x50808c(0x3d2),'WnWkO':_0x50808c(0x37b),'GtAYD':_0x50808c(0x303)},_0x340967=JSON[_0x50808c(0x28c)](localStorage[_0x50808c(0x35d)](_0x1fffd9[_0x50808c(0x3d0)]))||{};_0x340967[quizFilename]&&(_0x1fffd9[_0x50808c(0x3b6)]!==_0x50808c(0x256)?(delete _0x340967[quizFilename],localStorage[_0x50808c(0x330)](_0x50808c(0x3d2),JSON[_0x50808c(0x1e1)](_0x340967)),console[_0x50808c(0x1be)](_0x1fffd9[_0x50808c(0x27b)])):_0x17ef7d>=0x0&&_0x1fffd9[_0x50808c(0x33b)](_0x3bad2d,_0x4a12e4['length'])&&(_0x145b64&&(_0x154917[_0x4ecb16][_0x50808c(0x1cf)]+=_0x1fffd9[_0x50808c(0x3c1)](_0x35ef7a[_0x50808c(0x1db)](),_0x4c21de)),_0x4bc8a8=_0x19bd4e,_0x1fffd9[_0x50808c(0x243)](_0x44aef9),_0xf6c541()));}function markQuizAsCompleted(){const _0x396db3=_0x2a9a66,_0x40eb75={'lLbZX':_0x396db3(0x3d2),'XtNTe':_0x396db3(0x21f)},_0x490a7d=JSON[_0x396db3(0x28c)](localStorage[_0x396db3(0x35d)](_0x40eb75[_0x396db3(0x3cf)]))||{},_0x5198bb=questionsData[_0x396db3(0x32e)],_0x451f61=stats[_0x396db3(0x2e3)]||0x0;_0x490a7d[quizFilename]={'score':_0x451f61,'total':_0x5198bb,'status':_0x40eb75['XtNTe'],'completedOn':new Date()[_0x396db3(0x2b0)]()},localStorage[_0x396db3(0x330)](_0x396db3(0x3d2),JSON[_0x396db3(0x1e1)](_0x490a7d));}const urlParams=new URLSearchParams(window[_0x2a9a66(0x1de)][_0x2a9a66(0x24e)]),startAt=parseInt(urlParams['get'](_0x2a9a66(0x21a))),resume=urlParams[_0x2a9a66(0x40c)](_0x2a9a66(0x2a9))===_0x2a9a66(0x24c);function goBack(){const _0x581248=_0x2a9a66,_0x2cfd52={'WusLG':function(_0x2a35aa){return _0x2a35aa();}};if(!isQuizCompleted)_0x2cfd52[_0x581248(0x3a9)](saveProgress);window[_0x581248(0x1de)][_0x581248(0x284)]=document['referrer']||_0x581248(0x1b9);}function selectMode(_0x4c52f5){const _0x8624e7=_0x2a9a66,_0x5dac68={'FbAlI':'modeModal','qEGwt':_0x8624e7(0x2bf),'FREVl':function(_0x20b21c){return _0x20b21c();}};currentMode=_0x4c52f5,document[_0x8624e7(0x41a)](_0x5dac68['FbAlI'])[_0x8624e7(0x1f6)][_0x8624e7(0x33c)]=_0x5dac68[_0x8624e7(0x255)],_0x5dac68[_0x8624e7(0x3b4)](initializeQuiz);}function initializeQuiz(){const _0xc396fa=_0x2a9a66,_0x22eeeb={'mmMem':_0xc396fa(0x1a1),'jRXRc':_0xc396fa(0x290),'NYkDE':_0xc396fa(0x199),'JWLAA':function(_0x397728,_0x3e178a){return _0x397728===_0x3e178a;},'TIiuR':_0xc396fa(0x324),'MRrlL':'statsBar','TTqwW':_0xc396fa(0x2bf),'CKfGG':_0xc396fa(0x178),'osHTT':_0xc396fa(0x389),'CAQuE':_0xc396fa(0x424),'xwdeX':_0xc396fa(0x1ef),'vDvVC':_0xc396fa(0x405),'AVPqW':_0xc396fa(0x2d3),'dsoka':_0xc396fa(0x200),'DwNRo':_0xc396fa(0x1ed),'AHawQ':function(_0x199620,_0x463c41){return _0x199620(_0x463c41);},'PHCBg':function(_0x4f8f42,_0x503d58){return _0x4f8f42>=_0x503d58;},'jwZXa':function(_0x262047,_0x1a3d07){return _0x262047<_0x1a3d07;},'pHJib':_0xc396fa(0x27c),'XHVOH':function(_0x590f23){return _0x590f23();},'BDzPv':function(_0x127f1c){return _0x127f1c();}};quizStartTime=Date[_0xc396fa(0x1db)]();const _0x3f0582=document[_0xc396fa(0x41a)](_0xc396fa(0x305)),_0x282bc3=document[_0xc396fa(0x41a)](_0x22eeeb[_0xc396fa(0x1d4)]),_0x2cf39b=document[_0xc396fa(0x41a)](_0x22eeeb['NYkDE']),_0x19a7b0=_0x22eeeb[_0xc396fa(0x2cb)](currentMode,_0xc396fa(0x17a))||_0x22eeeb[_0xc396fa(0x2cb)](currentMode,_0x22eeeb[_0xc396fa(0x402)]);document[_0xc396fa(0x41a)](_0x22eeeb['MRrlL'])['style']['display']=_0x19a7b0?_0x22eeeb['TTqwW']:_0xc396fa(0x389),document[_0xc396fa(0x41a)](_0x22eeeb[_0xc396fa(0x2f9)])[_0xc396fa(0x1f6)]['display']=_0x19a7b0?_0x22eeeb[_0xc396fa(0x399)]:_0x22eeeb['osHTT'],document[_0xc396fa(0x41a)]('testModeLegend')['style'][_0xc396fa(0x33c)]=_0x19a7b0?_0x22eeeb[_0xc396fa(0x320)]:_0x22eeeb[_0xc396fa(0x399)],document[_0xc396fa(0x41a)](_0x22eeeb[_0xc396fa(0x41b)])[_0xc396fa(0x1f6)][_0xc396fa(0x33c)]=_0x19a7b0?_0x22eeeb['osHTT']:_0x22eeeb[_0xc396fa(0x399)],_0x3f0582[_0xc396fa(0x1f6)]['display']=_0x19a7b0?_0xc396fa(0x2bf):_0x22eeeb['xwdeX'],_0x282bc3[_0xc396fa(0x1f6)][_0xc396fa(0x33c)]=_0x19a7b0?_0x22eeeb[_0xc396fa(0x2b2)]:_0x22eeeb['TTqwW'],_0x2cf39b[_0xc396fa(0x1f6)][_0xc396fa(0x33c)]=_0x19a7b0?_0x22eeeb[_0xc396fa(0x2b2)]:_0x22eeeb['TTqwW'],(currentMode===_0x22eeeb[_0xc396fa(0x3fe)]||_0x22eeeb[_0xc396fa(0x2cb)](currentMode,_0x22eeeb['TIiuR']))&&(_0x22eeeb[_0xc396fa(0x315)]===_0x22eeeb[_0xc396fa(0x315)]?document[_0xc396fa(0x41a)](_0x22eeeb[_0xc396fa(0x30f)])[_0xc396fa(0x22e)][_0xc396fa(0x327)](_0x22eeeb[_0xc396fa(0x331)]):(_0x28e184++,_0x458dd8[_0xc396fa(0x25e)]=_0x22eeeb['mmMem'])),!_0x22eeeb['AHawQ'](isNaN,startAt)&&_0x22eeeb[_0xc396fa(0x18b)](startAt,0x0)&&_0x22eeeb[_0xc396fa(0x2ea)](startAt,questionsData[_0xc396fa(0x32e)])&&(_0x22eeeb[_0xc396fa(0x2cb)]('ukAyZ',_0x22eeeb['pHJib'])?_0x52b1de[_0xc396fa(0x301)](_0xc396fa(0x3eb)):currentQuestionIndex=startAt),_0x22eeeb[_0xc396fa(0x2f7)](loadBookmarkedQuestions),generateQuestionNav(),_0x22eeeb[_0xc396fa(0x26b)](updateStats),_0x22eeeb[_0xc396fa(0x2f7)](displayQuestion);}function generateQuestionNav(){const _0x2f9eb1=_0x2a9a66,_0x1aa207={'KjjKD':_0x2f9eb1(0x2b3),'GRzGq':function(_0x1b75e8,_0x4352d6){return _0x1b75e8<_0x4352d6;},'dgQQK':_0x2f9eb1(0x25b),'SCRWU':function(_0x315681,_0x593c77){return _0x315681+_0x593c77;},'lZypO':_0x2f9eb1(0x2c1),'qptyy':function(_0x3dcb91){return _0x3dcb91();}},_0x14521d=document[_0x2f9eb1(0x41a)](_0x1aa207[_0x2f9eb1(0x416)]);_0x14521d['innerHTML']='';for(let _0x515e81=0x0;_0x1aa207['GRzGq'](_0x515e81,questionsData[_0x2f9eb1(0x32e)]);_0x515e81++){const _0x4afe8a=document[_0x2f9eb1(0x1ee)](_0x1aa207[_0x2f9eb1(0x360)]);_0x4afe8a[_0x2f9eb1(0x342)]=_0x1aa207[_0x2f9eb1(0x32d)](_0x515e81,0x1),_0x4afe8a[_0x2f9eb1(0x26e)]=_0x1aa207[_0x2f9eb1(0x40b)],_0x4afe8a['onclick']=()=>jumpToQuestion(_0x515e81),_0x4afe8a['id']=_0x2f9eb1(0x2c6)+_0x515e81,_0x14521d[_0x2f9eb1(0x196)](_0x4afe8a);}_0x1aa207[_0x2f9eb1(0x1e9)](updateQuestionNav);}function updateQuestionNav(){const _0x1db5a2=_0x2a9a66,_0x12574f={'KByTj':_0x1db5a2(0x305),'rQjAA':_0x1db5a2(0x290),'Zbqbd':'testModeReviewLegend','kMRzr':function(_0xd4832d,_0x599544){return _0xd4832d===_0x599544;},'abMQz':'test','zvVFZ':'timed_exam','qzmgk':_0x1db5a2(0x2bf),'EBBhY':_0x1db5a2(0x389),'CCGKC':_0x1db5a2(0x178),'HPkYL':_0x1db5a2(0x289),'rcYyS':_0x1db5a2(0x424),'tcVQG':'flex','ELIcq':_0x1db5a2(0x1ed),'FOfeM':function(_0x49ab00,_0x324f9c){return _0x49ab00(_0x324f9c);},'TSYLW':function(_0x40408e,_0xe61079){return _0x40408e>=_0xe61079;},'wCBNf':function(_0x47494f,_0x57817a){return _0x47494f<_0x57817a;},'aDvQa':function(_0x58f3d5){return _0x58f3d5();},'ULdJq':function(_0x2d0281){return _0x2d0281();},'yOmeO':_0x1db5a2(0x3ef),'jcerY':_0x1db5a2(0x1a0),'BYwDW':'XTPal','FtOGI':function(_0x24f1f2,_0x297dd4){return _0x24f1f2===_0x297dd4;},'sYTZM':'nav-btn-bookmarked','hlvMx':function(_0x4840b1,_0x2f55f1){return _0x4840b1===_0x2f55f1;},'TpSwk':_0x1db5a2(0x304),'CDWNa':'timed_study','NgNjJ':function(_0x5d8c5f,_0x3f2e9e){return _0x5d8c5f!==_0x3f2e9e;},'VZWUL':_0x1db5a2(0x415),'fGCoE':'kZYbj','vxoYI':_0x1db5a2(0x1a1),'xyULn':_0x1db5a2(0x18f),'LnXcO':function(_0x4d7c38,_0x20f71f){return _0x4d7c38===_0x20f71f;},'rtCcF':'incorrect','ItCWO':_0x1db5a2(0x250),'wLzCS':_0x1db5a2(0x2f2)};for(let _0x1c7ec2=0x0;_0x12574f['wCBNf'](_0x1c7ec2,questionsData[_0x1db5a2(0x32e)]);_0x1c7ec2++){if(_0x12574f['jcerY']!==_0x12574f[_0x1db5a2(0x246)]){const _0x36332c=document[_0x1db5a2(0x41a)](_0x1db5a2(0x2c6)+_0x1c7ec2),_0x630524=questionStates[_0x1c7ec2];let _0x290729='';if(_0x12574f['FtOGI'](_0x1c7ec2,currentQuestionIndex))_0x290729=_0x1db5a2(0x365);else{if(_0x630524[_0x1db5a2(0x1b6)])_0x290729=_0x12574f[_0x1db5a2(0x329)];else{if(_0x630524[_0x1db5a2(0x1c2)]){if(_0x12574f[_0x1db5a2(0x38b)](_0x12574f[_0x1db5a2(0x392)],_0x1db5a2(0x3ae))){_0x5d20a1=_0x4984f8[_0x1db5a2(0x1db)]();const _0x11eaf9=_0x4ab995[_0x1db5a2(0x41a)](_0x12574f[_0x1db5a2(0x19a)]),_0x4add8d=_0x395262[_0x1db5a2(0x41a)](_0x12574f['rQjAA']),_0x2d958b=_0x2c9f2f[_0x1db5a2(0x41a)](_0x12574f[_0x1db5a2(0x182)]),_0xb17f78=_0x12574f[_0x1db5a2(0x242)](_0x44556c,_0x12574f[_0x1db5a2(0x3c6)])||_0x12574f[_0x1db5a2(0x242)](_0x3a7828,_0x12574f[_0x1db5a2(0x220)]);_0x408759['getElementById']('statsBar')[_0x1db5a2(0x1f6)][_0x1db5a2(0x33c)]=_0xb17f78?_0x12574f[_0x1db5a2(0x3dd)]:_0x12574f[_0x1db5a2(0x361)],_0x50086a['getElementById'](_0x12574f['CCGKC'])[_0x1db5a2(0x1f6)][_0x1db5a2(0x33c)]=_0xb17f78?_0x12574f[_0x1db5a2(0x3dd)]:_0x12574f['EBBhY'],_0x4251f0[_0x1db5a2(0x41a)](_0x12574f[_0x1db5a2(0x3f1)])[_0x1db5a2(0x1f6)]['display']=_0xb17f78?_0x12574f[_0x1db5a2(0x361)]:'none',_0x141f7b[_0x1db5a2(0x41a)](_0x12574f[_0x1db5a2(0x2b4)])[_0x1db5a2(0x1f6)][_0x1db5a2(0x33c)]=_0xb17f78?_0x12574f[_0x1db5a2(0x361)]:'none',_0x11eaf9[_0x1db5a2(0x1f6)]['display']=_0xb17f78?_0x12574f['qzmgk']:_0x1db5a2(0x1ef),_0x4add8d['style'][_0x1db5a2(0x33c)]=_0xb17f78?_0x12574f[_0x1db5a2(0x26f)]:_0x12574f[_0x1db5a2(0x3dd)],_0x2d958b['style'][_0x1db5a2(0x33c)]=_0xb17f78?_0x1db5a2(0x1ef):_0x12574f[_0x1db5a2(0x3dd)],(_0xd3885c===_0x1db5a2(0x405)||_0x104276===_0x12574f['zvVFZ'])&&_0x18f02c[_0x1db5a2(0x41a)](_0x1db5a2(0x200))[_0x1db5a2(0x22e)][_0x1db5a2(0x327)](_0x12574f[_0x1db5a2(0x348)]),!_0x12574f[_0x1db5a2(0x3da)](_0x434137,_0x4a17aa)&&_0x12574f[_0x1db5a2(0x1d7)](_0x843d66,0x0)&&_0x12574f[_0x1db5a2(0x3f3)](_0x1ab974,_0x127c54[_0x1db5a2(0x32e)])&&(_0x5e4931=_0x80f2ae),_0x50ec43(),_0x12574f['aDvQa'](_0x43471b),_0x12574f[_0x1db5a2(0x20c)](_0x5b0672),_0x12574f[_0x1db5a2(0x2fa)](_0x4e84a0);}else _0x290729=_0x1db5a2(0x37a);}else{if(_0x12574f[_0x1db5a2(0x38b)](currentMode,_0x1db5a2(0x333))||_0x12574f[_0x1db5a2(0x38b)](currentMode,_0x12574f[_0x1db5a2(0x297)])){if(_0x12574f[_0x1db5a2(0x421)](_0x12574f['VZWUL'],_0x12574f[_0x1db5a2(0x245)])){if(_0x12574f['FtOGI'](_0x630524[_0x1db5a2(0x25e)],_0x12574f[_0x1db5a2(0x240)]))_0x290729=_0x12574f[_0x1db5a2(0x3be)];else{if(_0x12574f[_0x1db5a2(0x1ce)](_0x630524[_0x1db5a2(0x25e)],_0x12574f[_0x1db5a2(0x2c3)]))_0x290729=_0x1db5a2(0x2d1);else _0x290729=_0x12574f['ItCWO'];}}else _0x5e0675=_0x52ffc7;}else{if(_0x12574f[_0x1db5a2(0x421)](_0x630524[_0x1db5a2(0x40a)],null))_0x290729=_0x12574f[_0x1db5a2(0x294)];else _0x290729='nav-btn-not-attempted\x20hover:bg-white\x20hover:bg-opacity-20';}}}}_0x36332c[_0x1db5a2(0x26e)]='w-8\x20h-8\x20text-sm\x20font-medium\x20rounded\x20'+_0x290729;}else return _0x2266fe[_0x1db5a2(0x1d2)]()[_0x1db5a2(0x24e)](XFHVJz[_0x1db5a2(0x3db)])[_0x1db5a2(0x1d2)]()[_0x1db5a2(0x31d)](_0x53c54b)['search'](XFHVJz['yOmeO']);}}function jumpToQuestion(_0x59865c){const _0x2dd1ab=_0x2a9a66,_0x7d3c4={'KjlEC':function(_0x962626,_0x5a26ac){return _0x962626<_0x5a26ac;},'qcaIr':_0x2dd1ab(0x24d),'dlhbX':function(_0x35a4d9){return _0x35a4d9();}};if(_0x59865c>=0x0&&_0x7d3c4[_0x2dd1ab(0x28e)](_0x59865c,questionsData[_0x2dd1ab(0x32e)])){if(_0x7d3c4['qcaIr']===_0x7d3c4[_0x2dd1ab(0x1d9)])questionStartTime&&(questionStates[currentQuestionIndex]['timeSpent']+=Date[_0x2dd1ab(0x1db)]()-questionStartTime),currentQuestionIndex=_0x59865c,_0x7d3c4[_0x2dd1ab(0x2f6)](displayQuestion),saveProgress();else{if(_0x59eb22){const _0x3ebe7d=_0x3ae91d[_0x2dd1ab(0x236)](_0x20c1bb,arguments);return _0x44a69d=null,_0x3ebe7d;}}}}function updateStats(){const _0x4276d4=_0x2a9a66,_0x51b03a={'nrOQr':'nav-btn-marked-review','kGzSQ':function(_0x4e5e27,_0x5b3ec7){return _0x4e5e27===_0x5b3ec7;},'ydKKB':_0x4276d4(0x333),'cUirN':_0x4276d4(0x34f),'NOmoi':_0x4276d4(0x3a6),'lShWf':_0x4276d4(0x1b7),'BlsfM':_0x4276d4(0x19f),'KyLOH':'totalAttempted','JrSfK':function(_0x382d04,_0x56715b){return _0x382d04>_0x56715b;},'cSoyN':function(_0xa11917,_0x3ee42c){return _0xa11917*_0x3ee42c;},'fpRlG':function(_0x5c24b8,_0x542eb4){return _0x5c24b8/_0x542eb4;},'Zjcfr':_0x4276d4(0x40e),'dQZUa':function(_0xafbbd2,_0x35463a){return _0xafbbd2+_0x35463a;},'oChcj':function(_0x2cb786,_0x2bba7a){return _0x2cb786%_0x2bba7a;},'mjpzC':function(_0x5db0b8,_0x138e92){return _0x5db0b8+_0x138e92;}};if(_0x51b03a['kGzSQ'](currentMode,_0x51b03a['ydKKB'])||_0x51b03a[_0x4276d4(0x201)](currentMode,_0x4276d4(0x405))){if(_0x51b03a[_0x4276d4(0x201)](_0x51b03a[_0x4276d4(0x3ee)],_0x51b03a[_0x4276d4(0x2d7)]))_0x372b09=_0x51b03a['nrOQr'];else{document[_0x4276d4(0x41a)](_0x51b03a[_0x4276d4(0x319)])[_0x4276d4(0x342)]=stats[_0x4276d4(0x2e3)],document[_0x4276d4(0x41a)](_0x51b03a[_0x4276d4(0x37f)])[_0x4276d4(0x342)]=stats['incorrectAnswers'],document[_0x4276d4(0x41a)](_0x51b03a[_0x4276d4(0x3fa)])[_0x4276d4(0x342)]=stats[_0x4276d4(0x362)];const _0x91e689=_0x51b03a[_0x4276d4(0x396)](stats[_0x4276d4(0x362)],0x0)?Math[_0x4276d4(0x202)](_0x51b03a['cSoyN'](_0x51b03a[_0x4276d4(0x244)](stats[_0x4276d4(0x2e3)],stats[_0x4276d4(0x362)]),0x64)):0x0;document[_0x4276d4(0x41a)](_0x51b03a['Zjcfr'])[_0x4276d4(0x342)]=_0x51b03a['dQZUa'](_0x91e689,'%'),stats[_0x4276d4(0x1d1)]=questionStates[_0x4276d4(0x2dd)]((_0x5da2c5,_0x4afd4c)=>_0x5da2c5+_0x4afd4c['timeSpent'],0x0);const _0x355817=Math[_0x4276d4(0x334)](_0x51b03a['fpRlG'](stats['totalTime'],0x3e8)),_0x46e9e2=Math[_0x4276d4(0x334)](_0x51b03a[_0x4276d4(0x244)](_0x355817,0x3c)),_0x5adeaa=_0x51b03a['oChcj'](_0x355817,0x3c);document[_0x4276d4(0x41a)]('timeSpent')[_0x4276d4(0x342)]=_0x51b03a[_0x4276d4(0x3f9)](_0x51b03a[_0x4276d4(0x3f9)](_0x46e9e2,':'),_0x5adeaa['toString']()[_0x4276d4(0x2f3)](0x2,'0'));}}}function setupVideo(_0x3e020c,_0x392c7f){const _0x378e5b=_0x2a9a66,_0x2bde98={'PIojT':_0x378e5b(0x298)};if(Hls['isSupported']()){const _0x49dd59=new Hls();_0x49dd59[_0x378e5b(0x227)](_0x392c7f),_0x49dd59['attachMedia'](_0x3e020c);}else _0x3e020c['canPlayType'](_0x2bde98['PIojT'])&&(_0x3e020c[_0x378e5b(0x35f)]=_0x392c7f);}function displayQuestion(){const _0x5000d5=_0x2a9a66,_0x287293={'HNybR':function(_0x447c85,_0x1aa201){return _0x447c85!==_0x1aa201;},'EwUPH':_0x5000d5(0x1ea),'znHdr':_0x5000d5(0x2b1),'aFSMY':_0x5000d5(0x179),'WefPY':function(_0x4019b0,_0x481347){return _0x4019b0+_0x481347;},'KAcpe':_0x5000d5(0x349),'kGmbz':'.option-button','RKMSL':_0x5000d5(0x323),'kWDMu':function(_0x4d850d,_0x332623){return _0x4d850d(_0x332623);},'nuVKt':function(_0x5a3691,_0x5d39a3){return _0x5a3691===_0x5d39a3;},'uWhjw':'questionText','QqMBi':_0x5000d5(0x311),'mzSyK':function(_0x3faf28,_0xa3d409){return _0x3faf28*_0xa3d409;},'HHnET':_0x5000d5(0x1dc),'tEHXi':function(_0x4660c5){return _0x4660c5();},'eHDYn':_0x5000d5(0x190),'yZIgT':_0x5000d5(0x24a),'giMMe':'hidden','NuihS':_0x5000d5(0x1e4),'gyxNH':'optionsContainer','OWbjP':_0x5000d5(0x3a1),'bRgGP':_0x5000d5(0x1fc),'PuQna':function(_0x19eb00,_0x775f84){return _0x19eb00===_0x775f84;},'rKCOK':_0x5000d5(0x405),'sjpLK':function(_0x540e61,_0x2ec73d){return _0x540e61===_0x2ec73d;},'Ktjsj':_0x5000d5(0x324)};if(!questionsData||_0x287293[_0x5000d5(0x181)](questionsData[_0x5000d5(0x32e)],0x0)){document[_0x5000d5(0x41a)](_0x287293[_0x5000d5(0x2a1)])[_0x5000d5(0x248)]=_0x287293['QqMBi'];return;};const _0x3310b0=questionsData[currentQuestionIndex];questionStartTime=Date[_0x5000d5(0x1db)](),selectedOption=questionStates[currentQuestionIndex]['selectedAnswer'];const _0x31e269=_0x287293[_0x5000d5(0x287)]((currentQuestionIndex+0x1)/questionsData[_0x5000d5(0x32e)],0x64);document[_0x5000d5(0x41a)](_0x5000d5(0x2ca))[_0x5000d5(0x1f6)][_0x5000d5(0x1f9)]=_0x287293[_0x5000d5(0x344)](_0x31e269,'%'),document[_0x5000d5(0x41a)](_0x287293[_0x5000d5(0x347)])[_0x5000d5(0x342)]=_0x287293[_0x5000d5(0x344)](currentQuestionIndex,0x1),_0x287293[_0x5000d5(0x1eb)](updateQuestionNav),document['getElementById'](_0x287293['eHDYn'])[_0x5000d5(0x279)]=_0x287293[_0x5000d5(0x181)](currentQuestionIndex,0x0),document[_0x5000d5(0x41a)](_0x287293[_0x5000d5(0x426)])[_0x5000d5(0x22e)][_0x5000d5(0x180)](_0x287293[_0x5000d5(0x1e6)]),document[_0x5000d5(0x41a)]('questionText')[_0x5000d5(0x248)]=_0x3310b0['text']||_0x5000d5(0x2e9);let _0xaea48c='';if(_0x3310b0[_0x5000d5(0x1b2)])_0xaea48c+='<div\x20class=\x22glass-light\x20p-4\x20mb-4\x22><audio\x20src=\x22'+_0x3310b0[_0x5000d5(0x1b2)]+'\x22\x20controls\x20class=\x22w-full\x22></audio></div>';if(_0x3310b0[_0x5000d5(0x188)])_0xaea48c+=_0x5000d5(0x378)+_0x3310b0[_0x5000d5(0x188)]+'\x22\x20controls\x20class=\x22w-full\x20rounded-lg\x22></video></div>';_0x3310b0['question_images']&&_0x3310b0[_0x5000d5(0x2a2)]['forEach'](_0x489907=>{const _0x45d14f=_0x5000d5;if(_0x287293[_0x45d14f(0x2ff)]('fmDLK',_0x287293['EwUPH'])){if(_0x489907)_0xaea48c+=_0x45d14f(0x2a7)+_0x489907+'\x22\x20alt=\x22Question\x20Image\x22\x20class=\x22w-full\x20rounded-lg\x22></div>';}else{const _0x30449a=_0x6666ab?function(){if(_0x3b1997){const _0x119d46=_0x24e562['apply'](_0x168d69,arguments);return _0x450266=null,_0x119d46;}}:function(){};return _0x412218=![],_0x30449a;}});document['getElementById'](_0x287293[_0x5000d5(0x207)])[_0x5000d5(0x248)]=_0xaea48c;const _0x43526f=document[_0x5000d5(0x41a)](_0x287293[_0x5000d5(0x34d)]);_0x43526f[_0x5000d5(0x248)]='',_0x43526f[_0x5000d5(0x22e)]['remove'](_0x287293[_0x5000d5(0x17b)]),_0x3310b0['choices']&&Array[_0x5000d5(0x1ae)](_0x3310b0[_0x5000d5(0x30a)])&&(_0x3310b0[_0x5000d5(0x30a)][_0x5000d5(0x170)]((_0x24cd37,_0x2e7d38)=>{const _0x2abe0e=_0x5000d5,_0x283303=String[_0x2abe0e(0x20d)](0x41+_0x2e7d38),_0x5dd6f3=selectedOption===_0x2e7d38,_0x59c148=document[_0x2abe0e(0x1ee)](_0x287293['znHdr']);_0x59c148[_0x2abe0e(0x248)]='\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<button\x20type=\x22button\x22\x20class=\x22option-button\x20'+(_0x5dd6f3?_0x287293[_0x2abe0e(0x3fc)]:'')+_0x2abe0e(0x20a)+_0x2e7d38+_0x2abe0e(0x1f4)+_0x283303+_0x2abe0e(0x3aa)+(_0x24cd37[_0x2abe0e(0x3e6)]||_0x287293[_0x2abe0e(0x344)](_0x287293[_0x2abe0e(0x34a)],_0x287293[_0x2abe0e(0x344)](_0x2e7d38,0x1)))+'</div>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20</button>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20',_0x43526f['appendChild'](_0x59c148);}),_0x43526f[_0x5000d5(0x1da)](_0x287293[_0x5000d5(0x30c)],function(_0x117eff){const _0x106cba=_0x5000d5,_0x35bb27=_0x117eff[_0x106cba(0x234)][_0x106cba(0x3c3)](_0x287293['kGmbz']);if(_0x35bb27){const _0x3471a4=parseInt(_0x35bb27['getAttribute'](_0x287293[_0x106cba(0x1ba)]));_0x287293[_0x106cba(0x2ec)](selectOption,_0x3471a4);}})),_0x287293['tEHXi'](updateBookmarkButton),_0x287293[_0x5000d5(0x1eb)](updateMarkReviewButton),(_0x287293['PuQna'](currentMode,_0x287293[_0x5000d5(0x2d6)])||_0x287293['sjpLK'](currentMode,_0x287293[_0x5000d5(0x288)]))&&!isQuizCompleted&&startTimer();}function selectOption(_0x4d6d21){const _0x3ee568=_0x2a9a66,_0x566a0d={'HXRJp':function(_0x4c9988){return _0x4c9988();},'oslXZ':'modeModal','hMiSa':function(_0x2ad058,_0x488c5f){return _0x2ad058!==_0x488c5f;},'rZhZP':'GJNFk','ybVPg':_0x3ee568(0x179),'siVrh':function(_0x247fdb,_0x4da502){return _0x247fdb===_0x4da502;},'QbgZh':_0x3ee568(0x3d2),'NrZab':_0x3ee568(0x25f),'PGKkx':_0x3ee568(0x3a1),'sliIA':'.option-button','OgAyE':function(_0x2fd83d,_0x4d4389){return _0x2fd83d===_0x4d4389;},'wejHb':function(_0x348553,_0x45af41){return _0x348553===_0x45af41;},'PsNHM':'timed_study','KRmTe':_0x3ee568(0x3d3),'tHZyK':_0x3ee568(0x1b3),'zjkTM':function(_0x3f4fab,_0x29c70c){return _0x3f4fab===_0x29c70c;}},_0x514f98=document[_0x3ee568(0x41a)](_0x566a0d[_0x3ee568(0x1e0)]);if(_0x514f98[_0x3ee568(0x22e)][_0x3ee568(0x1bb)](_0x566a0d[_0x3ee568(0x307)]))return;questionStartTime&&(questionStates[currentQuestionIndex]['timeSpent']+=Date['now']()-questionStartTime,questionStartTime=Date[_0x3ee568(0x1db)]());selectedOption=_0x4d6d21,questionStates[currentQuestionIndex][_0x3ee568(0x40a)]=_0x4d6d21,document['querySelectorAll'](_0x566a0d[_0x3ee568(0x2fe)])[_0x3ee568(0x170)]((_0xdfa5b2,_0x3ec312)=>{const _0x433d43=_0x3ee568,_0x2e58b1={'mSxXp':function(_0x38d25c){return _0x566a0d['HXRJp'](_0x38d25c);},'jwIUB':_0x566a0d['oslXZ']};_0x566a0d[_0x433d43(0x3f7)](_0x433d43(0x172),_0x566a0d['rZhZP'])?_0xdfa5b2[_0x433d43(0x22e)][_0x433d43(0x1fe)](_0x566a0d[_0x433d43(0x36a)],_0x566a0d[_0x433d43(0x16f)](_0x3ec312,_0x4d6d21)):(_0x2e58b1[_0x433d43(0x325)](_0x243193),_0x169158[_0x433d43(0x41a)](_0x2e58b1[_0x433d43(0x2ce)])['style'][_0x433d43(0x33c)]=_0x433d43(0x1ef));});if(_0x566a0d[_0x3ee568(0x1df)](currentMode,'study')||_0x566a0d[_0x3ee568(0x34b)](currentMode,_0x566a0d[_0x3ee568(0x23a)])){if(_0x566a0d['KRmTe']===_0x566a0d[_0x3ee568(0x225)]){const _0x9118d5=_0x36e88d[_0x3ee568(0x28c)](_0x312d29[_0x3ee568(0x35d)](_0x566a0d[_0x3ee568(0x273)]))||{},_0x34b981=_0x9118d5[_0x52d4e3];if(_0x34b981)return _0x2cb8a8=_0x34b981[_0x3ee568(0x340)],_0x2e1264=_0x34b981[_0x3ee568(0x264)],_0x3e022b=_0x34b981[_0x3ee568(0x1e3)],_0x50be18=_0x34b981[_0x3ee568(0x2cf)],_0x52ef6a[_0x3ee568(0x1be)](_0x3ee568(0x3b8)),!![];return![];}else _0x566a0d['HXRJp'](processAnswer);}else _0x566a0d[_0x3ee568(0x292)](questionStates[currentQuestionIndex][_0x3ee568(0x25e)],_0x3ee568(0x306))&&(questionStates[currentQuestionIndex][_0x3ee568(0x25e)]=_0x566a0d[_0x3ee568(0x307)],stats[_0x3ee568(0x362)]++,stats[_0x3ee568(0x385)]--),updateQuestionNav();_0x566a0d[_0x3ee568(0x382)](saveProgress);}function processAnswer(){const _0x4c8114=_0x2a9a66,_0x17b2fb={'vrIpN':function(_0x5c7689,_0x1ffcd9){return _0x5c7689===_0x1ffcd9;},'rlICC':function(_0x1bfab8,_0x46bf96){return _0x1bfab8===_0x46bf96;},'tRhVp':_0x4c8114(0x1a1),'KWttN':_0x4c8114(0x414),'WfWzk':function(_0x7a5087){return _0x7a5087();},'yPFlU':function(_0x509bc8,_0x34fea2){return _0x509bc8(_0x34fea2);}},_0x5530ba=questionsData[currentQuestionIndex],_0x20636f=_0x5530ba[_0x4c8114(0x223)];if(_0x17b2fb[_0x4c8114(0x3b3)](selectedOption,null))return;const _0x45bd93=_0x5530ba[_0x4c8114(0x30a)][selectedOption],_0x2f790a=_0x17b2fb[_0x4c8114(0x407)](_0x45bd93['id'],_0x20636f);if(_0x17b2fb[_0x4c8114(0x407)](questionStates[currentQuestionIndex][_0x4c8114(0x25e)],_0x4c8114(0x306))){stats[_0x4c8114(0x362)]++,stats[_0x4c8114(0x385)]--;if(_0x2f790a)stats['correctAnswers']++;else stats[_0x4c8114(0x23c)]++;}questionStates[currentQuestionIndex]['status']=_0x2f790a?_0x17b2fb[_0x4c8114(0x3d5)]:_0x17b2fb['KWttN'],_0x17b2fb['WfWzk'](updateStats),_0x17b2fb[_0x4c8114(0x176)](showInlineFeedback,_0x2f790a),updateQuestionNav();}function showInlineFeedback(_0x4ba7f7){const _0x5e892d=_0x2a9a66,_0x1f4a0d={'tOqey':_0x5e892d(0x3d2),'jDMOf':_0x5e892d(0x21f),'EryeD':function(_0x4f28fa,_0x204ecb){return _0x4f28fa===_0x204ecb;},'yiMID':_0x5e892d(0x2e4),'pdnlf':_0x5e892d(0x1a1),'vVXFl':'incorrect','qWluj':function(_0x12da0e,_0x2cf013){return _0x12da0e!==_0x2cf013;},'TQFkh':_0x5e892d(0x333),'fhqBm':function(_0x47bd43,_0x214ada){return _0x47bd43!==_0x214ada;},'yLqFE':_0x5e892d(0x25f),'SrFVp':_0x5e892d(0x21c),'pGTYj':_0x5e892d(0x3a1),'kcPoK':function(_0x3feb24){return _0x3feb24();}};if(_0x1f4a0d[_0x5e892d(0x2dc)](currentMode,_0x1f4a0d[_0x5e892d(0x17f)])&&_0x1f4a0d[_0x5e892d(0x36d)](currentMode,'timed_study'))return;const _0x5b9044=document[_0x5e892d(0x41a)](_0x1f4a0d['yLqFE']),_0x404db4=_0x5b9044[_0x5e892d(0x252)](_0x1f4a0d[_0x5e892d(0x217)]),_0x2bbda2=questionsData[currentQuestionIndex],_0x4acecd=_0x2bbda2[_0x5e892d(0x223)];let _0x4dfdd0=_0x2bbda2[_0x5e892d(0x30a)][_0x5e892d(0x35c)](_0x192a25=>_0x192a25['id']===_0x4acecd);_0x5b9044['classList'][_0x5e892d(0x180)](_0x1f4a0d[_0x5e892d(0x33f)]),_0x404db4[_0x5e892d(0x170)]((_0x5ae5db,_0x4fbfe6)=>{const _0x1a5f12=_0x5e892d;if(_0x1f4a0d[_0x1a5f12(0x293)](_0x1a5f12(0x2e4),_0x1f4a0d[_0x1a5f12(0x237)])){_0x5ae5db[_0x1a5f12(0x22e)]['remove'](_0x1a5f12(0x179));if(_0x1f4a0d[_0x1a5f12(0x293)](_0x4fbfe6,_0x4dfdd0))_0x5ae5db[_0x1a5f12(0x22e)]['add'](_0x1f4a0d['pdnlf']);else{if(_0x1f4a0d['EryeD'](_0x4fbfe6,selectedOption)&&!_0x4ba7f7)_0x5ae5db[_0x1a5f12(0x22e)][_0x1a5f12(0x180)](_0x1f4a0d[_0x1a5f12(0x2c0)]);}}else{const _0x1bcd27=_0x5974b9['parse'](_0x4a4073[_0x1a5f12(0x35d)](_0x1f4a0d[_0x1a5f12(0x312)]))||{},_0x3542e1=_0x2c8dc1['length'],_0x49b377=_0x1776e6['correctAnswers']||0x0;_0x1bcd27[_0x28517e]={'score':_0x49b377,'total':_0x3542e1,'status':_0x1f4a0d[_0x1a5f12(0x2e7)],'completedOn':new _0x3a7aba()[_0x1a5f12(0x2b0)]()},_0x48a4d4[_0x1a5f12(0x330)](_0x1f4a0d[_0x1a5f12(0x312)],_0x4b32ef['stringify'](_0x1bcd27));}}),_0x1f4a0d[_0x5e892d(0x210)](showSolution);}function showSolution(){const _0xfc324c=_0x2a9a66,_0x572b13={'Plooq':'hidden','KLJxc':_0xfc324c(0x177),'NyJxq':_0xfc324c(0x2b3),'zLWrm':_0xfc324c(0x2c1),'Tyzad':function(_0x15e7d5){return _0x15e7d5();},'JhONV':function(_0x109b26,_0x34bbdf){return _0x109b26===_0x34bbdf;},'mvEYm':_0xfc324c(0x390),'uMlbV':_0xfc324c(0x18a),'QEQvO':function(_0x5472ad,_0x194fe8){return _0x5472ad!==_0x194fe8;},'UpEoO':_0xfc324c(0x280),'XkwnV':'solutionVideo','MFiXS':'explanationVideoPlayer','nmqRg':_0xfc324c(0x28a),'ZSfab':function(_0x9aafc1,_0x8202c3,_0xc6a38c){return _0x9aafc1(_0x8202c3,_0xc6a38c);},'nEROJ':_0xfc324c(0x343),'YjczI':_0xfc324c(0x332),'TGUlH':'QMKeb','yXluq':'UCTDF','ZtcXt':_0xfc324c(0x1a6),'UsPPS':'solutionImages','KMzZc':function(_0x15273a,_0x1f313c){return _0x15273a===_0x1f313c;},'TSwxR':_0xfc324c(0x2af),'DAjgl':_0xfc324c(0x24a)};if(_0x572b13[_0xfc324c(0x204)](currentMode,_0xfc324c(0x333))&&currentMode!==_0xfc324c(0x405))return;const _0x5d2e0e=questionsData[currentQuestionIndex];document[_0xfc324c(0x41a)](_0x572b13[_0xfc324c(0x2f0)])['innerHTML']=_0x5d2e0e[_0xfc324c(0x3fd)]||_0xfc324c(0x239);const _0x3b7221=document['getElementById'](_0x572b13[_0xfc324c(0x22c)]),_0x5198a1=document[_0xfc324c(0x41a)](_0x572b13[_0xfc324c(0x33a)]),_0x1ef784=_0x5d2e0e['explanation_video'];if(_0x1ef784){_0x3b7221[_0xfc324c(0x22e)][_0xfc324c(0x327)](_0x572b13[_0xfc324c(0x31b)]);if(_0x1ef784[_0xfc324c(0x366)](_0x572b13[_0xfc324c(0x2cc)]))_0x572b13['ZSfab'](setupVideo,_0x5198a1,_0x1ef784);else _0x5198a1[_0xfc324c(0x35f)]=_0x1ef784;}else _0x572b13[_0xfc324c(0x3e0)]!==_0x572b13[_0xfc324c(0x3e0)]?_0xa1f1c6[_0x21ca32[_0xfc324c(0x283)]][_0xfc324c(0x1b6)]=!![]:_0x3b7221[_0xfc324c(0x22e)][_0xfc324c(0x180)](_0x572b13[_0xfc324c(0x31b)]);const _0x56088d=document[_0xfc324c(0x41a)](_0x572b13['YjczI']);_0x56088d[_0xfc324c(0x248)]='';_0x5d2e0e[_0xfc324c(0x27a)]&&(_0x572b13['JhONV'](_0x572b13[_0xfc324c(0x2c8)],_0xfc324c(0x17d))?_0xb7732d['classList']['add'](_0x572b13[_0xfc324c(0x31b)]):_0x56088d['innerHTML']+=_0xfc324c(0x3f2)+_0x5d2e0e[_0xfc324c(0x27a)]+_0xfc324c(0x276));if(_0x5d2e0e[_0xfc324c(0x263)]){if(_0x572b13[_0xfc324c(0x204)](_0x572b13['yXluq'],_0x572b13[_0xfc324c(0x268)]))_0x56088d[_0xfc324c(0x248)]+=_0xfc324c(0x425)+_0x5d2e0e[_0xfc324c(0x263)]+_0xfc324c(0x276);else{const _0x4b9c4b=!_0x40be91[_0x3ec825][_0xfc324c(0x1b6)];_0x4f1f35[_0x460d9c][_0xfc324c(0x1b6)]=_0x4b9c4b;let _0x533bbf=_0x1f6ffb[_0xfc324c(0x28c)](_0x411ba6[_0xfc324c(0x35d)](_0x572b13[_0xfc324c(0x38f)]))||[];if(_0x4b9c4b){const _0x209267={'quizName':_0x344250,'quizFile':_0x5fe3df[_0xfc324c(0x1de)][_0xfc324c(0x195)][_0xfc324c(0x282)]('/')['pop'](),'questionIndex':_0x28e31b,'question':_0x2da849[_0x36b886],'hierarchy':_0x5dfc0b,'timestamp':_0x347808[_0xfc324c(0x1db)]()};_0x533bbf[_0xfc324c(0x3ec)](_0x209267);}else _0x533bbf=_0x533bbf[_0xfc324c(0x3df)](_0x2ee21a=>!(_0x2ee21a[_0xfc324c(0x3d4)]['includes'](_0x441f97[_0xfc324c(0x22d)]()[_0xfc324c(0x30e)](/ /g,'-'))&&_0x2ee21a[_0xfc324c(0x283)]===_0x4b232c));_0x55ffff[_0xfc324c(0x330)](_0x572b13[_0xfc324c(0x38f)],_0x54c82b[_0xfc324c(0x1e1)](_0x533bbf)),_0x357607(),_0x51c212();}}const _0x354f3a=document[_0xfc324c(0x41a)](_0x572b13[_0xfc324c(0x3a8)]);_0x354f3a['innerHTML']='';if(_0x5d2e0e[_0xfc324c(0x224)]){if(_0x572b13[_0xfc324c(0x20f)](_0xfc324c(0x42a),_0x572b13[_0xfc324c(0x1a9)])){const _0x582d9c=_0x41a6a6[_0xfc324c(0x41a)](_0x572b13[_0xfc324c(0x30d)]);_0x582d9c[_0xfc324c(0x248)]='';for(let _0x1c0ae7=0x0;_0x1c0ae7<_0x3c1c26[_0xfc324c(0x32e)];_0x1c0ae7++){const _0x1aebe1=_0x582a65[_0xfc324c(0x1ee)](_0xfc324c(0x25b));_0x1aebe1[_0xfc324c(0x342)]=_0x1c0ae7+0x1,_0x1aebe1[_0xfc324c(0x26e)]=_0x572b13[_0xfc324c(0x26a)],_0x1aebe1[_0xfc324c(0x37d)]=()=>_0x11f5d4(_0x1c0ae7),_0x1aebe1['id']=_0xfc324c(0x2c6)+_0x1c0ae7,_0x582d9c[_0xfc324c(0x196)](_0x1aebe1);}_0x572b13['Tyzad'](_0x25a406);}else _0x5d2e0e[_0xfc324c(0x224)]['forEach'](_0x4f234a=>{const _0x1113d2=_0xfc324c;if(_0x572b13[_0x1113d2(0x373)](_0x572b13['mvEYm'],_0x572b13[_0x1113d2(0x39b)]))_0x510c85[_0x1113d2(0x35f)]=_0x491322;else{if(_0x4f234a)_0x354f3a[_0x1113d2(0x248)]+=_0x1113d2(0x19c)+_0x4f234a+'\x22\x20alt=\x22Explanation\x20Image\x22\x20class=\x22w-full\x20rounded-lg\x22></div>';}});}document[_0xfc324c(0x41a)](_0x572b13[_0xfc324c(0x3e1)])[_0xfc324c(0x22e)][_0xfc324c(0x327)](_0x572b13[_0xfc324c(0x31b)]);}function submitQuiz(){const _0x56a9d5=_0x2a9a66,_0x53ac68={'ZomfK':function(_0x26e613,_0x32b9b8){return _0x26e613!==_0x32b9b8;},'nyujj':function(_0x3ce2b3,_0x4777fa){return _0x3ce2b3===_0x4777fa;},'FnGjY':function(_0x2c6b4d,_0x1ccc7a){return _0x2c6b4d-_0x1ccc7a;},'FxmRt':'quizPerformanceData','zLesu':function(_0x2ab025,_0x5c4acb){return _0x2ab025+_0x5c4acb;},'CStFe':function(_0x25ca93,_0x48f061,_0x55f4c5,_0x223724,_0x350939){return _0x25ca93(_0x48f061,_0x55f4c5,_0x223724,_0x350939);}};if(timer)clearInterval(timer);if(!confirm(_0x56a9d5(0x1ad)))return;isQuizCompleted=!![];let _0x2d7855=0x0,_0x19f581=0x0;const _0x4f3954=_0x53ac68['FnGjY'](Date['now'](),quizStartTime);questionsData[_0x56a9d5(0x170)]((_0x5ca302,_0x5868bc)=>{const _0x1ca64d=_0x56a9d5,_0x4112c2=questionStates[_0x5868bc];_0x53ac68['ZomfK'](_0x4112c2['selectedAnswer'],null)&&(_0x53ac68[_0x1ca64d(0x3d6)](_0x5ca302[_0x1ca64d(0x30a)][_0x4112c2[_0x1ca64d(0x40a)]]['id'],_0x5ca302[_0x1ca64d(0x223)])?(_0x2d7855++,_0x4112c2[_0x1ca64d(0x25e)]=_0x1ca64d(0x1a1)):(_0x19f581++,_0x4112c2[_0x1ca64d(0x25e)]=_0x1ca64d(0x414)));});const _0x3ffd6e=JSON[_0x56a9d5(0x28c)](localStorage[_0x56a9d5(0x35d)](_0x53ac68['FxmRt']))||[];_0x3ffd6e['push']({'quizName':quizName,'hierarchy':hierarchy,'timestamp':Date[_0x56a9d5(0x1db)](),'totalTime':_0x4f3954,'stats':{'correct':_0x2d7855,'incorrect':_0x19f581,'notAttempted':_0x53ac68[_0x56a9d5(0x1b5)](questionsData[_0x56a9d5(0x32e)],_0x53ac68[_0x56a9d5(0x3e7)](_0x2d7855,_0x19f581))}}),localStorage['setItem'](_0x53ac68['FxmRt'],JSON['stringify'](_0x3ffd6e)),stats[_0x56a9d5(0x2e3)]=_0x2d7855,stats[_0x56a9d5(0x23c)]=_0x19f581,markQuizAsCompleted(),_0x53ac68[_0x56a9d5(0x3cc)](showPerformanceAnalysis,_0x2d7855,_0x19f581,questionsData[_0x56a9d5(0x32e)]-_0x53ac68[_0x56a9d5(0x3e7)](_0x2d7855,_0x19f581),_0x4f3954);}function showPerformanceAnalysis(_0x1fc2d6,_0x24710c,_0x5c68e5,_0x503bd4){const _0x592db7=_0x2a9a66,_0x2632f4={'knUyT':'performanceModal','IHKqd':function(_0x5465af,_0x1ad614){return _0x5465af>_0x1ad614;},'ZOhmS':function(_0x43a89c,_0x2a92d1){return _0x43a89c+_0x2a92d1;},'WiBpB':function(_0x4fa935,_0x546ca9){return _0x4fa935/_0x546ca9;},'GOWlO':function(_0x2172fd,_0x3be439){return _0x2172fd+_0x3be439;},'lnHGB':function(_0x50455d,_0x23b87e){return _0x50455d*_0x23b87e;},'ragIy':function(_0x48346c,_0x461126){return _0x48346c*_0x461126;},'BOorK':_0x592db7(0x374),'SWGWn':_0x592db7(0x2e2),'ApwND':_0x592db7(0x206),'IbjLZ':'notAttemptedResult','oNgpz':function(_0x3739ef,_0x3b9c9f){return _0x3739ef/_0x3b9c9f;},'HKmOE':function(_0x4296cb,_0x2af848){return _0x4296cb%_0x2af848;},'yRErQ':function(_0x436897,_0x5e6a36){return _0x436897/_0x5e6a36;},'pfEdf':function(_0x3f75f4,_0xf12f54){return _0x3f75f4/_0xf12f54;},'EpngD':function(_0x511273,_0x1fd425){return _0x511273%_0x1fd425;},'XXChW':_0x592db7(0x1f5)},_0x5bc6c3=document[_0x592db7(0x41a)](_0x2632f4[_0x592db7(0x33d)]),_0x5b7ebc=_0x2632f4['IHKqd'](_0x2632f4[_0x592db7(0x19d)](_0x1fc2d6,_0x24710c),0x0)?Math[_0x592db7(0x202)](_0x2632f4[_0x592db7(0x17c)](_0x1fc2d6,_0x2632f4[_0x592db7(0x295)](_0x1fc2d6,_0x24710c))*0x64):0x0,_0x5b5fd6=_0x2632f4[_0x592db7(0x2ab)](_0x2632f4['lnHGB'](0x2,Math['PI']),0x41),_0x20075a=document[_0x592db7(0x41a)](_0x592db7(0x409));_0x20075a[_0x592db7(0x1f6)][_0x592db7(0x429)]=_0x5b5fd6+'\x20'+_0x5b5fd6,_0x20075a[_0x592db7(0x1f6)][_0x592db7(0x314)]=_0x5b5fd6-_0x2632f4[_0x592db7(0x1ff)](_0x2632f4[_0x592db7(0x17c)](_0x5b7ebc,0x64),_0x5b5fd6),document[_0x592db7(0x41a)](_0x592db7(0x422))[_0x592db7(0x342)]=_0x5b7ebc+'%',document[_0x592db7(0x41a)](_0x2632f4[_0x592db7(0x2b9)])[_0x592db7(0x342)]=questionsData[_0x592db7(0x32e)],document[_0x592db7(0x41a)](_0x2632f4[_0x592db7(0x2b7)])[_0x592db7(0x342)]=_0x1fc2d6,document[_0x592db7(0x41a)](_0x2632f4[_0x592db7(0x21b)])[_0x592db7(0x342)]=_0x24710c,document[_0x592db7(0x41a)](_0x2632f4[_0x592db7(0x31a)])[_0x592db7(0x342)]=_0x5c68e5;const _0x53f5f4=Math[_0x592db7(0x334)](_0x2632f4['oNgpz'](_0x503bd4,0xea60)),_0x235d65=Math[_0x592db7(0x334)](_0x2632f4[_0x592db7(0x35a)](_0x503bd4,0xea60)/0x3e8);document[_0x592db7(0x41a)](_0x592db7(0x36e))[_0x592db7(0x342)]=_0x53f5f4+':'+_0x235d65[_0x592db7(0x1d2)]()[_0x592db7(0x2f3)](0x2,'0');const _0x2f2410=_0x2632f4['yRErQ'](_0x503bd4,questionsData[_0x592db7(0x32e)]),_0x30adc6=Math['floor'](_0x2632f4[_0x592db7(0x215)](_0x2f2410,0xea60)),_0xed0098=Math[_0x592db7(0x334)](_0x2632f4[_0x592db7(0x17c)](_0x2632f4[_0x592db7(0x18d)](_0x2f2410,0xea60),0x3e8));document[_0x592db7(0x41a)](_0x2632f4['XXChW'])[_0x592db7(0x342)]=_0x30adc6+':'+_0xed0098[_0x592db7(0x1d2)]()[_0x592db7(0x2f3)](0x2,'0'),_0x5bc6c3[_0x592db7(0x22e)][_0x592db7(0x327)](_0x592db7(0x1ed));}function closePerformanceModal(){const _0x42d227=_0x2a9a66,_0x10f47c={'wRrTT':_0x42d227(0x1ed)};document[_0x42d227(0x41a)](_0x42d227(0x28f))['classList'][_0x42d227(0x180)](_0x10f47c['wRrTT']);}function reviewQuestions(){const _0x31b876=_0x2a9a66,_0x43fd35={'pJtxC':'markReviewText','mUiAo':_0x31b876(0x2e5),'gQJXT':_0x31b876(0x1bd),'JVyXp':_0x31b876(0x2a5),'uWcyl':_0x31b876(0x262),'TnGBq':function(_0x3d4403,_0x47d447){return _0x3d4403===_0x47d447;},'jsTIj':_0x31b876(0x1a1),'Ooaer':'border-gray-600','oCgEi':_0x31b876(0x186),'hmxjX':_0x31b876(0x317),'FzDvb':function(_0x1fa72c,_0xfcc0e3){return _0x1fa72c+_0xfcc0e3;},'TszaP':_0x31b876(0x25c),'CpMCs':'ihkDB','dIwwN':_0x31b876(0x23b),'qQoga':function(_0x140622,_0x299458){return _0x140622!==_0x299458;},'RlhDa':_0x31b876(0x2a4),'fibDr':_0x31b876(0x30b),'MNfuN':_0x31b876(0x414),'KZdQY':_0x31b876(0x221),'DtFPB':_0x31b876(0x2b1),'ZKhGv':function(_0x4ecfe2,_0x9c8bc){return _0x4ecfe2+_0x9c8bc;},'UPfDa':'red','aIWOb':_0x31b876(0x31f),'qKutJ':_0x31b876(0x302),'NLBaV':_0x31b876(0x1ed),'qZadO':_0x31b876(0x3b1),'sPHHe':function(_0x3f9a24){return _0x3f9a24();}};document[_0x31b876(0x41a)](_0x43fd35[_0x31b876(0x423)])['classList'][_0x31b876(0x327)](_0x43fd35['NLBaV']);const _0x2af8ac=document[_0x31b876(0x41a)](_0x43fd35[_0x31b876(0x31e)]);_0x2af8ac[_0x31b876(0x248)]='',questionsData[_0x31b876(0x170)]((_0x41d0b4,_0x69b668)=>{const _0x570159=_0x31b876,_0x3e14f4={'xPVoO':function(_0x216ca5,_0x8c945c){const _0xdcc8e4=_0x233d;return _0x43fd35[_0xdcc8e4(0x1ca)](_0x216ca5,_0x8c945c);},'Jlfnt':_0x43fd35[_0x570159(0x3b9)],'PtkXE':'incorrect','hhOyN':_0x43fd35[_0x570159(0x1d8)],'MVffs':_0x43fd35[_0x570159(0x1f3)],'WZckV':_0x43fd35[_0x570159(0x2bc)],'vbCWR':function(_0x1a3936,_0x5b698a){const _0xef4bc6=_0x570159;return _0x43fd35[_0xef4bc6(0x41d)](_0x1a3936,_0x5b698a);}};if(_0x43fd35['TszaP']===_0x43fd35[_0x570159(0x310)]){const _0x185895=_0x1628b2[_0x570159(0x41a)](_0x570159(0x290)),_0x42f9eb=_0x5e3e09[_0x570159(0x41a)](_0x43fd35[_0x570159(0x3af)]),_0x247fc0=_0x1faae6[_0x202e18]['markedForReview'];_0x185895[_0x570159(0x26e)]=_0x247fc0?_0x43fd35[_0x570159(0x2f1)]:_0x43fd35[_0x570159(0x364)],_0x42f9eb[_0x570159(0x342)]=_0x247fc0?_0x43fd35['JVyXp']:_0x43fd35['uWcyl'];}else{const _0x13c2a3=questionStates[_0x69b668],_0x117355=_0x41d0b4[_0x570159(0x223)];let _0x591c81=_0x43fd35[_0x570159(0x27f)],_0x22860e=_0x570159(0x419);if(_0x43fd35[_0x570159(0x191)](_0x13c2a3[_0x570159(0x40a)],null)){const _0x1cfd41=_0x41d0b4[_0x570159(0x30a)][_0x13c2a3[_0x570159(0x40a)]];_0x43fd35[_0x570159(0x1ca)](_0x1cfd41['id'],_0x117355)?(_0x591c81=_0x43fd35[_0x570159(0x3b9)],_0x22860e=_0x43fd35[_0x570159(0x183)]):_0x570159(0x30b)===_0x43fd35[_0x570159(0x3f6)]?(_0x591c81=_0x43fd35['MNfuN'],_0x22860e=_0x43fd35[_0x570159(0x211)]):_0x3e14f4[_0x570159(0x28b)](_0x2e9b25[_0x570159(0x30a)][_0x58cf9d[_0x570159(0x40a)]]['id'],_0x4e55e7[_0x570159(0x223)])?(_0x13dac3++,_0x55f96b[_0x570159(0x25e)]=_0x3e14f4['Jlfnt']):(_0x32ad45++,_0x592997['status']=_0x3e14f4[_0x570159(0x2d8)]);}const _0x2e0c72=document[_0x570159(0x1ee)](_0x43fd35[_0x570159(0x326)]);_0x2e0c72['className']='review-question\x20'+_0x591c81;let _0x3595df=(_0x41d0b4[_0x570159(0x30a)]||[])[_0x570159(0x3e2)]((_0x5ee323,_0x497db4)=>{const _0x207c1a=_0x570159,_0x3ace99=_0x3e14f4[_0x207c1a(0x28b)](_0x13c2a3[_0x207c1a(0x40a)],_0x497db4),_0x48a56e=_0x3e14f4[_0x207c1a(0x28b)](_0x5ee323['id'],_0x117355);let _0x1643aa=_0x3e14f4[_0x207c1a(0x189)];if(_0x48a56e)_0x1643aa=_0x3e14f4[_0x207c1a(0x1fd)];else{if(_0x3ace99)_0x1643aa=_0x3e14f4[_0x207c1a(0x3c0)];}return _0x207c1a(0x29b)+_0x1643aa+_0x207c1a(0x1ac)+String[_0x207c1a(0x20d)](_0x3e14f4['vbCWR'](0x41,_0x497db4))+_0x207c1a(0x21d)+_0x5ee323[_0x207c1a(0x3e6)]+_0x207c1a(0x2d9);})[_0x570159(0x3c9)]('');const _0xff4106=_0x41d0b4[_0x570159(0x1f0)]?'<div\x20class=\x22mt-4\x22><video\x20id=\x22review-video-'+_0x69b668+_0x570159(0x403)+_0x41d0b4[_0x570159(0x1f0)]+_0x570159(0x3bc):'';let _0x41b7ed='';if(_0x41d0b4[_0x570159(0x27a)])_0x41b7ed+=_0x570159(0x2c4)+_0x41d0b4[_0x570159(0x27a)]+_0x570159(0x276);if(_0x41d0b4['explanation_audio_hin'])_0x41b7ed+=_0x570159(0x2ae)+_0x41d0b4[_0x570159(0x263)]+'\x22\x20controls\x20class=\x22w-full\x22></audio></div>';let _0x587efa=(_0x41d0b4[_0x570159(0x224)]||[])['map'](_0x56af5e=>_0x56af5e?_0x570159(0x19c)+_0x56af5e+_0x570159(0x171):'')[_0x570159(0x3c9)]('');_0x2e0c72[_0x570159(0x248)]=_0x570159(0x413)+_0x43fd35[_0x570159(0x367)](_0x69b668,0x1)+'</h4>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<span\x20class=\x22text-sm\x20px-3\x20py-1\x20rounded-full\x20bg-'+(_0x43fd35[_0x570159(0x1ca)](_0x591c81,_0x43fd35[_0x570159(0x3b9)])?_0x570159(0x357):_0x43fd35[_0x570159(0x1ca)](_0x591c81,_0x570159(0x414))?_0x43fd35[_0x570159(0x192)]:_0x570159(0x272))+_0x570159(0x22f)+_0x22860e+_0x570159(0x3bb)+_0x41d0b4['text']+_0x570159(0x352)+_0x3595df+'</div>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<div\x20class=\x22bg-green-900\x20bg-opacity-20\x20p-4\x20rounded-lg\x20border\x20border-green-700\x22>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<h5\x20class=\x22text-green-400\x20font-bold\x20mb-2\x22>Explanation:</h5>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<div\x20class=\x22text-white\x20text-opacity-90\x22>'+(_0x41d0b4[_0x570159(0x3fd)]||_0x43fd35[_0x570159(0x398)])+_0x570159(0x229)+_0xff4106+'\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20'+_0x41b7ed+_0x570159(0x1aa)+_0x587efa+'\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20</div>',_0x2af8ac[_0x570159(0x196)](_0x2e0c72);}}),_0x43fd35[_0x31b876(0x3b2)](initializeReviewVideos);}function _0x4bb1(){const _0xb2bf1b=['table','progressBar','JWLAA','nmqRg','Are\x20you\x20sure\x20you\x20want\x20to\x20retake\x20the\x20quiz?\x20This\x20will\x20reset\x20all\x20your\x20answers.','jwIUB','currentMode','<p><span\x20style=\x22font-size:12.0pt;\x22>Natalizumab</span></p>','nav-btn-incorrect','iRxTm','rxbjh','reload','sZTaX','rKCOK','NOmoi','PtkXE','</span></div>','<p><span\x20style=\x22font-size:12.0pt;\x22>A\x2071-year-old\x20woman\x20who\x20underwent\x20hip\x20replacement\x20was\x20discharged\x20from\x20the\x20hospital\x20with\x20an\x20appropriate\x20post-discharge\x20therapy\x20that\x20included\x20daily\x20subcutaneous\x20injection\x20of\x20regular\x20heparin.\x20Which\x20of\x20the\x20following\x20laboratory\x20examinations\x20should\x20be\x20performed\x20frequently\x20during\x20the\x20heparin\x20treatment?</span></p>','nxAjY','qWluj','reduce','hierarchy','<p><span\x20style=\x22font-size:12.0pt;\x22>Enoxaparin</span></p>','wqnUM','<p><span\x20style=\x22font-size:12.0pt;\x22>Dalteparin</span></p>','correctResult','correctAnswers','ULrGJ','gradient-purple\x20px-6\x20py-3\x20text-white\x20transition-all\x20duration-300\x20flex\x20items-center','udPTs','jDMOf','TDItL','No\x20question\x20text\x20available','jwZXa','<p><span\x20style=\x22font-size:12.0pt;\x22>Alteplase\x20has\x20no\x20risk\x20of\x20bleeding</span></p>','kWDMu','<p><span\x20style=\x22font-size:12.0pt;\x22>Warfarin\x20</span></p>','kKdfi','yDPCL','UpEoO','mUiAo','nav-btn-answered','padStart','zXGeW','key','dlhbX','XHVOH','<p><span\x20style=\x22font-size:12.0pt;\x22>Rivaroxaban</span></p>','CKfGG','ULdJq','Heparin\x20Lmwh\x20Direct\x20Thrombin\x20Inhibitors\x20Thromolytics\x20Warfarin\x20\x20Antiplatelets','<p><span\x20style=\x22font-size:12.0pt;\x22>Aspirin</span></p>','<p><span\x20style=\x22font-size:12.0pt;\x22>A\x2067-year-old\x20woman\x20presented\x20to\x20the\x20medicine\x20OPD\x20with\x20complaints\x20of\x20progressive\x20swelling\x20and\x20soreness\x20of\x20the\x20left\x20calf.\x20After\x20physical\x20examination\x20and\x20laboratory\x20examination,\x20a\x20diagnosis\x20of\x20deep\x20venous\x20thrombosis\x20was\x20made,\x20and\x20a\x20treatment\x20with\x20enoxaparin\x20was\x20started.\x20Which\x20of\x20the\x20following\x20is\x20the\x20main\x20advantage\x20of\x20this\x20drug\x20over\x20the\x20standard\x20unfractionated\x20heparin?</span></p>','sliIA','HNybR','amBHm','removeItem','questionReviewSection','Previous\x20progress\x20cleared.','QjwqN','bookmarkBtn','not_attempted','PGKkx','<p><span\x20style=\x22font-size:12.0pt;\x22>A\x2055-year-old\x20diabetic\x20female\x20patient\x20with\x20a\x20history\x20of\x20active\x20Tuberculosis\x20was\x20on\x20Isoniazid\x20and\x20Rifampicin\x20for\x20the\x20same.\x20Later,\x20she\x20was\x20brought\x20to\x20the\x20surgical\x20department\x20with\x20signs\x20of\x20Deep\x20Venous\x20Thrombosis\x20(DVT).\x20She\x20was\x20started\x20on\x20warfarin,\x20but\x20Prothrombin\x20time\x20(PT)\x20is\x20not\x20raised.\x20Which\x20of\x20the\x20following\x20is\x20the\x20most\x20accurate\x20step\x20to\x20be\x20taken?</span></p>','<img\x20class=\x22w-100\x22\x20style=\x22height:auto;\x20display:block;\x20vertical-align:middle;\x20border:0;\x20\x22src=\x22https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/202412236dcb78c0-64d6-4050-ae4b-63b92e8.jpg\x22>\x0d\x0a<p><strong>Clopidogrel:</strong></p>\x0d\x0a<ul>\x0d\x0a<li><em>This\x20is\x20a\x20more\x20potent\x20congener\x20of\x20</em><em>ticlopidine\x20that\x20acts\x20by\x20<u>irreversibly\x20blocking\x20the\x20P2Y12\x20type\x20of\x20purinergic\x20receptor\x20on\x20the\x20surface\x20of\x20platelets</u>.</em></li>\x0d\x0a<li><em>This\x20Gi-coupled\x20GPCR\x20<strong>mediates\x20ADP-induced\x20platelet\x20aggregation\x20by\x20inhibiting\x20adenylyl\x20cyclase\x20and\x20decreasing\x20cAMP</strong>.</em></li>\x0d\x0a<li><em>Clopidogrel\x20is\x20also\x20a\x20</em><em>\x20It\x20is\x20a\x20slow\x20acting\x20drug;\x20<strong>antiplatelet\x20action\x20takes\x20about\x204\x20hours\x20to\x20start\x20and\x20develops\x20over\x20days.</strong></em></li>\x0d\x0a<li><em>Since\x20</em><strong><em>CYP2C19\x20exhibits\x20genetic\x20polymorphism,\x20the\x20activation\x20of\x20clopidogrel\x20and\x20consequently\x20its\x20antiplatelet\x20action\x20shows\x20high\x20interindividual\x20variability.</em></strong></li>\x0d\x0a<li><em>Combination\x20of\x20clopidogrel\x20and\x20aspirin\x20is\x20synergistic\x20in\x20preventing\x20ischaemic\x20episodes.\x20This\x20<strong>&lsquo;dual\x20antiplatelet\x20therapy&rsquo;\x20(DAPT)\x20is\x20also\x20utilized\x20for\x20checking</strong></em><strong><em>\x20the\x20restenosis\x20of\x20stent</em></strong></li>\x0d\x0a<li><strong><em>The\x20most\x20important\x20adverse\x20effect\x20is\x20bleeding.\x20</em></strong><em>Neutropenia\x20is\x20rare\x20with\x20clopidogrel.\x20Other\x20side\x20effects\x20are\x20diarrhoea,\x20epigastric\x20pain\x20and\x20rashes.</em></li>\x0d\x0a</ul>\x0d\x0a<p><strong>Option\x20B:\x20</strong><em>Dipyridamole\x20acts\x20by\x20<strong>inhibiting\x20phosphodiesterase\x20</strong>(which\x20breaks\x20down\x20cAMP)\x20resulting\x20in\x20increased\x20cAMP\x20that\x20potentiates\x20prostacyclins\x20and\x20thus\x20anti-aggregation.</em></p>\x0d\x0a<p><strong>Option\x20C:\x20</strong><em>Abciximab\x20is\x20a\x20monoclonal\x20antibody\x20<strong>against\x20Gp\x20IIb/IIIa\x20receptor.\x20</strong>Gp\x20IIb/IIIa\x20antagonists\x20are\x20strongest\x20antiplatelet\x20drugs\x20as\x20they\x20block\x20aggregation\x20induced\x20by\x20all\x20agonists.</em></p>\x0d\x0a<p><strong>Option\x20D:\x20</strong><em>Warfarin\x20is\x20an\x20oral\x20anticoagulant\x20and\x20acts\x20by\x20inhibiting\x20the\x20activation\x20of\x20<strong>vitamin\x20K\x20dependent\x20clotting\x20factors.</strong></em></p>\x0d\x0a<p><strong><u>Key\x20Takeaway:\x20</u></strong></p>\x0d\x0a<ul>\x0d\x0a<li><em>Clopidogrel\x20is\x20a\x20congener\x20of\x20ticlopidine\x20that\x20acts\x20by\x20<u>irreversibly\x20blocking\x20the\x20P2Y12\x20type\x20of\x20purinergic\x20receptor\x20on\x20the\x20surface\x20of\x20platelets.</u></em></li>\x0d\x0a</ul>','choices','rcuAv','bRgGP','NyJxq','replace','dsoka','CpMCs','No\x20questions\x20available\x20for\x20this\x20quiz.','tOqey','ABpmI','strokeDashoffset','AVPqW','ZLbOD','border-red-500','DT1293237','lShWf','IbjLZ','Plooq','efukm','constructor','qZadO','No\x20solution\x20available.','osHTT','iDeXH','<p><em>Heparin\x20increases\x20the\x20activity\x20of\x20</em><em><u>antithrombin\x20by\x201000-fold.</u></em></p>\x0d\x0a<p><em>Anti-thrombin,\x20in\x20turn,\x20<strong>activates</strong>\x20serine\x20proteases\x20of\x20the\x20clotting\x20cascade.\x20Heparin\x20has\x20a\x20direct\x20anticoagulant\x20activity\x20and\x20can\x20<strong>inhibit</strong>\x20clotting\x20in\x20vitro.\x20</em></p>\x0d\x0a<p><strong><em><u>Heparin\x20enhances\x20the\x20action\x20of\x20AT-III\x20in\x20two\x20ways</u></em></strong></p>\x0d\x0a<p>(A)\x20The\x20<em><u>long\x20heparin\x20molecule\x20provides\x20a\x20scaffolding\x20for\x20the\x20clotting\x20factors\x20(mainly\x20Xa\x20and\x20IIa)\x20on\x20one\x20hand\x20and\x20AT-III\x20on\x20the\x20other,\x20so\x20that\x20they\x20interact\x20with\x20each\x20other.</u></em></p>\x0d\x0a<p>(B)\x20<em><u>Heparin\x20induces\x20conformational\x20change\x20in\x20AT-III\x20to\x20expose\x20its\x20interactive\x20sites.\x20</u></em></p>\x0d\x0a<p>A\x20<em><u>specific\x20pentasaccharide\x20sequence,\x20which\x20is\x20present\x20in\x20only\x20some\x20of\x20the\x20heparin\x20molecules,\x20binds\x20to\x20AT\x20III\x20with\x20high\x20affinity\x20to\x20induce\x20the\x20conformational\x20change</u></em>\x20needed\x20for\x20rapid\x20interaction\x20with\x20clotting\x20factors.</p>\x0d\x0a<img\x20class=\x22w-100\x22\x20style=\x22height:auto;\x20display:block;\x20vertical-align:middle;\x20border:0;\x20\x22src=\x22https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/20241223a385abf1-795e-4b0e-aca4-612c1b6.jpg\x22>\x0d\x0a<p>Option\x20B:\x20Serine\x20proteases\x20of\x20the\x20clotting\x20cascade\x20are\x20<strong>activated.</strong></p>\x0d\x0a<p>Option\x20C:\x20Heparin\x20<strong>Inhibits</strong>\x20clotting\x20in\x20vitro.</p>\x0d\x0a<p>Option\x20D:\x20Heparin\x20Provides\x20Scaffolding\x20To\x20Clotting\x20factors.</p>\x0d\x0a<p><strong><u>Key\x20Takeaway:\x20</u></strong></p>\x0d\x0a<ul>\x0d\x0a<li><em>Heparin\x20<strong>increases\x20the\x20activity\x20of\x20antithrombin\x20by\x201000-fold.\x20Anti-thrombin,\x20in\x20turn,\x20activates\x20serine\x20proteases\x20of\x20the\x20clotting\x20cascade.\x20Heparin\x20has\x20a\x20direct\x20anticoagulant\x20activity\x20and\x20can\x20inhibit\x20clotting\x20in\x20vitro.</strong></em></li>\x0d\x0a</ul>','data-option-index','timed_exam','mSxXp','DtFPB','remove','open','sYTZM','oHbiM','HvTcQ','smUhX','SCRWU','length','<p><span\x20style=\x22font-size:12.0pt;\x22>Dacetuzumab</span></p>','setItem','DwNRo','solutionAudio','study','floor','<p><span\x20style=\x22font-size:12.0pt;\x22>Unfractionated\x20heparin</span></p>','<p><span\x20style=\x22font-size:12.0pt;\x22>A\x2056-year-old\x20male\x20patient\x20presented\x20to\x20the\x20emergency\x20department\x20of\x20a\x20hospital\x20with\x20acute\x20left-sided\x20chest\x20pain.\x20ECG\x20of\x20the\x20patient\x20confirms\x20it\x20to\x20be\x20non\x20ST\x20elevation\x20myocardial\x20infarction.\x20Which\x20of\x20the\x20following\x20drug\x20is\x20useful\x20in\x20this\x20patient\x20acts\x20by\x20inhibiting\x20platelet\x20aggregation\x20via\x20blocking\x20Purinergic\x20receptors?</span></p>','<p><em>Coumarin\x20is\x20commonly\x20used\x20in\x20patients\x20<strong>with\x20atrial\x20fibrillation\x20</strong>for\x20prevention\x20of\x20thromboembolic\x20events,\x20such\x20as\x20stroke.\x20</em></p>\x0d\x0a<p><strong><em>Prothrombin\x20time(PT)</em></strong><em>\x20should\x20be\x20frequently\x20monitored\x20in\x20patients\x20taking\x20coumarin,\x20as\x20bleeding\x20is\x20a\x20common\x20adverse\x20effect.\x20</em></p>\x0d\x0a<p><strong>Dose\x20regulation\x20</strong></p>\x0d\x0a<ul>\x0d\x0a<li>The\x20<em>dose\x20of\x20vit\x20K\x20antagonist\x20oral\x20anticoagulant\x20must\x20be\x20individualised\x20by\x20<strong>repeated\x20measurement\x20of\x20prothrombin\x20time;</strong>\x20the\x20aim\x20is\x20to\x20achieve\x20a\x20therapeutic\x20effect\x20without\x20unduly\x20increasing\x20the\x20chances\x20of\x20bleeding.</em></li>\x0d\x0a</ul>\x0d\x0a<p><strong><em><u>Recommended\x20INR\x20for\x20various\x20indications\x20of\x20oral\x20anticoagulants</u></em></strong></p>\x0d\x0a<img\x20class=\x22w-100\x22\x20style=\x22height:auto;\x20display:block;\x20vertical-align:middle;\x20border:0;\x20\x22src=\x22https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/202412230a56cac8-69cb-48f4-b421-0f3746a.jpg\x22>\x0d\x0a<p><strong><em><u>Comparative\x20differences\x20between\x20Warfarin\x20and\x20Heparin</u></em></strong></p>\x0d\x0a<img\x20class=\x22w-100\x22\x20style=\x22height:auto;\x20display:block;\x20vertical-align:middle;\x20border:0;\x20\x22src=\x22https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/2024122364a97318-4da6-419e-84b4-af9a07c.jpg\x22>\x0d\x0a<p><strong>Option\x20A</strong>:\x20Heparin\x20is\x20monitored\x20with\x20<strong>partial\x20thromboplastin\x20time(aPTT).\x20</strong></p>\x0d\x0a<p><strong>Option\x20B</strong>:\x20<strong>Protamine\x20is\x20an\x20agent\x20used\x20for\x20heparin\x20reversal.</strong></p>\x0d\x0a<p><strong>Option\x20C</strong>:\x20<strong>LMWH\x20usually\x20requires\x20no\x20monitoring</strong></p>\x0d\x0a<p><strong><u>Key\x20Takeaway\x20:</u></strong></p>\x0d\x0a<ul>\x0d\x0a<li><em>Warfarin\x20is\x20commonly\x20used\x20in\x20patients\x20with\x20<strong>atrial\x20fibrillation\x20</strong>for\x20prevention\x20of\x20thromboembolic\x20events\x20&amp;\x20<strong>Prothrombin\x20time(PT)</strong>\x20should\x20be\x20frequently\x20monitored\x20in\x20patients\x20taking\x20the\x20same</em></li>\x0d\x0a</ul>','eNMqW','video[data-src]','MFiXS','GXcKX','display','knUyT','preventDefault','pGTYj','questionStates','hELKJ','textContent','eQMjd','WefPY','\x20>\x20','<p><span\x20style=\x22font-size:12.0pt;\x22>Complete\x20absence\x20of\x20bleeding\x20complications</span></p>','HHnET','ELIcq','Option\x20','KAcpe','wejHb','Zztys','gyxNH','hGINv','iReVp','<p><span\x20style=\x22font-size:12.0pt;\x22>Heparin\x20</span></p>','IHYpB','</div>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20</div>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<div\x20class=\x22space-y-2\x20mb-4\x22>','CqyRI','DT1293211','<p><span\x20style=\x22font-size:12.0pt;\x22>Heparin\x20catalyzes\x20clotting\x20in\x20vitro</span></p>','markReviewText','green','<p><em>Various\x20anticoagulation\x20regimens\x20are\x20always\x20<u>performed\x20before,\x20during,\x20and\x20after\x20angioplasty\x20to\x20reduce\x20the\x20incidence\x20of\x20thrombosis</u>.\x20</em></p>\x0d\x0a<p><strong><em><u>Heparin\x20and\x20abciximab\x20are\x20the\x20two\x20drugs\x20given\x20intravenously\x20for\x20this\x20purpose.</u></em></strong></p>\x0d\x0a<p><strong><em><u>Acute\x20coronary\x20syndromes\x20(ACSs)</u></em></strong></p>\x0d\x0a<ul>\x0d\x0a<li><strong><u>Soluble\x20aspirin\x20(325\x20mg\x20oral)\x20and\x20a\x20LMW\x20heparin\x20(s.c.)\x20are\x20given\x20at\x20presentation\x20to\x20all\x20patients\x20with\x20ACS.</u></strong></li>\x0d\x0a</ul>\x0d\x0a<p><strong><em>Unstable\x20angina\x20(UA)\x20:</em></strong></p>\x0d\x0a<ul>\x0d\x0a<li><em>Aspirin\x20reduces\x20the\x20risk\x20of\x20progression\x20to\x20MI\x20and\x20sudden\x20death.<u>Clopidogrel\x20is\x20generally\x20combined\x20with</u>\x20<u>aspirin,</u>\x20or\x20may\x20be\x20used\x20</em><em>as\x20an\x20alternative\x20if\x20aspirin\x20cannot\x20be\x20given.</em></li>\x0d\x0a<li><em>For\x20maximum\x20protection,\x20the\x20<u>antiplatelet\x20drugs\x20are\x20supplemented\x20with\x20LMW\x20heparin\x20followed\x20by\x20warfarin.</u></em></li>\x0d\x0a</ul>\x0d\x0a<p><strong><em>NSTEMI\x20:\x20</em></strong></p>\x0d\x0a<ul>\x0d\x0a<li><em>Patients\x20of\x20NSTEMI\x20who\x20are\x20managed\x20without\x20PCI/thrombolysis\x20are\x20generally\x20put\x20on\x20a\x20<u>combination\x20of\x20aspirin\x20+\x20clopidogrel\x20or\x20ticagrelor,\x20which\x20is\x20continued\x20for\x20upto\x20one\x20year.</u></em></li>\x0d\x0a</ul>\x0d\x0a<p><strong><em>STEMI\x20:\x20</em></strong></p>\x0d\x0a<ul>\x0d\x0a<li><em><u>Primary\x20PCI\x20with\x20or\x20without\x20stent\x20placement\x20is\x20the\x20procedure\x20of\x20choice\x20for\x20all\x20STEMI\x20as\x20well\x20as\x20high\x20risk\x20NSTEMI\x20patients\x20who\x20present\x20within\x2012\x20hours.</u></em></li>\x0d\x0a<li><em><u>Prasugrel\x20or\x20ticagrelor\x20+\x20aspirin\x20is\x20the\x20antiplatelet\x20regimen</u></em><em>\x20most\x20commonly\x20selected\x20for\x20patients\x20who\x20are\x20to\x20undergo\x20PCI.</em></li>\x0d\x0a<li><strong><em>The\x20GPIIb/IIIa\x20antagonists\x20are\x20the\x20most\x20powerful\x20antiplatelet\x20drugs.\x20</em></strong><em><u>Abciximab/eptifibatide/tirofiban\x20infused\x20i.v.\x20along\x20with\x20oral\x20aspirin\x20and\x20s.c.\x20heparin\x20markedly\x20reduce\x20incidence\x20of\x20restenosis\x20and\x20subsequent\x20MI\x20after\x20coronary\x20angioplasty.</u></em></li>\x0d\x0a<li><em>The\x20GPIIb/IIIa\x20antagonists\x20are\x20infused\x20for\x20a\x20maximum\x20of\x2072\x20hours.</em></li>\x0d\x0a</ul>\x0d\x0a<p><strong>Option\x20A\x20&amp;\x20B</strong>:\x20<em>Warfarin\x20and\x20clopidogrel\x20both\x20are\x20given\x20<strong>orally</strong>.</em></p>\x0d\x0a<p><strong>Option\x20D</strong>:\x20<em>Recombinant\x20factor\x20VIIa\x20is\x20given\x20intravenously\x20for\x20treatment\x20of\x20<strong>haemophilia\x20patients.\x20</strong></em></p>\x0d\x0a<p><strong><u>Key\x20Takeaway\x20:\x20</u></strong></p>\x0d\x0a<ul>\x0d\x0a<li><strong><u>Heparin\x20and\x20abciximab</u></strong>\x20<em>are\x20the\x20two\x20drugs\x20given\x20<strong>intravenously</strong>\x20for\x20</em>percutaneous\x20coronary\x20angioplasty\x20procedure.</li>\x0d\x0a</ul>','dJgsw','HKmOE','dEEPv','findIndex','getItem','DT1293249','src','dgQQK','EBBhY','totalAttempted','pop','gQJXT','nav-btn-current','includes','ZKhGv','EGgWn','tYutm','ybVPg','mitIz','<p><span\x20style=\x22font-size:12.0pt;\x22>A\x2050-year-old\x20woman\x20admitted\x20to\x20the\x20coronary\x20unit\x20because\x20of\x20a\x20myocardial\x20infarction\x20received\x20an\x20appropriate\x20multidrug\x20therapy.\x20The\x20next\x20day\x20she\x20complained\x20of\x20an\x20abrupt\x20headache,\x20followed\x20shortly\x20by\x20vomiting\x20and\x20loss\x20of\x20consciousness.\x20A\x20computed\x20tomography\x20scan\x20of\x20the\x20brain\x20confirmed\x20the\x20diagnosis\x20of\x20stroke\x20due\x20to\x20cerebral\x20hemorrhage.\x20Which\x20of\x20the\x20following\x20drugs\x20most\x20likely\x20contributed\x20to\x20the\x20appearance\x20of\x20the\x20patient\x27s\x20stroke?</span></p>','fhqBm','totalTimeResult','<p><strong><em><u>Effects\x20of\x20fondaparinux\x20cannot\x20be\x20reversed\x20by\x20protamine\x20sulfate\x20</u></em></strong></p>\x0d\x0a<ul>\x0d\x0a<li><strong>Protamine\x20sulfate\x20</strong>It\x20is\x20a\x20strongly\x20<strong><u>basic,\x20low\x20molecular\x20weight\x20protein</u></strong>\x20obtained\x20from\x20the\x20sperm\x20of\x20certain\x20fish.\x20Given\x20i.v.\x20it\x20neutralises\x20heparin\x20mg\x20for\x20mg,\x20i.e.\x20<strong><em>1\x20mg\x20is\x20needed\x20for\x20every\x20100\x20U\x20of\x20heparin.</em></strong></li>\x0d\x0a<li><strong><em>Protamine\x20is\x20more\x20commonly\x20used\x20when\x20heparin\x20action\x20needs\x20to\x20be\x20terminated\x20rapidly</em></strong>,\x20e.g.\x20after\x20cardiac\x20or\x20vascular\x20surgery.</li>\x0d\x0a<li><em>Protamine\x20sulfate\x20binds\x20and\x20neutralizes\x20unfractionated\x20</em><em>heparin,\x20resulting\x20in\x20the\x20complete\x20reversal\x20of\x20both\x20anti-factor\x20Ila\x20and\x20Xa\x20activity.</em></li>\x0d\x0a<li>Protamine\x20sulfate\x20<strong><u>reverses\x20the\x20anti-factor\x20lla\x20activity\x20of\x20LMWH\x20completely</u></strong>\x20and\x20anti-factor\x20Xa\x20partially\x20because\x20the\x20shorter\x20chains\x20cannot\x20be\x20neutralized.</li>\x0d\x0a<li>Protamine\x20<strong><em><u>does\x20not</u>\x20neutralize\x20fondaparinux</em></strong>,\x20and\x20it\x20only\x20<strong><em><u>partially</u>\x20reverses\x20the\x20anticoagulant\x20effect\x20of\x20LMW\x20heparins.</em></strong></li>\x0d\x0a</ul>\x0d\x0a<p><strong>Option\x20A\x20:\x20</strong><em>Protamine\x20sulfate\x20binds\x20and\x20neutralizes\x20unfractionated\x20heparin\x20<strong>completely.\x20</strong></em></p>\x0d\x0a<p><strong>Option\x20B\x20:\x20</strong><em>Protamine\x20sulfate\x20binds\x20and\x20neutralizes\x20LMWH\x20<strong>Partially.</strong></em></p>\x0d\x0a<p><strong>Option\x20C</strong>:\x20<em>Protamine\x20sulfate\x20binds\x20and\x20neutralizes\x20LMWH\x20<strong>Partially.</strong></em></p>\x0d\x0a<p><strong><u>Key\x20Takeaway:\x20</u></strong></p>\x0d\x0a<ul>\x0d\x0a<li>Protamine\x20<strong><em><u>does\x20not</u>\x20neutralize</em></strong><em>\x20fondaparinux</em>,\x20and\x20it\x20<strong>only\x20<em><u>partially</u>\x20reverses</em></strong><em>\x20the\x20anticoagulant\x20effect\x20of\x20LMW\x20heparins.</em></li>\x0d\x0a</ul>','tZCYN','<p><span\x20style=\x22font-size:12.0pt;\x22>Alteplase</span></p>','oiXqn','JhONV','totalQuestionsResult','EBqDG','jPOdz','<p><span\x20style=\x22font-size:12.0pt;\x22>A\x2053-year-old\x20obese\x20woman\x20is\x20brought\x20into\x20the\x20emergency\x20room\x20within\x20an\x20hour\x20after\x20complaining\x20of\x20constant\x20abdominal\x20pain,\x20nausea,\x20and\x20shortness\x20of\x20breath.\x20An\x20electrocardiogram\x20(ECG)\x20and\x20cardiac\x20enzyme\x20tests\x20indicate\x20a\x20moderate\x20myocardial\x20infarction\x20(MI)\x20due\x20to\x20occlusion\x20of\x20the\x20left\x20descending\x20coronary\x20artery.\x20Which\x20of\x20the\x20following\x20would\x20be\x20the\x20best\x20course\x20of\x20treatment\x20for\x20this\x20patient?</span></p>','<div\x20class=\x22glass-light\x20p-4\x20mb-4\x22><video\x20src=\x22','fZTNY','nav-btn-marked-review','axrsG','attachMedia','onclick','<p><em>The\x20<u>sudden\x20dyspnea,\x20hypotension,\x20and\x20pleuritic\x20chest\x20pain,\x20particularly\x20in\x20a\x20high-risk\x20setting,\x20would\x20suggest\x20the\x20diagnosis\x20of\x20massive\x20pulmonary\x20embolism,\x20which\x20is\x20confirmed\x20by\x20the\x20computed\x20tomography</u>\x20scan.\x20</em></p>\x0d\x0a<p><strong><em>Heparin\x20is\x20a\x20drug\x20of\x20choice\x20to\x20prevent\x20further\x20thrombus\x20formation\x20and\x20embolization.</em></strong></p>\x0d\x0a<p><strong>Option\x20B</strong>:\x20Aspirin\x20has\x20been\x20<strong><u>tried\x20to\x20prevent</u></strong>\x20thromboembolism,\x20but\x20results\x20are\x20<strong>inconclusive</strong>.\x20Moreover,\x20they\x20are\x20not\x20given\x20parenterally.</p>\x0d\x0a<p><strong>Option\x20C</strong>:\x20The\x20systemic\x20hypotension\x20and\x20extreme\x20hypoxemia\x20warrant\x20consideration\x20of\x20thrombolytic\x20therapy.\x20However,\x20<strong><em><u>recent\x20surgery\x20(as\x20in\x20this\x20case)\x20is\x20a\x20major\x20contraindication\x20for\x20fibrinolytic\x20drugs</u></em>.</strong></p>\x0d\x0a<p><strong>Option\x20D</strong>:\x20Warfarin\x20is\x20not\x20used\x20for\x20the\x20acute\x20treatment\x20of\x20pulmonary\x20embolism\x20because\x20of\x20its\x20<strong>slow\x20onset\x20of\x20action.</strong></p>\x0d\x0a<p><strong><u>Key\x20Takeaway:\x20</u></strong></p>\x0d\x0a<ul>\x0d\x0a<li><strong><em>When\x20Thrombolytics\x20are\x20Contraindicated</em></strong><em>\x20in\x20Massive\x20Pulmonary\x20Embolism,\x20heparin\x20is\x20a\x20drug\x20of\x20choice\x20<strong>to\x20prevent\x20further\x20thrombus\x20formation\x20and\x20embolization.\x20</strong></em></li>\x0d\x0a</ul>','BlsfM','DT1293213','fQbCM','HXRJp','DT1293253','WnTgc','notAttempted','<p><span\x20style=\x22font-size:12.0pt;\x22>Lovastatin</span></p>','incomplete','BpZnd','block','gwwGT','hlvMx','GXfxR','12678000EruqUY','hUKXJ','KLJxc','GuQxR','dkLcV','TpSwk','fMCzu','<p><span\x20style=\x22font-size:12.0pt;\x22>Heparin\x20aids\x20sequestration\x20of\x20lipoproteins</span></p>','qkkAe','JrSfK','ndzZP','aIWOb','TTqwW','<p><span\x20style=\x22font-size:12.0pt;\x22>Alteplase\x20does\x20not\x20cross\x20react\x20with\x20anti-streptococcal\x20antibodies</span></p>','uMlbV','Suqko','<p>The\x20<strong><em>anticoagulant\x20effect\x20of\x20warfarin\x20is\x20assessed\x20by\x20the\x20measurement\x20of\x20prothrombin\x20time\x20(PT).</em></strong>\x20Failure\x20of\x20<u>elevation\x20of\x20PT\x20indicates\x20the\x20decreased\x20effect\x20of\x20warfarin.</u></p>\x0d\x0a<p><strong><em>The\x20effect\x20of\x20oral\x20anticoagulants\x20is\x20always\x20delayed\x20(develops\x20gradually\x20over\x201-3\x20days)\x20and\x20these\x20are\x20thus\x20used\x20for\x20maintenance\x20of\x20anticoagulation\x20rather\x20than\x20initiation\x20of\x20treatment.</em></strong></p>\x0d\x0a<p>Option\x20A\x20:\x20<strong><em>Effect\x20of\x20warfarin\x20starts\x20in\x204-5\x20days.\x20Therefore,\x20if\x20we\x20increase\x20the\x20dose\x20of\x20warfarin,\x20it\x20will\x20take\x205\x20days\x20to\x20prevent\x20DVT.\x20</em></strong>For\x20<strong><u>immediate\x20action,\x20heparin,\x20or\x20LMWH\x20has\x20to\x20be\x20started</u></strong>.</p>\x0d\x0a<p><strong>Option\x20B:</strong>\x20Acenocoumarin\x20is\x20also\x20an\x20oral\x20anticoagulant\x20<strong>with\x20MOA\x20Like\x20Warfarin</strong>\x20with\x20delayed\x20effects.\x20Its\x20metabolism\x20is\x20also\x20subjected\x20to\x20<strong>induction\x20by\x20rifampicin.\x20</strong></p>\x0d\x0a<p><strong>Option\x20C:</strong>\x20<em><u>Rifampicin\x20is\x20an\x20<strong>enzyme\x20inducer\x20</strong>and\x20can\x20decrease\x20the\x20effect\x20of\x20warfarin.</u></em>\x20However,\x20Rifampicin\x20is\x20the\x20most\x20effective\x20drug\x20for\x20tuberculosis\x20and\x20<strong>should\x20not\x20be\x20replaced.</strong></p>\x0d\x0a<p><strong><u>Key\x20Takeaway\x20:\x20</u></strong></p>\x0d\x0a<ul>\x0d\x0a<li><em>The\x20effect\x20of\x20oral\x20anticoagulants\x20is\x20<strong>always\x20delayed</strong>\x20(develops\x20gradually\x20over\x201-3\x20days)\x20and\x20these\x20are\x20thus\x20used\x20for\x20<strong>maintenance\x20of\x20anticoagulation\x20rather\x20than\x20initiation\x20of\x20treatment.</strong></em></li>\x0d\x0a</ul>','ZvdEh','CTrAe','<p><em><u>High-molecular-weight\x20heparin\x20(HMWH)\x20causes\x20<strong>transient</strong>\x20thrombocytopenia\x20in\x20up\x20to\x20<strong>15</strong>%\x20of\x20patients</u></em><em>\x20and\x20<strong>severe</strong>\x20thrombocytopenia\x20(which\x20is\x20antibody-mediated)\x20in\x20up\x20to\x20<strong>5</strong>%\x20of\x20patients.\x20</em></p>\x0d\x0a<p><em>Because\x20<u>heparin-induced\x20thrombocytopenia\x20(HIT)\x20is\x20a\x20serious\x20adverse\x20effect\x20of\x20heparin</u>,\x20a\x20<strong>platelet\x20count\x20should\x20be\x20performed\x20weekly\x20during\x20heparin\x20treatment.\x20</strong></em></p>\x0d\x0a<p><strong><em>Any\x20thrombocytopenia\x20appearing\x20during\x20treatment\x20should\x20be\x20considered\x20suspicious\x20for\x20HIT.</em></strong></p>\x0d\x0a<img\x20class=\x22w-100\x22\x20style=\x22height:auto;\x20display:block;\x20vertical-align:middle;\x20border:0;\x20\x22src=\x22https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/20241223d48c9e7a-c5ed-4a1b-a67a.jpg\x22>\x0d\x0a<p>Option\x20A:\x20Heparin\x20doesn\x27t\x20alter\x20RBC\x20Count.</p>\x0d\x0a<p>Option\x20C:\x20Heparin\x20causes\x20Hyperkalemia\x20but\x20It\x20doesn\x27t\x20Require\x20Periodic\x20Checkup.</p>\x0d\x0a<p>Option\x20D:\x20Heparin\x20action\x20is\x20monitored\x20with\x20aPTT.\x20(\x20Vs\x20BT\x20Not\x20Required)</p>\x0d\x0a<p><strong><u>Key\x20Takeaway\x20:\x20</u></strong></p>\x0d\x0a<ul>\x0d\x0a<li><strong><em>Heparin-induced\x20thrombocytopenia\x20(HIT)\x20is\x20a\x20serious\x20</em></strong><em>adverse\x20effect\x20of\x20heparin,\x20<strong>a\x20platelet\x20count\x20should\x20be\x20performed\x20weekly\x20</strong>during\x20heparin\x20treatment.</em></li>\x0d\x0a</ul>','answered','3616650PPvrsQ','<p><span\x20style=\x22font-size:12.0pt;\x22>Clopidogrel</span></p>','DT1293251','DT1293241','PgRAD','NPfFg','UsPPS','WusLG','</div>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<div\x20class=\x22option-text\x22>','Pharmacology','cjaOw','sgxjz','vePia','pJtxC','PrkeC','reviewQuestionsContainer','sPHHe','vrIpN','FREVl','GQhIK','WnWkO','nVnpq','Progress\x20loaded.','jsTIj','ayuud','</span>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20</div>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<div\x20class=\x22text-white\x20mb-4\x22>','\x22\x20class=\x22w-full\x20rounded-lg\x22\x20controls></video></div>','PCurT','xyULn','<p><span\x20style=\x22font-size:12.0pt;\x22>Platelet\x20count</span></p>','WZckV','EayeT','ZZSBP','closest','<p><span\x20style=\x22font-size:12.0pt;\x22>Lower\x20incidence\x20of\x20drug-induced\x20thrombocytopenia</span></p>','BDsNt','abMQz','prototype','mtnLD','join','<p><span\x20style=\x22font-size:12.0pt;\x22>Thromboxane\x20A2\x20activity</span></p>','DT1292834','CStFe','OCWyU','<p><em><u>Ticlopidine\x20produces\x20serious\x20adverse\x20effects\x20like\x20neutropenia,\x20thrombocytopenia,\x20haemolysis,\x20jaundice.\x20</u></em>Which\x20is\x20P2Y12\x20Inhibitors,\x20so\x20answer\x20is\x20C.</p>\x0d\x0a<p><strong>Ticlopidine</strong></p>\x0d\x0a<ul>\x0d\x0a<li>It\x20is\x20the\x20first\x20thienopyridine\x20drug\x20that\x20acts\x20by\x20blocking\x20the\x20P2Y12\x20type\x20of\x20purinergic\x20receptors\x20on\x20the\x20surface\x20of\x20platelets\x20and\x20inhibits\x20ADP-induced\x20aggregation.</li>\x0d\x0a</ul>\x0d\x0a<p><strong><u>Ticlopidine\x20produces\x20beneficial\x20effects\x20in\x20following\x20conditions\x20</u></strong></p>\x0d\x0a<ul>\x0d\x0a<li><em><u>TIAs\x20stroke\x20prevention,\x20</u></em></li>\x0d\x0a<li><em><u>UA,</u></em></li>\x0d\x0a<li><em><u>Secondary\x20prophylaxis\x20of\x20MI</u></em></li>\x0d\x0a<li><em><u>Synergized\x20with\x20aspirin\x20to\x20lower\x20the\x20incidence\x20of\x20restenosis\x20after\x20PCI\x20and\x20stent\x20thrombosis.\x20</u></em></li>\x0d\x0a</ul>\x0d\x0a<p><strong>However,\x20it\x20produced\x20serious\x20adverse\x20effects\x20like\x20</strong></p>\x0d\x0a<ul>\x0d\x0a<li><em>Neutropenia,\x20</em></li>\x0d\x0a<li><em>Thrombocytopenia</em></li>\x0d\x0a<li><em>Haemolysis</em></li>\x0d\x0a<li><em>Jaundice.</em></li>\x0d\x0a</ul>\x0d\x0a<p><strong><u>Key\x20Takeaway:\x20</u></strong></p>\x0d\x0a<ul>\x0d\x0a<li><em>Ticlopidine\x20produces\x20serious\x20adverse\x20effects\x20like\x20<strong>neutropenia,\x20thrombocytopenia,\x20haemolysis,\x20jaundice.</strong></em></li>\x0d\x0a</ul>','lLbZX','YPZns','dCdeV','userHistory','kEaAJ','quizFile','tRhVp','nyujj','<p><span\x20style=\x22font-size:12.0pt;\x22>Increase\x20the\x20dose\x20of\x20warfarin\x20</span></p>','LIvOs','<p><span\x20style=\x22font-size:12.0pt;\x22>A\x2077-year-old\x20male,\x20Sureshbhai\x20presented\x20to\x20medicine\x20OPD\x20with\x20fever,\x20malaise,\x20sore\x20throat\x20with\x20mouth\x20ulcers.\x20He\x20had\x20a\x20history\x20of\x20myocardial\x20infarction,\x20for\x20that\x20he\x20was\x20on\x20antiplatelet\x20drugs.\x20His\x20complete\x20blood\x20count\x20shows:\x20Hb\x2013\x20g/dL,\x20Platelet\x20count\x20100000/mm3,\x20WBC\x201000/mm3.\x20If\x20the\x20above\x20given\x20antiplatelet\x20drug\x20is\x20suspected\x20to\x20be\x20responsible\x20for\x20the\x20above\x20symptoms\x20of\x20the\x20patients,\x20which\x20of\x20the\x20following\x20is\x20most\x20likely\x20the\x20mechanism\x20of\x20by\x20<br><img\x20class=\x22w-100\x22\x20style=\x22height:auto;\x20display:block;\x20vertical-align:middle;\x20border:0;\x20\x22src=\x22https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/20241223255cb279-28b4-40b9-9ea6-b1b6ecc.jpg\x22><br>Which\x20this\x20antiplatelet\x20agent\x20is\x20acting?\x20</span></p>','FOfeM','yOmeO','SIDkg','qzmgk','MynMV','filter','nEROJ','DAjgl','map','<p><span\x20style=\x22font-size:12.0pt;\x22>A\x2056-year-old\x20male\x20patient\x20had\x20a\x20history\x20of\x20ongoing\x20cancer\x20chemotherapy\x20presented\x20to\x20medicine\x20OPD\x20with\x20sudden\x20onset\x20breathlessness,\x20chest\x20pain,\x20palpitations\x20and\x20cough.\x20On\x20further\x20investigations,\x20CT\x20scan\x20of\x20chest\x20confirmed\x20the\x20diagnosis\x20of\x20pulmonary\x20embolism.\x20Which\x20of\x20the\x20following\x20anticoagulant\x20agent\x20is\x20the\x20drug\x20of\x20choice\x20for\x20the\x20management\x20of\x20cancer-associated\x20thromboembolism?\x20</span></p>','<p><span\x20style=\x22font-size:12.0pt;\x22>Warfarin</span></p>','<p><span\x20style=\x22font-size:12.0pt;\x22>Anticoagulant\x20activity\x20of\x20which\x20amongst\x20the\x20following\x20agents\x20is\x20not\x20affected\x20by\x20use\x20of\x20protamine\x20sulfate?</span></p>','text','zLesu','dGtmc','rTGSb','<p><span\x20style=\x22font-size:12.0pt;\x22>Eptifibatide</span></p>','customQuizData','push','{}.constructor(\x22return\x20this\x22)(\x20)','cUirN','(((.+)+)+)+$','CcTts','HPkYL','<div\x20class=\x22mt-2\x22><p\x20class=\x22text-sm\x20text-white\x20text-opacity-70\x20mb-1\x22>English\x20Explanation:</p><audio\x20src=\x22','wCBNf','nSdcD','GlLdq','fibDr','hMiSa','KhbsT','mjpzC','KyLOH','VpnIg','aFSMY','solution','vDvVC','<p><span\x20style=\x22font-size:12.0pt;\x22>A\x2075-year-old\x20male\x20patient\x20post\x20surgery\x20was\x20admitted\x20to\x20the\x20emergency\x20department\x20with\x20deep\x20vein\x20thrombosis.\x20He\x20was\x20later\x20started\x20on\x20an\x20Anticoagulant\x20therapy\x20by\x20his\x20attending\x20physician.\x20Next\x20day,\x20the\x20patient\x20presented\x20with\x20the\x20features\x20shown\x20in\x20the\x20diagram\x20below.\x20Which\x20of\x20the\x20following\x20drug\x20is\x20most\x20likely\x20implicated\x20for\x20this\x20adverse\x20effect?<br><img\x20class=\x22w-100\x22\x20style=\x22height:auto;\x20display:block;\x20vertical-align:middle;\x20border:0;\x20\x22src=\x22https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/202412235af6898a-701e-4fb8-9de5-770ac7f.jpg\x22></span></p>','ReHzC','<img\x20class=\x22w-100\x22\x20style=\x22height:auto;\x20display:block;\x20vertical-align:middle;\x20border:0;\x20\x22src=\x22https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/202412235096c23f-fc07-4ce1-ae83-e8cb240.jpg\x22><p><strong>Option\x20A,\x20B\x20&amp;\x20D:\x20</strong><em>The\x20major\x20adverse\x20effect\x20of\x20these\x20drugs\x20also\x20is\x20bleeding,\x20but\x20all\x20of\x20them\x20don&rsquo;t\x20lead\x20to\x20<strong>ecchymosis</strong></em>\x20<em>as\x20is\x20the\x20case\x20here.\x20</em></p>\x0d\x0a<p><strong><u>Key\x20Takeaway\x20:\x20</u></strong></p>\x0d\x0a<ul>\x0d\x0a<li><em><u>Bleeding\x20is\x20the\x20most\x20common\x20adverse\x20effect\x20of\x20all\x20anticoagulants</u></em>.\x20If\x20a\x20patient\x20develops\x20bleeding\x20due\x20to\x20overdose\x20of\x20warfarin,\x20<strong>four\x20factor\x20concentrate\x20or\x20fresh\x20frozen\x20plasma</strong>\x20(to\x20supply\x20clotting\x20factors)\x20is\x20the\x20treatment\x20of\x20choice\x20but\x20<strong><em>specific\x20antidote\x20is\x20vitamin\x20K</em></strong><strong><em>1</em></strong>\x20(but\x20the\x20action\x20will\x20be\x20delayed).</li>\x0d\x0a</ul>','TIiuR','\x22\x20data-src=\x22','getAttribute','timed_study','jYthD','rlICC','yGMgY','scoreCircle','selectedAnswer','lZypO','get','FenEW','accuracy','hvRVM','<p><span\x20style=\x22font-size:12.0pt;\x22>D</span></p>','grNPz','ArrowRight','\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<div\x20class=\x22mb-4\x22>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<div\x20class=\x22flex\x20justify-between\x20items-center\x20mb-3\x22>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<h4\x20class=\x22text-lg\x20font-bold\x20text-white\x22>Question\x20','incorrect','IhYth','KjjKD','<p><em><u>Dabigatran\x20is\x20a\x20new\x20oral\x20anticoagulant\x20that\x20acts\x20by\x20binding\x20reversibly\x20to\x20thrombin,\x20thus\x20blocking\x20thrombin\x20activity</u></em>.</p>\x0d\x0a<p><strong><em>Advantages\x20of\x20direct\x20thrombin\x20inhibitor\x20over\x20Warfarin</em></strong></p>\x0d\x0a<ul>\x0d\x0a<li><em><u>Rapid\x20onset\x20of\x20action,\x20</u></em></li>\x0d\x0a<li><em><u>Does\x20not\x20interact\x20with\x20p-450-interacting\x20drugs</u></em></li>\x0d\x0a<li><em><u>Gives\x20a\x20predictable\x20anticoagulant\x20response</u></em></li>\x0d\x0a<li><em><u>Routine\x20anticoagulant\x20monitoring\x20not\x20required</u></em>.</li>\x0d\x0a</ul>\x0d\x0a<p><strong><em><u>ORAL\x20ANTICOAGULANTS</u></em></strong></p>\x0d\x0a<img\x20class=\x22w-100\x22\x20style=\x22height:auto;\x20display:block;\x20vertical-align:middle;\x20border:0;\x20\x22src=\x22https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/20241223a88a8367-1f7a-4854-b37d.jpg\x22>\x0d\x0a<p>Option\x20A:\x20Prothrombin\x20Synthesis\x20inhibited\x20by\x20Coumarins.</p>\x0d\x0a<p>Option\x20B:\x20TAX-2\x20Activity\x20inhibited\x20by\x20Aspirin.</p>\x0d\x0a<p>Option\x20D:\x20AT-3\x20Activity\x20is\x20increased\x20by\x20Heparin.</p>\x0d\x0a<p><strong><u>Key\x20Takeaway\x20:\x20</u></strong></p>\x0d\x0a<ul>\x0d\x0a<li><em>Dabigatran\x20is\x20a\x20new\x20oral\x20anticoagulant\x20that\x20acts\x20by\x20<strong>binding\x20reversibly\x20to\x20thrombin,\x20thus\x20blocking\x20thrombin\x20activity</strong></em><strong>.</strong></li>\x0d\x0a</ul>','intermediate','Not\x20Attempted','getElementById','CAQuE','AYlus','FzDvb','udbCE','<p><em><u>High-molecular-weight\x20heparin\x20(HMWH)\x20causes\x20<strong>transient</strong>\x20thrombocytopenia\x20<strong>in\x20up\x20to\x2015%\x20of\x20patients</strong></u></em><em>\x20and\x20<strong>severe</strong>\x20thrombocytopenia\x20(which\x20is\x20antibody-mediated)\x20<strong>in\x20up\x20to\x205%\x20of\x20patients.</strong></em></p>\x0d\x0a<p><strong><em><u>Enoxaparin\x20is\x20a\x20low-molecular-weight\x20heparin\x20(LMWH).\x20</u></em></strong><em><u>LMWH-induced\x20thrombocytopenia\x20is\x20seen\x20in\x20less\x20than\x201%\x20of\x20patients.</u></em></p>\x0d\x0a<p><em>A\x20<u>LMWHs\x20cause\x20a\x20<strong>lower\x20incidence\x20of\x20bleeding\x20complications</strong></u><strong>,\x20</strong>which\x20could\x20be\x20related\x20to\x20the\x20fact\x20that\x20these\x20agents\x20<strong><u>preferentially\x20inhibit\x20factor\x20Xa\x20more\x20potently\x20than\x20they\x20inhibit\x20thrombin\x20(thrombin\x20inhibition\x20requires\x20a\x20larger\x20heparin\x20molecule).</u></strong></em></p>\x0d\x0a<p><strong><em><u>Advantages\x20of\x20LMWH\x20over\x20Heparin</u></em></strong></p>\x0d\x0a<img\x20class=\x22w-100\x22\x20style=\x22height:auto;\x20display:block;\x20vertical-align:middle;\x20border:0;\x20\x22src=\x22https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/202412234a3a0707-c58c-4d5d-aa7a-567b94a.jpg\x22>\x0d\x0a<p>Option\x20A:\x20<em>bleeding\x20complications\x20are\x20less,\x20do\x20occur\x20even\x20with\x20LMWH.</em></p>\x0d\x0a<p>Option\x20B:\x20LMWH\x20has\x20Greater\x20Bioavailability\x20but\x20when\x20given\x20Subcutaneously.</p>\x0d\x0a<p>Option\x20C:\x20LMWH\x20has\x20Lesser\x20anti\x20platelet\x20activity\x20and\x20Bleeding\x20Complications.</p>\x0d\x0a<p><strong><u>Key\x20Takeaway:\x20</u></strong></p>\x0d\x0a<ul>\x0d\x0a<li><strong><em>LMWH\x20has\x20Lower\x20incidence\x20of\x20Drug\x20induced\x20Thrombocytopenia\x20&amp;\x20Bleeding\x20Risk\x20compared\x20to\x20Unfractionated\x20HMWH.\x20</em></strong></li>\x0d\x0a</ul>','<p><span\x20style=\x22font-size:12.0pt;\x22>Abciximab</span></p>','NgNjJ','accuracyScore','qKutJ','submitSection','<div\x20class=\x22mt-2\x22><p\x20class=\x22text-sm\x20text-white\x20text-opacity-70\x20mb-1\x22>Hinglish\x20Explanation:</p><audio\x20src=\x22','yZIgT','waAde','isSupported','strokeDasharray','oCZZX','glass-light\x20px-6\x20py-3\x20text-white\x20hover:bg-yellow-500\x20hover:bg-opacity-20\x20transition-all\x20duration-300\x20flex\x20items-center','ERHUt','<p><span\x20style=\x22font-size:12.0pt;\x22>A\x2072-year-old\x20man\x20recently\x20diagnosed\x20with\x20atrial\x20fibrillation\x20started\x20a\x20treatment\x20that\x20included\x20dabigatran.\x20The\x20inhibition\x20of\x20which\x20of\x20the\x20following\x20molecular\x20actions\x20most\x20likely\x20mediated\x20the\x20therapeutic\x20effect\x20of\x20the\x20drug\x20in\x20this\x20patient?</span></p>','siVrh','forEach','\x22\x20alt=\x22Explanation\x20Image\x22\x20class=\x22w-full\x20rounded-lg\x22></div>','lPlCV','2956182kjUmll','OUinZ','questions','yPFlU','bookmarkedQuestions','studyModeLegend','selected','test','OWbjP','WiBpB','epoBl','wlQUb','TQFkh','add','nuVKt','Zbqbd','RlhDa','<p><span\x20style=\x22font-size:12.0pt;\x22>A\x2065-year-old\x20man\x20developed\x20sudden\x20dyspnea\x20and\x20chest\x20pain\x202\x20days\x20post\x20surgery.\x20Physical\x20examination\x20revealed\x20an\x20anxious\x20man\x20in\x20severe\x20respiratory\x20distress\x20with\x20the\x20following\x20vital\x20signs:\x20temperature\x2099.5&deg;F,\x20pulse\x20120\x20bpm,\x20blood\x20pressure\x2090/50\x20mm\x20Hg,\x20respirations\x2028\x20breaths/min.\x20A\x20computed\x20tomography\x20scan\x20showed\x20complete\x20obstruction\x20of\x20a\x20branch\x20of\x20the\x20left\x20pulmonary\x20artery.\x20Which\x20of\x20the\x20following\x20drugs\x20should\x20be\x20included\x20in\x20the\x20acute\x20parenteral\x20treatment\x20of\x20this\x20patient?</span></p>','DT1293244','border-green-500','<p><span\x20style=\x22font-size:12.0pt;\x22>Streptokinase\x20induced\x20hypotension</span></p>','question_video','hhOyN','fhstR','PHCBg','<p><span\x20style=\x22font-size:12.0pt;\x22>A\x2055-year-old\x20woman\x20undergoes\x20an\x20open\x20cholecystectomy.\x20She\x20is\x20admitted\x20for\x20postoperative\x20observation\x20and\x20started\x20on\x20subcutaneous\x20heparin\x20treatment\x20to\x20prevent\x20formation\x20of\x20deep\x20venous\x20thrombosis,\x20a\x20major\x20risk\x20factor\x20for\x20pulmonary\x20embolism.\x20Which\x20of\x20the\x20following\x20is\x20the\x20most\x20accurate\x20regarding\x20the\x20mechanism\x20of\x20action\x20of\x20heparin?</span></p>','EpngD','<p><span\x20style=\x22font-size:12.0pt;\x22>Coumarin</span></p>','nav-btn-correct','prevBtn','qQoga','UPfDa','quizHierarchy','<p><span\x20style=\x22font-size:12.0pt;\x22>B</span></p>','pathname','appendChild','POEts','2199940NRhMzk','testModeReviewLegend','KByTj','zCeyC','<div\x20class=\x22mt-4\x22><img\x20src=\x22','ZOhmS','DocTutorial','incorrectCount','ekJTv','correct','gYLSt','oCwgJ','<p><span\x20style=\x22font-size:12.0pt;\x22>A\x2063-year-old\x20man\x20has\x20a\x20history\x20of\x20atrial\x20fibrillation.\x20To\x20reduce\x20his\x20risk\x20of\x20a\x20stroke,\x20his\x20physician\x20had\x20given\x20him\x20an\x20anticoagulant\x20medication.\x20This\x20agent\x20comes\x20with\x20risks\x20of\x20spontaneous\x20hemorrhage.\x20To\x20monitor\x20the\x20appropriatenessof\x20the\x20current\x20dosage\x20of\x20the\x20medication,\x20the\x20patient\x20comes\x20in\x20frequently\x20to\x20have\x20the\x20laboratory\x20check\x20his\x20prothrombin\x20level.\x20Which\x20of\x20the\x20following\x20medication\x20most\x20likely\x20this\x20patient\x20is\x20taking?</span></p>','<p><span\x20style=\x22font-size:12.0pt;\x22>Ticlopidine</span></p>','pRoIO','JJkCP','ZRRrV','TSwxR','\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20','MMpIV','\x22><span\x20class=\x22font-bold\x20mr-3\x22>','Are\x20you\x20sure\x20you\x20want\x20to\x20submit\x20the\x20quiz?','isArray','Factual','cizLh','WcRAM','question_audio','ASHor','totalQuestions','FnGjY','bookmarked','correctCount','<img\x20class=\x22w-100\x22\x20style=\x22height:auto;\x20display:block;\x20vertical-align:middle;\x20border:0;\x20\x22src=\x22https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/202412239e51025d-69be-49ee-bec1-2578fa6.jpg\x22>\x0d\x0a<p><strong><u>Streptokinase\x20</u></strong></p>\x0d\x0a<ul>\x0d\x0a<li><em>Obtained\x20from\x20<u>&beta;\x20haemolytic\x20Streptococci</u>\x20group\x20C</em><em>.\x20It\x20is\x20the\x20first\x20fibrinolytic\x20drug\x20to\x20be\x20used\x20clinically,\x20but\x20is\x20<strong><u>not\x20employed\x20now\x20because\x20it\x20is\x20non-fibrin\x20specific,\x20i.e.\x20activates\x20both\x20circulating\x20as\x20well\x20as\x20fibrin\x20bound\x20plasminogen.\x20</u></strong>Therefore,\x20it\x20depletes\x20circulating\x20fibrinogen\x20and\x20predisposes\x20to\x20bleeding.</em></li>\x0d\x0a<li><em>Compared\x20to\x20newer,\x20more\x20fibrin-specific\x20tissue\x20plasminogen\x20activators\x20(alteplase,\x20etc.)\x20it\x20is\x20<u>less\x20effective\x20in\x20opening\x20occluded\x20coronary\x20arteries,\x20and\x20causes\x20a\x20less\x20reduction\x20in\x20MI\x20related\x20mortality</u>.</em></li>\x0d\x0a<li><em>Other\x20disadvantages\x20are\x20</em><em>needed\x20for\x20a\x20<u>loading\x20dose\x20due\x20to\x20presence\x20of\x20anti-streptococcal\x20antibodies.\x20</u><strong>Streptokinase\x20is\x20antigenic-can\x20cause\x20hypersensitivity\x20reactions;\x20anaphylaxis\x20occurs\x20in\x201-2%\x20patients</strong>.</em></li>\x0d\x0a<li><em>Fever,\x20hypotension\x20and\x20arrhythmias\x20are\x20reported.</em><em>\x20It\x20<strong>cannot\x20be\x20used\x20a\x20second\x20time\x20due\x20to\x20neutralization\x20by\x20antibodies\x20generated\x20in\x20response\x20to\x20the\x20earlier\x20dose</strong>.</em></li>\x0d\x0a</ul>\x0d\x0a<p><strong><u>Alteplase\x20</u></strong></p>\x0d\x0a<ul>\x0d\x0a<li><strong><em><u>Recombinant\x20tissue\x20plasminogen\x20activator</u></em></strong><em>\x20(rt-PA)\x20It\x20catalyses\x20the\x20cleavage\x20of\x20endogenous\x20plasminogen\x20to\x20generate\x20plasmin,\x20and\x20is\x20<u>moderately\x20specific\x20for\x20fibrin\x20bound\x20plasminogen,\x20so\x20that\x20circulating\x20fibrinogen\x20is\x20lowered\x20only\x20by\x20~\x2050%.</u></em></li>\x0d\x0a<li><em>It\x20is\x20rapidly\x20cleared\x20</em><em>by\x20the\x20liver\x20and\x20is\x20inactivated\x20by\x20plasminogen\x20Activator\x20inhibitor-1\x20(PAI-1).\x20The\x20plasma\x20t&frac12;\x20is\x204-8\x20min.\x20<u>Because\x20of\x20the\x20short\x20t&frac12;,\x20it\x20needs\x20to\x20be\x20given\x20by\x20slow\x20i.v.\x20infusion\x20and\x20often\x20requires\x20heparin\x20coadministration</u>.</em></li>\x0d\x0a<li><em>Aspirin\x20is\x20also\x20routinely\x20given\x20after\x20establishing\x20reperfusion.\x20Risk\x20of\x20bleeding\x20(0.5-5%)\x20is\x20the\x20most\x20important\x20concern.</em></li>\x0d\x0a<li><strong><em>Alteplase\x20is\x20nonantigenic,\x20but\x20nausea,\x20mild\x20hypotension\x20and\x20fever\x20may\x20occur.\x20It\x20is\x20expensive.</em></strong></li>\x0d\x0a</ul>\x0d\x0a<p>Option\x20A:\x20All\x20Thrombolytics\x20are\x20relatively\x20contraindicated\x20In\x20patient\x20above\x20&gt;75\x20years.</p>\x0d\x0a<p>Option\x20B:\x20Streptokinase\x20and\x20alteplase\x20both\x20cause\x20hypotension.\x20However,\x20alteplase\x20is\x20preferred\x20due\x20to\x20clot\x20selectivity.</p>\x0d\x0a<p>Option\x20D:\x20With\x20Alteplase,\x20<em>risk\x20of\x20bleeding\x20(0.5-5%)\x20is\x20the\x20most\x20important\x20concern.\x20</em></p>\x0d\x0a<p><strong><u>Key\x20Takeaway:\x20</u></strong></p>\x0d\x0a<ul>\x0d\x0a<li><em>Streptokinase\x20is\x20<strong>antigenic-can\x20cause\x20hypersensitivity\x20reaction.</strong>\x20It\x20cannot\x20be\x20used\x20second\x20time\x20due\x20to\x20<strong>neutralization\x20by\x20antibodies\x20generated\x20in\x20response\x20to\x20the\x20earlier\x20dose.</strong></em></li>\x0d\x0a</ul>','index.html','RKMSL','contains','<p><span\x20style=\x22font-size:12.0pt;\x22>Protamine</span></p>','glass-light\x20px-6\x20py-3\x20text-white\x20hover:bg-purple-500\x20hover:bg-opacity-20\x20transition-all\x20duration-300\x20flex\x20items-center','log','BxgQB','<p><span\x20style=\x22font-size:12.0pt;\x22>Dipyridamole</span></p>','DT1293247','markedForReview','9038IyqulB','Pjdhm','PEzIE','uCbym','AHfJL','hlUdS','WIztR','TnGBq','<p><span\x20style=\x22font-size:12.0pt;\x22>Dabigatran</span></p>','heparin-lmwh-direct-thrombin-inhibitors-thromolytics-warfarin-antiplatelets-177ce420.html','name','LnXcO','timeSpent','DT1293216','totalTime','toString','<p><span\x20style=\x22font-size:12.0pt;\x22>A</span></p>','jRXRc','<p><span\x20style=\x22font-size:12.0pt;\x22>Propranolol</span></p>','<p><span\x20style=\x22font-size:12.0pt;\x22>Heparin\x20increases\x20activity\x20of\x20antithrombin</span></p>','TSYLW','Ooaer','qcaIr','addEventListener','now','currentQuestion','nasaN','location','OgAyE','NrZab','stringify','<p><em><u>Heparin,\x20LMWH,\x20or\x20fondaparinux</u></em><em>\x20can\x20be\x20used\x20to\x20initiate\x20treatment\x20of\x20deep\x20vein\x20thrombosis\x20and\x20pulmonary\x20embolism.\x20They\x20also\x20can\x20be\x20used\x20for\x20the\x20<strong><u>initial\x20management\x20of\x20patients\x20with\x20unstable\x20angina\x20or\x20acute\x20myocardial\x20infarction</u></strong></em><strong><em>.</em></strong></p>\x0d\x0a<ul>\x0d\x0a<li><strong><em><u>For\x20most\x20of\x20these\x20indications,\x20LMWH\x20or\x20fondaparinux\x20has\x20replaced\x20continuous\x20heparin\x20infusions\x20because\x20of\x20the\x20following\x20advantages:</u></em></strong>\x0d\x0a<ul>\x0d\x0a<li><strong><em>Pharmacokinetic\x20advantages:</em></strong></li>\x0d\x0a<li><em>Subcutaneous\x20administration\x20once\x20or\x20twice\x20daily\x20in\x20fixed\x20or\x20weight-adjusted\x20doses\x20</em></li>\x0d\x0a<li><strong><em>No\x20need\x20for\x20coagulation\x20monitoring.</em></strong></li>\x0d\x0a</ul>\x0d\x0a</li>\x0d\x0a<li><em>Thus,\x20LMWH\x20or\x20<u>fondaparinux\x20can\x20be\x20used\x20for\x20out-of-hospital\x20management\x20of\x20patients\x20with\x20deep\x20vein\x20thrombosis\x20or\x20pulmonary\x20embolism.</u></em></li>\x0d\x0a</ul><img\x20class=\x22w-100\x22\x20style=\x22height:auto;\x20display:block;\x20vertical-align:middle;\x20border:0;\x20\x22src=\x22https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/202412237c19a6b8-784a-48c5-a038.jpg\x22>\x0d\x0a<p><strong>Option\x20B:\x20</strong><em>The\x20effect\x20of\x20oral\x20anticoagulants\x20<strong>is\x20always\x20delayed\x20</strong>(develops\x20gradually\x20over\x201-3\x20days)\x20and\x20these\x20are\x20thus\x20used\x20for\x20<strong>maintenance</strong>\x20of\x20anticoagulation\x20rather\x20than\x20initiation\x20of\x20treatment.\x20</em></p>\x0d\x0a<p><strong>Option\x20C\x20&amp;\x20D:\x20</strong><em>Heparin\x20and\x20dabigatran\x20can\x20be\x20used\x20in\x20pulmonary\x20embolism\x20but\x20<strong>because\x20of\x20the\x20pharmacokinetic\x20advantages\x20and\x20safety\x20profile,</strong>\x20fondaparinux\x20is\x20a\x20more\x20preferred\x20agent.</em></p>\x0d\x0a<p><strong><u>Key\x20Takeaway\x20:\x20</u></strong></p>\x0d\x0a<ul>\x0d\x0a<li><em>Fondaparinux\x20can\x20be\x20used\x20for\x20<strong>out-of-hospital\x20management\x20of\x20patients\x20with\x20deep\x20vein\x20thrombosis\x20or\x20pulmonary\x20embolism\x20</strong>because\x20of\x20the\x20safety\x20profile\x20of\x20it\x20as\x20compared\x20to\x20other\x20agents.</em></li>\x0d\x0a</ul>','currentQuestionIndex','questionMedia','kIRud','giMMe','DT1293238','DT1293233','qptyy','TYDlI','tEHXi','<p><strong><em>Ticagrelor\x20is\x20more\x20commonly\x20associated\x20with\x20dyspnea.\x20</em></strong></p>\x0d\x0a<p>The\x20dyspnea\x20is\x20<strong><u>transient\x20and\x20not\x20associated\x20with\x20pulmonary\x20disease</u></strong>.\x20Other\x20Side\x20effects\x20are\x20dizziness,\x20nausea,\x20<u>shortness\x20of\x20breath,\x20tightness\x20in\x20chest</u>\x20and\x20irregular\x20pulse.</p>\x0d\x0a<p><strong><em>Dyspnea\x20</em></strong>is\x20more\x20commonly\x20seen\x20with\x20<strong>reversible</strong>\x20P2Y12\x20inhibitors\x20like\x20ticagrelor,\x20cangrelor\x20and\x20elinogrel.\x20It\x20is\x20<strong>uncommon\x20with\x20irreversible\x20P2Y12\x20</strong><strong>inhibitors\x20like\x20clopidogrel,\x20prasugrel\x20and\x20ticlopidine.</strong></p>\x0d\x0a<p><strong>Option\x20A,\x20B\x20&amp;\x20D</strong>:\x20Dyspnea\x20is\x20<strong><u>uncommon\x20with\x20irreversible\x20P2Y12\x20inhibitors\x20like\x20clopidogrel,\x20prasugrel\x20and\x20ticlopidine.</u></strong></p>\x0d\x0a<p><strong><u>Key\x20Takeaway\x20:\x20</u></strong></p>\x0d\x0a<ul>\x0d\x0a<li><em>Ticagrelor\x20is\x20more\x20commonly\x20associated\x20with\x20dyspnea\x20amongst\x20P2Y12\x20inhibitors.\x20<strong>Dyspnea\x20is\x20more\x20seen\x20with\x20reversible\x20P2Y12\x20inhibitors.</strong></em></li>\x0d\x0a</ul>','hidden','createElement','flex','explanation_video','iToUE','233NCYlYj','oCgEi','\x22>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<div\x20class=\x22option-letter\x22>','avgTimeResult','style','5741796XwgcWd','<p><span\x20style=\x22font-size:12.0pt;\x22>Switch\x20ethambutol\x20for\x20rifampicin\x20</span></p>','width','IGPYv','<p><span\x20style=\x22font-size:12.0pt;\x22>Heparin</span></p>','click','MVffs','toggle','ragIy','timerContainer','kGzSQ','round','__proto__','QEQvO','<p><span\x20style=\x22font-size:12.0pt;\x22>Serine\x20proteases\x20of\x20the\x20clotting\x20cascade\x20are\x20deactivated</span></p>','incorrectResult','NuihS','phvVp','<p><em><u>Bleeding\x20is\x20the\x20major\x20side\x20effect\x20of\x20dabigatran.\x20</u></em></p>\x0d\x0a<p><em>In\x20elderly\x20patients\x20with\x20atrial\x20fibrillation,\x20<u>the\x20risk\x20of\x20major\x20bleeding\x20with\x20dabigatran\x20is\x20like\x20that\x20with\x20warfarin,\x20about\x203.0%.</u>\x20However,\x20the\x20risk\x20of\x20<strong>intracranial\x20bleeding\x20is\x20reduced\x20by\x2070%</strong>\x20with\x20dabigatran\x20compared\x20with\x20warfarin.\x20</em></p>\x0d\x0a<p><em><u>Additional\x20risk\x20factors\x20for\x20bleeding\x20with\x20dabigatran\x20<strong>include\x20renal\x20impairment\x20and\x20concurrent\x20use\x20of\x20antiplatelet\x20agents\x20or\x20nonsteroidal\x20anti-inflammatory\x20drugs</strong></u></em><strong><em>.\x20</em></strong></p>\x0d\x0a<p><strong><em><u>Idarucizumab</u></em></strong></p>\x0d\x0a<ul>\x0d\x0a<li><em><u>Idarucizumab,\x20A\x20specific\x20reversal\x20agent\x20for\x20dabigatran,\x20is\x20a\x20humanized\x20mouse\x20monoclonal\x20antibody\x20fragment\x20directed\x20against\x20dabigatran.</u></em></li>\x0d\x0a<li><em>The\x20<strong>antibody\x20binds\x20dabigatran\x20with\x20an\x20affinity\x20350-fold\x20higher\x20than\x20that\x20of\x20dabigatran\x20for\x20thrombin</strong>,\x20and\x20the\x20<u>essentially\x20irreversible\x20idarucizumab-dabigatran\x20complex\x20is\x20cleared\x20by\x20the\x20kidneys.</u></em></li>\x0d\x0a<li><em>It\x20<u>rapidly\x20reverses\x20the\x20anticoagulant\x20effects\x20of\x20dabigatran,\x20and\x20patients\x20</u></em><em><u>have\x20then\x20safely\x20undergone\x20major\x20surgery.</u></em></li>\x0d\x0a</ul>\x0d\x0a<p><strong><u>Reversal\x20Agents\x20for\x20Direct\x20Oral\x20Anticoagulants</u></strong></p>\x0d\x0a<img\x20class=\x22w-100\x22\x20style=\x22height:auto;\x20display:block;\x20vertical-align:middle;\x20border:0;\x20\x22src=\x22https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/202412233001c94d-fa99-45ce-b3f2.jpg\x22>\x0d\x0a<p><strong>Option\x20A:\x20TCR\x20signaling\x20on\x20CD4+\x20cells\x20after\x20engagement\x20with\x20an\x20MHC\x20class\x20II-peptide\x20complex\x20</strong>is\x20enhanced\x20by\x20activating\x20coreceptors\x20CD\x2040\x20&amp;\x20CD\x20150\x20which\x20is\x20activated\x20by\x20Dacetuzumab.</p>\x0d\x0a<p><strong>Option\x20C:\x20</strong>Pembrolizumab\x20is\x20monoclonal\x20antibodies\x20<strong>against\x20PD-1\x20receptors\x20on\x20T-cells.</strong></p>\x0d\x0a<p><strong>Option\x20D:\x20</strong>Natalizumab\x20is\x20highly\x20effective\x20in\x20<strong>multiple\x20sclerosis.</strong></p>\x0d\x0a<p><strong><u>Key\x20Takeaway\x20:\x20</u></strong></p>\x0d\x0a<ul>\x0d\x0a<li><em>Idarucizumab,\x20<strong>A\x20specific\x20reversal\x20agent\x20for\x20dabigatran,</strong>\x20is\x20a\x20humanized\x20mouse\x20monoclonal\x20antibody\x20fragment\x20directed\x20against\x20dabigatran.</em></li>\x0d\x0a</ul>','\x22\x20data-option-index=\x22','canPlayType','aDvQa','fromCharCode','HEtFo','KMzZc','kcPoK','KZdQY','RzOzv','tbgGX','<p><span\x20style=\x22font-size:12.0pt;\x22>Pronounced\x20anti-platelet\x20activity</span></p>','pfEdf','SIZUH','SrFVp','<p><span\x20style=\x22font-size:12.0pt;\x22>Use\x20LMWH\x20</span></p>','exception','startAt','ApwND','.option-button','</span><span>','CYKlp','completed','zvVFZ','Incorrect','1|3|4|0|5|2','correct_choice_id','explanation_images','tHZyK','error','loadSource','<p><span\x20style=\x22font-size:12.0pt;\x22>Red\x20blood\x20cell\x20count\x20(RBC)</span></p>','</div>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20','<p><span\x20style=\x22font-size:12.0pt;\x22>Antithrombin\x20III\x20activity</span></p>','hcMAF','XkwnV','toLowerCase','classList','-600\x20text-white\x22>','<p><span\x20style=\x22font-size:12.0pt;\x22>Streptokinase</span></p>','GXwUg','VlSCJ','utazd','target','xpFDl','apply','yiMID','5995318jsMLHt','No\x20solution\x20provided','PsNHM','not-attempted','incorrectAnswers','<p><span\x20style=\x22font-size:12.0pt;\x22>A\x2030-year-old\x20woman\x20presented\x20to\x20her\x20family\x20physician\x20complaining\x20of\x20black,\x20tarry\x20stools.\x20The\x20woman\x20had\x20a\x20history\x20of\x20prosthetic\x20valve\x20replacement\x20before\x20a\x20few\x20months\x20earlier\x20for\x20severe\x20aortic\x20stenosis\x20secondary\x20to\x20rheumatic\x20disease\x20and\x20had\x20been\x20receiving\x20daily\x20oral\x20anticoagulant\x20therapy\x20since\x20then.\x20Physical\x20examination\x20revealed\x20subconjunctival\x20hemorrhage\x20and\x20bruises\x20on\x20her\x20arms\x20and\x20legs.\x20Which\x20of\x20the\x20following\x20drugs\x20most\x20likely\x20caused\x20the\x20patient\x27s\x20signs\x20and\x20symptoms?</span></p>','Bookmark','<p><em><u>The\x20patient\x20has\x20symptoms\x20consistent\x20with\x20a\x20transient\x20ischemic\x20attack\x20(TIA).\x20Prophylactic\x20antiplatelet\x20therapy\x20should\x20be\x20instituted\x20while\x20the\x20diagnosis\x20is\x20confirmed.</u></em></p>\x0d\x0a<p><strong><em><u>Cerebrovascular\x20disease\x20</u></em></strong></p>\x0d\x0a<ul>\x0d\x0a<li><em>Antiplatelet\x20drugs\x20do\x20not\x20alter\x20the\x20course\x20of\x20stroke\x20due\x20to\x20cerebral\x20thrombosis.</em></li>\x0d\x0a<li><em>However,\x20<u>aspirin\x20has\x20reduced\x20the\x20incidence\x20of\x20TIAs\x20and\x20of\x20stroke\x20in\x20patients\x20with\x20TIAs.</u></em></li>\x0d\x0a<li><em>Occurrence\x20of\x20stroke\x20is\x20also\x20reduced\x20in\x20patients\x20with\x20persistent\x20atrial</em><em>\x20fibrillation\x20and\x20in\x20those\x20with\x20a\x20history\x20of\x20stroke\x20in\x20the\x20past.</em></li>\x0d\x0a<li><strong><em><u>Aspirin\x20or\x20clopidogrel\x20is\x20given\x20to\x20all\x20patients\x20of\x20TIAs\x20who\x20are\x20not\x20to\x20be</u></em></strong><strong><em><u>\x20treated\x20with\x20anticoagulants</u></em></strong><em>.</em></li>\x0d\x0a<li><em>Though\x20short-term\x20use\x20of\x20aspirin\x20+\x20clopidogrel\x20DAPT\x20may\x20be\x20beneficial,\x20long-term\x20use\x20of\x20the\x20<strong><u>combination\x20increases\x20the\x20risk\x20of\x20haemorrhage</u>.</strong></em></li>\x0d\x0a</ul>\x0d\x0a<p><strong>Option\x20A</strong>:\x20Streptokinase\x20is\x20thrombolytic\x20that\x20may\x20be\x20used\x20within\x20hours\x20of\x20a\x20thrombotic\x20stroke\x20<strong>but\x20not\x20after\x202\x20days\x20after\x20a\x20possible\x20TIA.</strong></p>\x0d\x0a<p><strong>Option\x20C</strong>:\x20Heparin\x20is\x20<strong>not\x20suitable\x20for\x20outpatient\x20use.\x20</strong></p>\x0d\x0a<p><strong>Option\x20D\x20:\x20</strong><em>Abciximab\x20<strong>does\x20not\x20alter\x20the\x20course\x20of\x20stroke\x20due\x20to\x20cerebral\x20thrombosis.</strong></em><strong>\x20It\x27s\x20not\x20suitable\x20also\x20for\x20outpatient\x20use\x20dt\x20Intravenous\x20Route\x20of\x20administration.</strong></p>\x0d\x0a<p><strong><u>Key\x20Takeaway\x20:\x20</u></strong></p>\x0d\x0a<ul>\x0d\x0a<li><em>Clopidogrel\x20is\x20given\x20to\x20all\x20patients\x20of\x20<strong>TIAs\x20who\x20are\x20not\x20to\x20be\x20treated\x20with\x20anticoagulants.</strong></em></li>\x0d\x0a</ul>','vxoYI','<p><span\x20style=\x22font-size:12.0pt;\x22>Plasma\x20K+\x20level</span></p>','kMRzr','GqXSl','fpRlG','fGCoE','BYwDW','<p>The\x20standard\x20therapy\x20of\x20myocardial\x20infarction\x20(MI)\x20includes\x20an\x20intravenous\x20thrombolytic\x20drug\x20(alteplase,\x20reteplase,\x20etc.),\x20which\x20is\x20most\x20effective\x20in\x20the\x20first\x20few\x20hours\x20after\x20onset.</p>\x0d\x0a<p>Bleeding\x20(most\x20common\x20in\x20cerebral\x20vessels)\x20is\x20the\x20most\x20frequent\x20adverse\x20effect\x20of\x20these\x20drugs.</p>\x0d\x0a<img\x20class=\x22w-100\x22\x20style=\x22height:auto;\x20display:block;\x20vertical-align:middle;\x20border:0;\x20\x22src=\x22https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/20241223e3735c0b-5531-4029-9ea3-e58ad46.jpg\x22>\x0d\x0a<p><strong>Option\x20A</strong>:\x20Aspirin,\x20if\x20not\x20contraindicated,\x20is\x20given\x20at\x20presentation\x20and\x20daily\x20indefinitely\x20thereafter.\x20Its\x20antiplatelet\x20effect\x20reduces\x20short-\x20and\x20long-term\x20mortality.\x20<strong>Bleeding,\x20however,\x20is\x20not\x20as\x20common\x20as\x20with\x20thrombolytic\x20drugs.</strong></p>\x0d\x0a<p><strong>Option\x20B:</strong>\x20Beta-blockers,\x20if\x20not\x20contraindicated,\x20are\x20given\x20within\x20the\x20first\x20few\x20hours\x20after\x20onset\x20because\x20they\x20reduce\x20recurrence\x20rate\x20and\x20mortality.\x20<strong>Bleeding\x20is\x20not\x20an\x20adverse\x20effect\x20of\x20this\x20drug\x20class.</strong></p>\x0d\x0a<p><strong>Option\x20C:</strong>\x20Nitroglycerin\x20is\x20recommended\x20for\x20the\x20first\x2024\x20to\x2048\x20hours\x20in\x20patients\x20with\x20MI\x20and\x20heart\x20failure\x20or\x20hypertension.\x20<strong>Bleeding\x20is\x20not\x20an\x20adverse\x20effect\x20of\x20this\x20drug\x20class.</strong></p>\x0d\x0a<p><strong><u>Key\x20Takeaway:\x20</u></strong></p>\x0d\x0a<ul>\x0d\x0a<li><strong><em>Bleeding\x20(most\x20common\x20in\x20cerebral\x20vessels)\x20is\x20the\x20most\x20frequent\x20adverse\x20effect\x20</em></strong><em>of\x20these\x20drugs,\x20which\x20is\x20because\x20of\x20the\x20dissolution\x20of\x20an\x20already\x20formed\x20clot.</em></li>\x0d\x0a</ul>','innerHTML','vPSEL','solutionContainer','pyucP','true','UFurm','search','DmCVJ','nav-btn-not-attempted\x20hover:bg-white\x20hover:bg-opacity-20','bottom','querySelectorAll','<p><span\x20style=\x22font-size:12.0pt;\x22>LMWH</span></p>','<p><span\x20style=\x22font-size:12.0pt;\x22>Fondaparinux</span></p>','qEGwt','wliuJ','timeDisplay','Veywy','RgXqH','DT1293248','button','bOZEZ','gXwUm','status','optionsContainer','XRcKx','ZVYZT','Mark\x20for\x20Review','explanation_audio_hin','stats','pEJam','trace','<p><span\x20style=\x22font-size:12.0pt;\x22>Prothrombin\x20synthesis</span></p>','ZtcXt','DT1293239','zLWrm','BDzPv','bind','custom_quiz.html','className','tcVQG','<p><span\x20style=\x22font-size:12.0pt;\x22>Clopidogrel\x20</span></p>','Bookmarked','gray','QbgZh','OKgwa','DT1293209','\x22\x20controls\x20class=\x22w-full\x22></audio></div>','Lcfbj','fKICe','disabled','explanation_audio_eng','GtAYD','ffBNe','modeModal','zxuHk','dIwwN','solutionText','oQajP','split','questionIndex','href','<p><em><u>Thrombolytics\x20such\x20as\x20the\x20recombinant\x20tissue\x20plasminogen\x20activator(tPA)\x20reteplase\x20reduce\x20morbidity\x20and\x20mortality</u></em><em>\x20if\x20used\x20shortly\x20after\x20an\x20acute\x20myocardial\x20infarction\x20(AMI).\x20</em></p>\x0d\x0a<img\x20class=\x22w-100\x22\x20style=\x22height:auto;\x20display:block;\x20vertical-align:middle;\x20border:0;\x20\x22src=\x22https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/202412232936e067-422f-46a7-b296.jpg\x22>\x0d\x0a<p>Option\x20B:\x20<em><u>Heparin\x20might\x20be\x20used\x20after\x20resolution\x20of\x20the\x20Acute\x20MI.\x20</u></em></p>\x0d\x0a<p>However\x20it\x27s\x20not\x20a\x20suitable\x20choice\x20for\x20acute\x20myocardial\x20infarction\x20on\x20an\x20immediate\x20basis.</p>\x0d\x0a<p>Option\x20C:\x20Eptifibatide\x20is\x20a\x20glycoprotein\x20IIb/IIIa\x20class\x20platelet\x20inhibitor\x20drug\x20that\x20reduces\x20ischemic\x20cardiac\x20events\x20in\x20specific\x20patient\x20populations.\x20However\x20STEMI\x20Requires\x20Thrombolytics\x20therapy.</p>\x0d\x0a<p>Option\x20D:\x20<em>If\x20the\x20patient\x20is\x20above\x20recommended\x20levels\x20of\x20low-density\x20lipoprotein\x20(LDL)\x20cholesterol,\x20she\x20should\x20be\x20treated\x20with\x20a\x20cholesterol-lowering\x20drug\x20such\x20as\x20lovastatin.\x20However,\x20it\x27s\x20</em>not\x20a\x20suitable\x20choice\x20for\x20acute\x20myocardial\x20infarction\x20on\x20an\x20immediate\x20basis.</p>\x0d\x0a<p><strong><u>Key\x20Takeaway\x20:\x20</u></strong></p>\x0d\x0a<ul>\x0d\x0a<li><em>Thrombolytics\x20such\x20as\x20the\x20recombinant\x20tissue\x20plasminogen\x20activator\x20(tPA)\x20reduce\x20morbidity\x20and\x20mortality\x20if\x20used\x20shortly\x20after\x20an\x20acute\x20myocardial\x20infarction\x20(AMI).</em></li>\x0d\x0a</ul>','LWUBw','mzSyK','Ktjsj','testModeLegend','.m3u8','xPVoO','parse','Fpvjt','KjlEC','performanceModal','markReviewBtn','BcJCH','zjkTM','EryeD','wLzCS','GOWlO','TsyAU','CDWNa','application/vnd.apple.mpegurl','DKXYR','JUrtO','<div\x20class=\x22p-3\x20rounded-lg\x20border\x20','KNWMs','<p><span\x20style=\x22font-size:12.0pt;\x22>A\x2056-year-old\x20female\x20presented\x20to\x20medicine\x20OPD\x20seeking\x20treatment\x20for\x20deep\x20vein\x20thrombosis.\x20Later,\x20she\x20was\x20prescribed\x20dabigatran\x20by\x20her\x20physician.\x20As\x20the\x20patient\x20was\x20also\x20having\x20mild\x20renal\x20impairment,\x20there\x20were\x20multiple\x20hemorrhagic\x20episodes\x20due\x20to\x20dabigatran\x20toxicity.\x20Which\x20of\x20the\x20following\x20monoclonal\x20antibody\x20is\x20approved\x20for\x20the\x20reversal\x20of\x20serious\x20bleeding\x20due\x20to\x20dabigatran\x20toxicity?\x20</span></p>','<p><span\x20style=\x22font-size:12.0pt;\x22>C</span></p>','CXzAw','DDNRS','uWhjw','question_images','console','Correct','Marked','fuGRM','<div\x20class=\x22glass-light\x20p-4\x20mb-4\x22><img\x20src=\x22','CUwFG','resume','gYeRJ','lnHGB','DT1293230','<p><span\x20style=\x22font-size:12.0pt;\x22>A\x2056-year-old\x20male\x20patient\x20with\x20a\x20recent\x20history\x20of\x20acute\x20myocardial\x20infarction\x20was\x20prescribed\x20an\x20antiplatelet\x20agent\x20acting\x20via\x20P2Y12\x20inhibition.\x20Later\x20that\x20patient\x20came\x20to\x20the\x20medicine\x20department\x20with\x20complaints\x20of\x20Dyspnea.\x20Which\x20of\x20the\x20following\x20agents\x20is\x20commonly\x20associated\x20Dyspnea?</span></p>','<div\x20class=\x22mt-2\x22><p\x20class=\x22text-sm\x20text-white\x20text-opacity-70\x20mb-1\x22>Hinglish:</p><audio\x20src=\x22','DERBp','toISOString','div','xwdeX','questionNav','rcYyS','YLvpi','endsWith','SWGWn','jyYac','BOorK','<p><span\x20style=\x22font-size:12.0pt;\x22>Ticagrelor</span></p>','vKgBc','hmxjX','IUUUr','OVLMD','none','vVXFl','w-8\x20h-8\x20text-sm\x20font-medium\x20rounded\x20transition-all\x20duration-200','<p><span\x20style=\x22font-size:12.0pt;\x22>A\x2056-year-old\x20man\x20admitted\x20to\x20the\x20hospital\x20with\x20a\x20myocardial\x20infarction\x20underwent\x20a\x20percutaneous\x20coronary\x20angioplasty\x20for\x20the\x20revascularization\x20of\x20his\x20left\x20coronary.\x20Which\x20of\x20the\x20following\x20drugs\x20was\x20most\x20likely\x20given\x20intravenously\x20during\x20the\x20procedure?</span></p>','rtCcF','<div\x20class=\x22mt-2\x22><p\x20class=\x22text-sm\x20text-white\x20text-opacity-70\x20mb-1\x22>English:</p><audio\x20src=\x22','<p><span\x20style=\x22font-size:12.0pt;\x22>Pembrolizumab</span></p>','navBtn_','<p><em>The\x20primary\x20approach\x20to\x20prevent\x20valvular\x20thrombosis\x20and\x20systemic\x20thromboembolism\x20associated\x20with\x20<strong><u>mechanical\x20prosthetic\x20valve\x20replacement\x20is\x20long-term\x20anticoagulation\x20with\x20warfarin</u>.\x20</strong></em></p>\x0d\x0a<p><em>Most\x20likely,\x20<u>the\x20dose\x20of\x20warfarin\x20was\x20too\x20high,\x20so\x20bleeding\x20occurred,\x20as\x20pointed\x20out\x20by\x20the\x20signs\x20and\x20symptoms\x20of\x20the\x20patient.</u></em></p>\x0d\x0a<img\x20class=\x22w-100\x22\x20style=\x22height:auto;\x20display:block;\x20vertical-align:middle;\x20border:0;\x20\x22src=\x22https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/202412238e660f30-d0bd-4cb8-939e.jpg\x22>\x0d\x0a<p><strong>Option\x20A</strong>:\x20Fibrinolytic\x20drugs\x20such\x20as\x20streptokinase\x20are\x20<strong>not\x20indicated\x20for\x20long-term\x20prevention\x20of\x20thrombosis.</strong></p>\x0d\x0a<p><strong>Option\x20B</strong>:\x20Aspirin\x20is\x20sometimes\x20used\x20together\x20with\x20warfarin\x20in\x20treating\x20patients\x20with\x20prosthetic\x20valves,\x20mainly\x20when\x20evidence\x20of\x20thromboembolism\x20exists\x20despite\x20adequate\x20anticoagulation.\x20<strong>However,\x20it\x20is\x20not\x20effective\x20for\x20prevention\x20when\x20given\x20alone.</strong></p>\x0d\x0a<p><strong>Option\x20C</strong>:\x20Heparin\x20and\x20bivalirudin\x20<strong>must\x20be\x20given\x20parenterally</strong>\x20and\x20therefore\x20are\x20not\x20suited\x20for\x20long-term\x20anticoagulation.</p>\x0d\x0a<p><strong><u>Key\x20Takeaway\x20:</u></strong></p>\x0d\x0a<ul>\x0d\x0a<li><strong><em><u>Bleeding\x20is\x20the\x20most\x20common</u></em></strong><em><u>\x20adverse\x20effect\x20of\x20all\x20anticoagulants</u></em>.\x20If\x20a\x20patient\x20develops\x20bleeding\x20due\x20to\x20overdose\x20of\x20warfarin,\x20<strong>four\x20factor\x20concentrate\x20or\x20fresh\x20frozen\x20plasma</strong>\x20(to\x20supply\x20clotting\x20factors)\x20is\x20the\x20treatment\x20of\x20choice\x20but\x20<strong><em>specific\x20antidote\x20is\x20vitamin\x20K</em></strong><strong><em>1</em></strong>\x20(but\x20the\x20action\x20will\x20be\x20delayed).</li>\x0d\x0a</ul>','TGUlH'];_0x4bb1=function(){return _0xb2bf1b;};return _0x4bb1();}function initializeReviewVideos(){const _0x152a62=_0x2a9a66,_0x442de6={'nVnpq':'.m3u8','bXzDo':function(_0x53db94,_0x40f9b2,_0x5adef1){return _0x53db94(_0x40f9b2,_0x5adef1);},'ABpmI':function(_0x248b5e,_0x515c72){return _0x248b5e===_0x515c72;},'XRcKx':_0x152a62(0x339)};document[_0x152a62(0x252)](_0x442de6[_0x152a62(0x260)])['forEach'](_0x27593f=>{const _0x2a31fd=_0x152a62,_0x24fa10=_0x27593f['dataset'][_0x2a31fd(0x35f)];if(_0x24fa10&&_0x24fa10[_0x2a31fd(0x366)](_0x442de6[_0x2a31fd(0x3b7)]))_0x442de6['bXzDo'](setupVideo,_0x27593f,_0x24fa10);else _0x24fa10&&(_0x442de6[_0x2a31fd(0x313)]('hKzGd',_0x2a31fd(0x411))?_0x420144[_0x2089d3][_0x2a31fd(0x1cf)]+=_0x5aaad2['now']()-_0x25dd51:_0x27593f['src']=_0x24fa10);});}function retakeQuiz(){const _0x2157b9=_0x2a9a66,_0x47aaa3={'yZmDA':function(_0x43900b,_0x1ec453){return _0x43900b(_0x1ec453);},'nxAjY':_0x2157b9(0x2cd),'wxUrI':'custom_quiz.html','reKec':_0x2157b9(0x3eb)};_0x47aaa3['yZmDA'](confirm,_0x47aaa3[_0x2157b9(0x2db)])&&(window[_0x2157b9(0x1de)][_0x2157b9(0x195)][_0x2157b9(0x2b6)](_0x47aaa3['wxUrI'])&&localStorage[_0x2157b9(0x301)](_0x47aaa3['reKec']),clearProgress(),location[_0x2157b9(0x2d4)]());}function loadBookmarkedQuestions(){const _0x5358b6=_0x2a9a66,_0x542f8f={'GXfxR':function(_0x2ee7a9,_0xbac19a){return _0x2ee7a9===_0xbac19a;},'zxuHk':function(_0x2c9ad0,_0x29876e){return _0x2c9ad0===_0x29876e;},'pyucP':_0x5358b6(0x1a1),'oCwgJ':_0x5358b6(0x414),'BxgQB':function(_0x6d6e4a){return _0x6d6e4a();},'KNWMs':function(_0x5753ca,_0x6d7625){return _0x5753ca(_0x6d7625);},'DKXYR':function(_0x2e8fd1){return _0x2e8fd1();},'tZCYN':'nav-btn-current','BpZnd':function(_0x1b8418,_0x5415c5){return _0x1b8418===_0x5415c5;},'TsyAU':'zKyCr','PrkeC':'kQBIB','lGMIx':function(_0x127c5f,_0x29fc71){return _0x127c5f<_0x29fc71;},'rTGSb':function(_0x5cff69,_0x1288f7){return _0x5cff69===_0x1288f7;},'IUUUr':_0x5358b6(0x1dd),'WnTgc':'NuAyu','fMCzu':_0x5358b6(0x177)},_0x52fc53=JSON[_0x5358b6(0x28c)](localStorage[_0x5358b6(0x35d)](_0x542f8f[_0x5358b6(0x393)]))||[];_0x52fc53[_0x5358b6(0x170)](_0x3b699e=>{const _0x4f5a07=_0x5358b6;if(_0x542f8f[_0x4f5a07(0x388)](_0x542f8f[_0x4f5a07(0x296)],_0x542f8f[_0x4f5a07(0x3b0)])){const _0x50fb88=_0x41d936[_0x550bd1],_0x4e14cd=_0x50fb88['correct_choice_id'];if(_0x542f8f[_0x4f5a07(0x38c)](_0x18c850,null))return;const _0x12109e=_0x50fb88[_0x4f5a07(0x30a)][_0x357059],_0x32b4fa=_0x542f8f[_0x4f5a07(0x38c)](_0x12109e['id'],_0x4e14cd);if(_0x542f8f[_0x4f5a07(0x27e)](_0x3321de[_0x8fc7ef][_0x4f5a07(0x25e)],'not_attempted')){_0x3eae0a[_0x4f5a07(0x362)]++,_0xc61e6['notAttempted']--;if(_0x32b4fa)_0x9f1c2c[_0x4f5a07(0x2e3)]++;else _0x420fda['incorrectAnswers']++;}_0x1c5eb4[_0x1f8eea][_0x4f5a07(0x25e)]=_0x32b4fa?_0x542f8f[_0x4f5a07(0x24b)]:_0x542f8f[_0x4f5a07(0x1a3)],_0x542f8f[_0x4f5a07(0x1bf)](_0x2e2610),_0x542f8f[_0x4f5a07(0x29c)](_0x21a6da,_0x32b4fa),_0x542f8f[_0x4f5a07(0x299)](_0x138c50);}else _0x3b699e['quizFile'][_0x4f5a07(0x366)](quizName[_0x4f5a07(0x22d)]()['replace'](/ /g,'-'))&&(_0x542f8f['lGMIx'](_0x3b699e['questionIndex'],questionsData[_0x4f5a07(0x32e)])&&(_0x542f8f[_0x4f5a07(0x3e9)](_0x542f8f[_0x4f5a07(0x2bd)],_0x542f8f[_0x4f5a07(0x384)])?_0x4df342=_0x542f8f[_0x4f5a07(0x370)]:questionStates[_0x3b699e[_0x4f5a07(0x283)]][_0x4f5a07(0x1b6)]=!![]));});}function toggleBookmark(){const _0x330735=_0x2a9a66,_0x2f4f27={'oHbiM':function(_0x1b1394){return _0x1b1394();},'OKgwa':_0x330735(0x177),'VlSCJ':function(_0x452486,_0x54b0f1){return _0x452486!==_0x54b0f1;},'jYthD':'xpFDl','KqKlJ':'ERHUt'},_0x169069=!questionStates[currentQuestionIndex][_0x330735(0x1b6)];questionStates[currentQuestionIndex][_0x330735(0x1b6)]=_0x169069;let _0x17d020=JSON['parse'](localStorage[_0x330735(0x35d)](_0x2f4f27[_0x330735(0x274)]))||[];if(_0x169069){if(_0x2f4f27[_0x330735(0x232)](_0x330735(0x235),_0x2f4f27[_0x330735(0x406)]))_0x2f4f27[_0x330735(0x32a)](_0x463088);else{const _0x3c9fdc={'quizName':quizName,'quizFile':window['location']['pathname']['split']('/')[_0x330735(0x363)](),'questionIndex':currentQuestionIndex,'question':questionsData[currentQuestionIndex],'hierarchy':hierarchy,'timestamp':Date['now']()};_0x17d020['push'](_0x3c9fdc);}}else _0x2f4f27[_0x330735(0x232)](_0x330735(0x42c),_0x2f4f27['KqKlJ'])?_0x2858eb[_0x330735(0x248)]+=_0x330735(0x425)+_0x211256[_0x330735(0x263)]+_0x330735(0x276):_0x17d020=_0x17d020['filter'](_0x36c607=>!(_0x36c607[_0x330735(0x3d4)][_0x330735(0x366)](quizName['toLowerCase']()[_0x330735(0x30e)](/ /g,'-'))&&_0x36c607[_0x330735(0x283)]===currentQuestionIndex));localStorage[_0x330735(0x330)](_0x2f4f27[_0x330735(0x274)],JSON[_0x330735(0x1e1)](_0x17d020)),updateBookmarkButton(),_0x2f4f27[_0x330735(0x32a)](updateQuestionNav);}function updateBookmarkButton(){const _0x3f9522=_0x2a9a66,_0x364a4f={'mtnLD':'gradient-yellow\x20px-6\x20py-3\x20text-white\x20transition-all\x20duration-300\x20flex\x20items-center','tLrdy':_0x3f9522(0x42b),'GlLdq':_0x3f9522(0x271),'ZVYZT':_0x3f9522(0x23e)},_0x20cbda=document[_0x3f9522(0x41a)](_0x3f9522(0x305)),_0x5e7b94=document[_0x3f9522(0x41a)]('bookmarkText'),_0x178da5=questionStates[currentQuestionIndex][_0x3f9522(0x1b6)];_0x20cbda[_0x3f9522(0x26e)]=_0x178da5?_0x364a4f[_0x3f9522(0x3c8)]:_0x364a4f['tLrdy'],_0x5e7b94[_0x3f9522(0x342)]=_0x178da5?_0x364a4f[_0x3f9522(0x3f5)]:_0x364a4f[_0x3f9522(0x261)];}function toggleMarkForReview(){const _0x44c432=_0x2a9a66,_0x3dfc87={'POEts':function(_0x465ed2){return _0x465ed2();}};questionStates[currentQuestionIndex][_0x44c432(0x1c2)]=!questionStates[currentQuestionIndex][_0x44c432(0x1c2)],_0x3dfc87['POEts'](updateMarkReviewButton),_0x3dfc87[_0x44c432(0x197)](updateQuestionNav);}function updateMarkReviewButton(){const _0x2e5206=_0x2a9a66,_0x400492={'EBqDG':'markReviewBtn','gYLSt':_0x2e5206(0x356),'RzOzv':_0x2e5206(0x2e5),'HmMZK':'Marked'},_0x53ff07=document[_0x2e5206(0x41a)](_0x400492[_0x2e5206(0x375)]),_0x37f2c9=document[_0x2e5206(0x41a)](_0x400492[_0x2e5206(0x1a2)]),_0x26f5d7=questionStates[currentQuestionIndex][_0x2e5206(0x1c2)];_0x53ff07[_0x2e5206(0x26e)]=_0x26f5d7?_0x400492[_0x2e5206(0x212)]:_0x2e5206(0x1bd),_0x37f2c9['textContent']=_0x26f5d7?_0x400492['HmMZK']:_0x2e5206(0x262);}function previousQuestion(){const _0x457f4a=_0x2a9a66,_0x4f8332={'hGINv':function(_0x479402,_0x2d0623){return _0x479402-_0x2d0623;},'mitIz':function(_0x3173c6){return _0x3173c6();},'Czjuh':function(_0x39f999){return _0x39f999();}};currentQuestionIndex>0x0&&(questionStartTime&&(questionStates[currentQuestionIndex][_0x457f4a(0x1cf)]+=_0x4f8332[_0x457f4a(0x34e)](Date[_0x457f4a(0x1db)](),questionStartTime)),currentQuestionIndex--,_0x4f8332[_0x457f4a(0x36b)](displayQuestion),_0x4f8332['Czjuh'](saveProgress));}function nextQuestion(){const _0x28c657=_0x2a9a66,_0x301dc1={'dCdeV':function(_0x405224,_0x11f6d0){return _0x405224-_0x11f6d0;},'BDsNt':function(_0x35abd8){return _0x35abd8();},'FerkO':function(_0x3a8f7b,_0x3951dc){return _0x3a8f7b(_0x3951dc);},'TPVyS':function(_0x3e4cb7,_0x23b4bc){return _0x3e4cb7+_0x23b4bc;},'dEEPv':'return\x20(function()\x20','phvVp':'{}.constructor(\x22return\x20this\x22)(\x20)','efukm':function(_0x4f82a1,_0x597baa){return _0x4f82a1===_0x597baa;},'ZRRrV':_0x28c657(0x3ad),'udPTs':function(_0xe654ea){return _0xe654ea();},'ZLbOD':_0x28c657(0x381),'ZvdEh':function(_0x3f4b91,_0x3ed526){return _0x3f4b91===_0x3ed526;},'PEzIE':_0x28c657(0x17a),'KhbsT':_0x28c657(0x324),'hUKXJ':function(_0x42718a,_0x45fcee){return _0x42718a(_0x45fcee);},'waAde':'You\x20have\x20reached\x20the\x20end\x20of\x20the\x20quiz.\x20Would\x20you\x20like\x20to\x20submit\x20your\x20answers\x20now?','yDPCL':function(_0x46b4c0,_0x321338){return _0x46b4c0!==_0x321338;},'fuGRM':_0x28c657(0x2d5),'iDeXH':function(_0x3eb984,_0x37d237){return _0x3eb984===_0x37d237;},'DSKyH':_0x28c657(0x2e8),'qTNrL':'VNFwM','hlUdS':'You\x20have\x20completed\x20all\x20questions.\x20Would\x20you\x20like\x20to\x20review\x20from\x20the\x20beginning?','gYeRJ':function(_0x19f7d6){return _0x19f7d6();},'iToUE':function(_0x4a912e){return _0x4a912e();}};questionStartTime&&(_0x301dc1[_0x28c657(0x31c)](_0x301dc1[_0x28c657(0x1a8)],_0x301dc1[_0x28c657(0x1a8)])?questionStates[currentQuestionIndex][_0x28c657(0x1cf)]+=_0x301dc1[_0x28c657(0x3d1)](Date[_0x28c657(0x1db)](),questionStartTime):(_0x2ba36f&&(_0x12e625[_0xdc6403][_0x28c657(0x1cf)]+=_0x301dc1['dCdeV'](_0x1fd77b[_0x28c657(0x1db)](),_0x43aa0b)),_0x592942--,_0x78708a(),_0x301dc1[_0x28c657(0x3c5)](_0xad9cc9)));if(currentQuestionIndex<questionsData[_0x28c657(0x32e)]-0x1)currentQuestionIndex++,_0x301dc1['BDsNt'](displayQuestion),_0x301dc1[_0x28c657(0x2e6)](saveProgress);else{if(_0x301dc1[_0x28c657(0x316)]===_0x301dc1[_0x28c657(0x316)]){if(_0x301dc1[_0x28c657(0x39e)](currentMode,_0x301dc1[_0x28c657(0x1c5)])||_0x301dc1[_0x28c657(0x39e)](currentMode,_0x301dc1[_0x28c657(0x3f8)]))_0x301dc1[_0x28c657(0x38e)](confirm,_0x301dc1[_0x28c657(0x427)])&&(_0x301dc1[_0x28c657(0x2ef)](_0x28c657(0x39c),_0x301dc1[_0x28c657(0x2a6)])?_0x301dc1[_0x28c657(0x3c5)](submitQuiz):_0x1030f7=bcQTwi['FerkO'](_0x5c3abd,bcQTwi['TPVyS'](bcQTwi[_0x28c657(0x35b)],bcQTwi[_0x28c657(0x208)])+');')());else{if(_0x301dc1[_0x28c657(0x321)](_0x301dc1['DSKyH'],_0x301dc1['qTNrL'])){const _0x1c5ca3=_0x301dc1['FerkO'](_0x40d131,_0x56271f[_0x28c657(0x404)](_0x28c657(0x323)));_0x234fce(_0x1c5ca3);}else _0x301dc1[_0x28c657(0x38e)](confirm,_0x301dc1[_0x28c657(0x1c8)])&&(currentQuestionIndex=0x0,_0x301dc1[_0x28c657(0x2aa)](displayQuestion),_0x301dc1[_0x28c657(0x1f1)](saveProgress));}}else _0x2f5018=_0x4ae43e[_0x28c657(0x3df)](_0x31f626=>!(_0x31f626[_0x28c657(0x3d4)][_0x28c657(0x366)](_0x2b3529[_0x28c657(0x22d)]()[_0x28c657(0x30e)](/ /g,'-'))&&_0x31f626[_0x28c657(0x283)]===_0x1cf83a));}}function _0x233d(_0x2a9d9e,_0x19864b){const _0x3f5654=_0x4bb1();return _0x233d=function(_0x55e1bf,_0x9e9acd){_0x55e1bf=_0x55e1bf-0x16e;let _0x3e6d93=_0x3f5654[_0x55e1bf];return _0x3e6d93;},_0x233d(_0x2a9d9e,_0x19864b);}function startTimer(){const _0x18d036=_0x2a9a66,_0x31c2cf={'DmCVJ':function(_0x438d3d,_0xd385b6){return _0x438d3d(_0xd385b6);},'GQhIK':_0x18d036(0x2cd),'kKdfi':'custom_quiz.html','fZTNY':function(_0x27af30){return _0x27af30();},'CcTts':function(_0x394ef1){return _0x394ef1();},'JUrtO':'none','uCbym':function(_0xe0c376){return _0xe0c376();},'jQwuJ':_0x18d036(0x27d),'FenEW':'flex','MynMV':function(_0x443f65){return _0x443f65();},'tbgGX':function(_0x5a6ce0,_0x982201){return _0x5a6ce0<=_0x982201;},'hELKJ':function(_0x36318a,_0x3cd4da){return _0x36318a===_0x3cd4da;},'CYKlp':'WGLJy','wlQUb':'mnIxu','dGtmc':_0x18d036(0x3fb),'cYqoR':function(_0x375d14,_0x2673a6){return _0x375d14===_0x2673a6;},'BcJCH':_0x18d036(0x28d),'cKYKI':function(_0x43cae0){return _0x43cae0();},'vKgBc':function(_0x48cf28,_0x1f263d,_0x3ae7a8){return _0x48cf28(_0x1f263d,_0x3ae7a8);}};if(timer)clearInterval(timer);timeRemaining=0x78,_0x31c2cf[_0x18d036(0x3de)](updateTimerDisplay),timer=_0x31c2cf[_0x18d036(0x2bb)](setInterval,()=>{const _0x1dca08=_0x18d036,_0x1f199d={'kIRud':function(_0x1614fb){const _0xb6d1d3=_0x233d;return _0x31c2cf[_0xb6d1d3(0x3f0)](_0x1614fb);}};timeRemaining--,_0x31c2cf[_0x1dca08(0x3de)](updateTimerDisplay),_0x31c2cf[_0x1dca08(0x213)](timeRemaining,0x0)&&(_0x31c2cf[_0x1dca08(0x341)](_0x31c2cf[_0x1dca08(0x21e)],_0x31c2cf[_0x1dca08(0x21e)])?(clearInterval(timer),_0x31c2cf[_0x1dca08(0x341)](currentMode,_0x1dca08(0x324))?_0x31c2cf[_0x1dca08(0x17e)]!==_0x31c2cf[_0x1dca08(0x3e8)]?_0x31c2cf[_0x1dca08(0x3de)](submitQuiz):_0x31c2cf[_0x1dca08(0x24f)](_0x1de702,_0x31c2cf[_0x1dca08(0x3b5)])&&(_0x313766[_0x1dca08(0x1de)]['pathname']['endsWith'](_0x31c2cf[_0x1dca08(0x2ee)])&&_0x1c049e[_0x1dca08(0x301)](_0x1dca08(0x3eb)),_0x31c2cf[_0x1dca08(0x379)](_0x1f37b2),_0x1aa0c1[_0x1dca08(0x2d4)]()):_0x31c2cf['cYqoR'](_0x1dca08(0x25d),_0x31c2cf[_0x1dca08(0x291)])?(_0x1a9bf5=0x0,_0x3fecd5(),_0x1f199d[_0x1dca08(0x1e5)](_0xf3cd9f)):_0x31c2cf['cKYKI'](nextQuestion)):_0x31c2cf[_0x1dca08(0x3f0)](_0x438b67)?(_0x6b5a69['getElementById'](_0x1dca08(0x27d))[_0x1dca08(0x1f6)]['display']=_0x31c2cf[_0x1dca08(0x29a)],_0x15c461()):(_0x31c2cf[_0x1dca08(0x1c6)](_0x5a85bb),_0x3d326b[_0x1dca08(0x41a)](_0x31c2cf['jQwuJ'])[_0x1dca08(0x1f6)]['display']=_0x31c2cf[_0x1dca08(0x40d)]));},0x3e8);}function updateTimerDisplay(){const _0x58c10b=_0x2a9a66,_0x5d60e5={'PCurT':function(_0x4ed704,_0x3854a3){return _0x4ed704/_0x3854a3;},'ReHzC':function(_0x59b019,_0x33d7b1){return _0x59b019%_0x33d7b1;},'yGMgY':_0x58c10b(0x257),'Pjdhm':function(_0xb2dbea,_0x2ca504){return _0xb2dbea+_0x2ca504;},'ndzZP':function(_0x38db20,_0x280cfa){return _0x38db20+_0x280cfa;}},_0x31e00d=Math[_0x58c10b(0x334)](_0x5d60e5[_0x58c10b(0x3bd)](timeRemaining,0x3c)),_0x5395af=_0x5d60e5[_0x58c10b(0x400)](timeRemaining,0x3c);document[_0x58c10b(0x41a)](_0x5d60e5[_0x58c10b(0x408)])[_0x58c10b(0x342)]=_0x5d60e5[_0x58c10b(0x1c4)](_0x5d60e5[_0x58c10b(0x397)](_0x31e00d,':'),_0x5395af[_0x58c10b(0x1d2)]()[_0x58c10b(0x2f3)](0x2,'0'));}function toggleSidebar(){const _0x3c821e=_0x2a9a66,_0x169121={'WcRAM':'quizSidebar','IHYpB':_0x3c821e(0x328)};document[_0x3c821e(0x41a)](_0x169121[_0x3c821e(0x1b1)])[_0x3c821e(0x22e)][_0x3c821e(0x1fe)](_0x169121[_0x3c821e(0x351)]);}document[_0x2a9a66(0x1da)]('DOMContentLoaded',()=>{const _0x469ac7=_0x2a9a66,_0x15767b={'wqnUM':function(_0x13944b){return _0x13944b();},'cizLh':function(_0x1044f1){return _0x1044f1();},'OCWyU':_0x469ac7(0x2bf),'HEtFo':_0x469ac7(0x1ef),'zCeyC':_0x469ac7(0x26d),'CqyRI':'modeModal','dkLcV':_0x469ac7(0x216),'eNMqW':function(_0xe60c32){return _0xe60c32();}};if(resume)_0x15767b[_0x469ac7(0x1b0)](loadProgress)?(document[_0x469ac7(0x41a)]('modeModal')[_0x469ac7(0x1f6)]['display']=_0x15767b[_0x469ac7(0x3cd)],_0x15767b['wqnUM'](initializeQuiz)):(clearProgress(),document[_0x469ac7(0x41a)](_0x469ac7(0x27d))[_0x469ac7(0x1f6)][_0x469ac7(0x33c)]=_0x15767b[_0x469ac7(0x20e)]);else!window[_0x469ac7(0x1de)][_0x469ac7(0x195)][_0x469ac7(0x2b6)](_0x15767b[_0x469ac7(0x19b)])?(_0x15767b[_0x469ac7(0x1b0)](clearProgress),document[_0x469ac7(0x41a)](_0x15767b[_0x469ac7(0x353)])[_0x469ac7(0x1f6)]['display']=_0x15767b[_0x469ac7(0x20e)]):_0x469ac7(0x216)!==_0x15767b[_0x469ac7(0x391)]?_0x15767b[_0x469ac7(0x2e0)](_0x251b9e):_0x15767b[_0x469ac7(0x338)](initializeQuiz);}),document[_0x2a9a66(0x1da)]('keydown',function(_0x203c75){const _0xc55b47=_0x2a9a66,_0x277f35={'OVLMD':function(_0x12fafd){return _0x12fafd();},'CTrAe':function(_0x1fcde0,_0x50f330){return _0x1fcde0===_0x50f330;},'zXGeW':_0xc55b47(0x1ed),'CXzAw':function(_0x55dc58,_0x64f16e){return _0x55dc58>=_0x64f16e;},'udbCE':function(_0x2eb939,_0x389c26){return _0x2eb939<=_0x389c26;},'oQajP':function(_0xdf745a,_0x5cb0b8){return _0xdf745a-_0x5cb0b8;},'SIDkg':function(_0x53a09c,_0x2b898b){return _0x53a09c(_0x2b898b);},'UDFTh':_0xc55b47(0x21c),'CUwFG':function(_0x5ea948,_0x44059e){return _0x5ea948<_0x44059e;},'DDNRS':'ArrowLeft','EGgWn':function(_0x580d47,_0x550cb5){return _0x580d47===_0x550cb5;},'tYutm':_0xc55b47(0x412),'utazd':'timed_study','ayuud':function(_0x4fa11d,_0x67dbb7){return _0x4fa11d===_0x67dbb7;},'TRKTE':_0xc55b47(0x17a),'pEJam':_0xc55b47(0x324),'uywLb':function(_0x4d1d31,_0x5036f1){return _0x4d1d31!==_0x5036f1;},'jyYac':_0xc55b47(0x1fa)};if(document['getElementById']('modeModal')[_0xc55b47(0x1f6)][_0xc55b47(0x33c)]!==_0xc55b47(0x2bf))return;if(_0x277f35[_0xc55b47(0x39f)](document[_0xc55b47(0x41a)](_0xc55b47(0x28f))[_0xc55b47(0x22e)]['contains'](_0x277f35[_0xc55b47(0x2f4)]),![]))return;if(_0x277f35[_0xc55b47(0x29f)](_0x203c75[_0xc55b47(0x2f5)],'1')&&_0x277f35[_0xc55b47(0x41e)](_0x203c75[_0xc55b47(0x2f5)],'4')){const _0x3c5e45=_0x277f35[_0xc55b47(0x281)](_0x277f35[_0xc55b47(0x3dc)](parseInt,_0x203c75[_0xc55b47(0x2f5)]),0x1),_0xffec7e=document[_0xc55b47(0x252)](_0x277f35['UDFTh']);if(_0x277f35[_0xc55b47(0x2a8)](_0x3c5e45,_0xffec7e[_0xc55b47(0x32e)]))selectOption(_0x3c5e45);}else{if(_0x277f35[_0xc55b47(0x39f)](_0x203c75['key'],_0x277f35[_0xc55b47(0x2a0)]))previousQuestion();else{if(_0x277f35[_0xc55b47(0x368)](_0x203c75[_0xc55b47(0x2f5)],_0x277f35[_0xc55b47(0x369)])||_0x277f35[_0xc55b47(0x39f)](_0x203c75['key'],'\x20'))_0x203c75[_0xc55b47(0x33e)](),_0x277f35[_0xc55b47(0x2be)](nextQuestion);else{if(_0x277f35[_0xc55b47(0x39f)](_0x203c75[_0xc55b47(0x2f5)][_0xc55b47(0x22d)](),'b')&&(_0x277f35[_0xc55b47(0x368)](currentMode,_0xc55b47(0x333))||currentMode===_0x277f35[_0xc55b47(0x233)]))_0x277f35[_0xc55b47(0x2be)](toggleBookmark);else{if(_0x277f35['EGgWn'](_0x203c75['key']['toLowerCase'](),'m')&&(_0x277f35[_0xc55b47(0x3ba)](currentMode,_0x277f35['TRKTE'])||_0x277f35[_0xc55b47(0x368)](currentMode,'timed_exam')))_0x277f35['OVLMD'](toggleMarkForReview);else _0x203c75[_0xc55b47(0x2f5)][_0xc55b47(0x22d)]()==='s'&&(currentMode===_0xc55b47(0x17a)||_0x277f35[_0xc55b47(0x39f)](currentMode,_0x277f35[_0xc55b47(0x265)]))&&(_0x277f35['uywLb'](_0x277f35[_0xc55b47(0x2b8)],_0x277f35[_0xc55b47(0x2b8)])?_0x277f35[_0xc55b47(0x2be)](_0x211169):submitQuiz());}}}}});</script>

</body></html>